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Abstract
Oxidoreductases play pivotal roles in energy capturing and converting processes of life. During these
processes, quinones shuttle protons and reducing equivalents between membrane-bound
oxidoreductases that generate the proton motive force during oxidative phosphorylation and
photophosphorylation. A key mechanistic feature of these oxidoreductases is their ability to tune the
reduction potentials of the hydroquinone, semiquinone and oxidized states of their substrate quinones.
This level of control allows for maximization of conversion efficiency between the energy of the quinone
reducing equivalents and the proton motive force, and prevents side reactions that may be fatal to cells. A
half-century of experimental study and computational modeling of the respiratory and photosynthetic
complexes has revealed little information on how this mechanistic control is accomplished. To obtain
mechanistic insights into the control process, it is necessary to eliminate the biological complexity
intrinsic to natural quinone oxidoreductases and create experimental systems that are simplified
maquettes of quinone active sites. In this work, development of a naphthoquinone amino acid (Naq),
modeled after vitamin K, allowed the creation of a range of quinone peptide maquettes designed to
address uncertain mechanistic details of biological quinone control. In a simple heptamer, Naq acquires
properties of quinone cofactors found in the three distinct classes of active sites of membrane
oxidoreductases under different experimental conditions. Study of Naq in a lanthanide ion binding EF
hand peptide allowed observation of the effect of a structural transition from coil to alpha-helix on the
aqueous midpoint potential of Naq and measurement of the rate of electron transfer between reduced
and oxidized Naq. Naq was also incorporated into a structured miniprotein based upon the TrpCage using
a combination of the SCADS computational approach and iterative redesign by hand, creating a simple
scaffold for evaluating effects of changing the local environment on Naq. Finally, using expressed protein
ligation, Naq was incorporated into a single chain heme-binding maquette. Studies using this multicofactor protein to explore electron transfer reactions to and from Naq like those critical to respiration
and photosynthesis are underway.
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ABSTRACT
A NEW APROACH TO UNDERSTANDING BIOLOGICAL CONTROL OF QUINONE
ELECTROCHEMISTRY
Bruce R. Lichtenstein
Advisor: P. Leslie Dutton
Oxidoreductases play pivotal roles in energy capturing and converting processes of life.
During these processes, quinones shuttle protons and reducing equivalents between
membrane-bound oxidoreductases that generate the proton motive force during oxidative
phosphorylation and photophosphorylation. A key mechanistic feature of these
oxidoreductases is their ability to tune the reduction potentials of the hydroquinone,
semiquinone and oxidized states of their substrate quinones. This level of control allows for
maximization of conversion efficiency between the energy of the quinone reducing
equivalents and the proton motive force, and prevents side reactions that may be fatal to
cells. A half-century of experimental study and computational modeling of the respiratory
and photosynthetic complexes has revealed little information on how this mechanistic
control is accomplished. To obtain mechanistic insights into the control process, it is
necessary to eliminate the biological complexity intrinsic to natural quinone oxidoreductases
and create experimental systems that are simplified maquettes of quinone active sites. In this
work, development of a naphthoquinone amino acid (Naq), modeled after vitamin K,
allowed the creation of a range of quinone peptide maquettes designed to address uncertain
mechanistic details of biological quinone control. In a simple heptamer, Naq acquires
properties of quinone cofactors found in the three distinct classes of active sites of
membrane oxidoreductases under different experimental conditions. Study of Naq in a
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lanthanide ion binding EF hand peptide allowed observation of the effect of a structural
transition from coil to alpha-helix on the aqueous midpoint potential of Naq and
measurement of the rate of electron transfer between reduced and oxidized Naq. Naq was
also incorporated into a structured miniprotein based upon the TrpCage using a
combination of the SCADS computational approach and iterative redesign by hand, creating
a simple scaffold for evaluating effects of changing the local environment on Naq. Finally,
using expressed protein ligation, Naq was incorporated into a single chain heme-binding
maquette. Studies using this multi-cofactor protein to explore electron transfer reactions to
and from Naq like those critical to respiration and photosynthesis are underway.
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Chapter 1: Introduction

1.1 Quinones
All known life depends upon the generation of a chemical gradient across a
membrane. Chemiosmosis of protons across membranes in every known cellular life form is
used to drive the production of ATP and all of the cellular functions dependent upon it.
Prior to the chemiosmotic hypothesis, it was generally believed that photosynthesis and
respiration produced a high-energy intermediate leading to ATP synthesis. When Mitchell
originally theorized the possibility that proton translocation across a membrane could effect
the same action as the proposed intermediate, there was no clear mechanism or species by
which the so-called proton motive force could be generated. Eventually however, it became
clear that the lipophilic quinone cofactors which were known to be involved in electron
transport as substrates for various respiratory complexes were both the proton and electron
carrier driving a large part of chemiosmosis.3-5
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The quinones are a diverse class of
biological redox molecules implicated in
everything from the electron transfer
pathways of photosynthesis and respiration
to catalysis of critical reactions in the cross
linking of interstitial tissue and alternative
metabolic pathways6-8 to antibacterial and
antigenic quinones used in a broad array of
biological defense mechanisms.9,10 This

Figure 1.1. Genetic para- and ortho-quinones
showing two electron, two-proton redox chemistry
common at physiological pH.

	
   expansive utility comes from modifications
around a quinone core; loosely defined as a
cyclic, fully conjugated dione which can

alternate between aromatic and non-aromatic forms in a two-electron (and often, two
proton) reaction. Differing only in the placement of the ketone/hydroxyl substituents, the
para-quinone and ortho-quinone isomers, Figure 1.1, are used in very different manners in
nature. para-Quinones, like those found in the membranes of mitochondria and chloroplasts,
Figure 1.2, are principally involved in electron transport in the generation of the proton
motive force that ultimately drives ATP synthesis. Vitamin K, a naphthoquinone, is a
notable exception as a critical cofactor in the Vitamin K dependent carboxylases.6,7,11. As will
be discussed in more detail in Chapter 2, the common ortho-quinone cofactors derived from
amino acids in situ in the quinoprotein family, Figure 1.2, also act directly on substrates
including glucose,12,13 methanol,14 and lysine.15 The reasons behind the functional segregation
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of para- and ortho- quinones in nature is not clear, but it might indicate a general need for
ortho- positioned ketones to allow quinones to effect substrate level redox transformations.

Figure 1.2. Natural quinone cofactors. PQQ, pyrroloquinoline quinone; TPQ, topaquinone; LTQ, lysine
tyrosylquinone; TTQ, tryptophan tryptophylquinone; CTQ, cysteine tryptophylquinone.
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1.1.1 Quinone Electrochemistry
Quinones are almost universally
capable of being reduced by two
electrons and concomitantly acquiring
two protons. This generates nine
possible redox states, Figure 1.3. In
solution at physiological pH, most

Figure 1.3. The nine redox states of quinones shown
with 2-methyl-1,4-naphthoquinone’s redox couples.2
Values in parentheses are educated guesses or
calculated from educated guesses. All known natural
proteins make use of the states indicated in bold.

	
  

quinones are reduced from the fully
oxidized quinone form to the fully
reduced, fully protonated hydroquinone
in a concerted two-electron, two-

proton reaction.16 Deviations from this behavior, however, can be observed if the typically
unstable single electron semiquinone state is somehow stabilized. The stability of a
semiquinone is a measure of the likelihood that a quinone and a hydroquinone colliding in
solution will react to produce two semiquinones

K stab
•


Q + QH 2 

 2SQ
where Q, QH2 and SQ• are the fully oxidized, fully reduced and singly reduced species,
respectively, without consideration of their protonation state. The energetic gauge of a
semiquinone’s stability is simply the free energy of this reaction
ΔG = −RT ln(K stab ) = −FEm ( Q → SQ i ) + FEm (SQ i → QH 2 )
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where F is Faraday’s constant, Em ( Q → SQ i ) and Em (SQ i → QH 2 ) are the midpoint
potentials for the half-cell reactions indicated in the parentheses, and K stab is the equilibrium
constant for this reaction
K stab =

[SQ i ]2
.
[ QH 2 ][ Q]

Kstab is a measure of the stability of the semiquinone; the greater the Kstab the more
semiquinone will be present at a given pH and potential. At neutral pH in aqueous solutions,
most quinones have a very low semiquinone stability (Kstab<10-3) thus become reduced in a
concerted manner. 17

1.2 Biological Control of
Quinone Electrochemistry
While most quinones are
reduced in a concerted twoelectron, two-proton reaction at
physiological conditions, natural
	
  

Figure 1.4. Natural quinone oxidoreductases classes (orange,
teal, and purple) in relation to semiquinone stability (log(Kstab))
of quinones in active sites. Also shown (black lines) is the
relation of redox potential of the semiquinone redox couples to
log(Kstab). Observed log(Kstab) in DMF and water at various pHs
are indicated. Figure after Ding et al.1

quinone oxidoreductases are not
limited to alternating between the
quinone and fully reduced, fully
protonated hydroquinone state at

their active sites. Through an array of poorly understood mechanisms, the active sites of
quinone oxidoreductases selectively stabilize certain of the nine redox states seen in Figure
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1.3. The active sites can be broken down into three broad classes, Figure 1.4. Quinones in
Qo-type sites, like that in bc1, show semiquinone stabilities similar to those seen in water and
are typically found with multiple cofactors nearby to allow concerted uptake or release of
electrons and protons.18-21 Quinones in Qi-type sites, also found in bc1, have semiquinone
stabilities much closer to parity and thus can form the single electron state on the way to
being fully reduced. Unlike the Qo-type sites, there is no need for multiple nearby cofactors
since electrons can go onto or off of a quinone in the site one at a time. Finally, quinones in
QA-type sites in bacterial photosynthetic reaction centers demonstrate highly stabilized
semiquinones, but cannot be doubly reduced under most circumstance. Quinones in these
sites are typically involved in the first electron transfer steps after photo-oxidation of water
and thus need to have very low potentials and only transiently hold electrons.22,23
While the differentiation of the active sites of quinone oxidoreductases demonstrate
a 1 V (23 kcal mol-1) difference in the stability of the semiquinone, there is little known about
the actual mechanisms of control. Recent theoretical treatments24-26 have added to the
understanding of the interplay between protein environment and active site quinones with
particular focus on pKa and electrostatic effects, but have yet to clarify a great deal of the
mechanistic ambiguity. Most experimental approaches have focused on mutational studies of
the readily modified and studied bacterial reaction centers that, while providing a rough
sketch of factors involved in controlling protonation and electrostatic drivers of quinone
properties, have not been particularly well suited to giving a broad view, especially of the Qotype sites.22,23 In contrast, most of what is known about how quinones are likely to operate in
natural systems comes from aqueous solution studies performed thirty years ago.16,27,28 In
addition, studies of quinone properties in organic solvents have expanded understanding of
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the role of structural modifications on their electrochemistry29-31 as well as revealing a great
deal about the effects of hydrogen bonding and electrostatic interactions on quinone redox
properties and electron transfer rates.32-35 Despite the fact that these studies have increased
understanding of physical-chemical attributes of quinones, they are of little immediate utility
in determining the manner in which biological control is manifest as quinone properties
change radically between protic and aprotic mediums.
The nature of the divergent activities of quinones in the active sites of membrane
oxidoreductases remains an open question. Further, the interplay of quinone electrochemical
properties and active site architecture in producing productive vectorial electron transfer
reactions is not fully understood.21 Due to the experimental limitations of mutagenic studies
on complex multisubunit proteins, it is not clear whether continued systematic study of the
respiratory and photosynthetic complexes will yield any additional insights into the
mechanisms of control. Rather, a new approach may be needed that carries the advantages
of the small molecule studies in water and organic solvents, but maintains the structural and
architectural diversity of peptide polymers. The non-natural protein maquettes were
originally developed to explore the mechanisms of control of the redox properties of heme
binding sites in membrane oxidoreductases.36 Removed from the complex overlapping
functions of the primary sequence of amino acids in any naturally evolved protein, the
maquettes have been used to simplify the study of a growing set of cofactors in a protein
environment,36-53 including quinones as will be discussed in detail in Chapter 2.54-57 Maquettes
are not limited to incorporating single cofactors,49 and provide an unprecedented
opportunity to construct electron transfer active sites that emulate the function of natural
oxidoreductase active sites. In seeking to understand the natural engineering principles
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guiding biological mechanisms of quinone electrochemical control and oxidoreductase
quinone active site design, it is clear that the development of a quinone maquette family
would greatly expand the cache of tools that can be brought to bear on this pursuit.
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Chapter 2: Design, Development and Exploration of a New
Naphthoquinone Cofactor

2.1 Introduction
It is somewhat remarkable that no generic, well-defined motif for quinone binding
exists across the many various quinone oxidoreductases associated with metabolism,
respiration and photosynthesis. While a weak motif was identified that was mildly predictive
of Qi-type sites,2 it is apparent that the conserved amino acids in the preserved sequences are
mostly important for increased semiquinone stability rather than direct and generic binding
of the quinone head group or common phytyl tails which offer very little in the way of
specific contacts. It is interesting to consider that specificity might not actually be
biologically essential in energy converting protein complexes, and in fact it may have been
selected against in organisms capable of using various quinone cofactors under different
metabolic conditions.
This lack of a well-defined quinone-binding motif precludes the adoption of a
conserved sequence to create a quinone-binding site in a maquette. However, nature has
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circumvented the need for binding specificity by making use of covalent quinone cofactors
generated in situ from amino acids in the primary sequence of proteins. These so called
quinoproteins are a relatively new class of alternative oxidoreductases that perform a variety
of biological substrate level redox functions normally associated with enzymes that use flavin
and nicotinamide cofactors, for instance, in amine oxidases and alcohol dehydrogenases,
amongst others. Discovered in 1979 with the identification of the PQQ soluble cofactor, a
variety of post-translationally generated quinone cofactors have been described, Figure 2.1.3-7
The mechanism of maturation of the cofactor generically involves oxidation and
simultaneous covalent modification of either tyrosine or tryptophan.8 However, the detailed
mechanisms for cofactor generation vary widely. The major biosynthetic route to tyrosinederived cofactors appears to involve direct oxidation of the source aromatic residue with
molecular oxygen in an autocatalytic copper-dependent manner.8 The mechanisms for
formation of tryptophan-derived cofactors are seemingly more complex, requiring the
involvement of heme-containing maturation oxidoreductases for formation of the TTQ
cofactor9 and a variety of chaperons for formation of the CTQ cofactor.10
While the inclusion of a fully self-maturing quinone cofactor would obviously be an
ideal approach to developing a quinone-containing maquette, it would require mimicry of the
natural quinoproteins. The extent of the mimicry would prevent full control and thus
understanding of the effects of the cofactor’s environment on the quinone redox chemistry,
a crucial piece of knowledge still broadly lacking. Rather, the inspiration gained from nature’s
use of covalent quinone-amino acids suggests another possibility: the use of a natural or
synthetic quinone amino acid in the primary sequence of the protein maquette. In fact, one
such natural amino acid exists, L-3,4-dihydroxyphenylalanine (DOPA), Figure 2.1,
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Figure 2.1. Naturally occurring quinone cofactors derived from amino acids. PQQ, pyrroloquinoline
quinone; TPQ, topaquinone; LTQ, lysine tyrosylquinone; TTQ, tryptophan tryptophylquinone; CTQ,
cysteine tryptophylquinone.

	
  

commonly used as a treatment for Parkinson’s disease, and is, importantly, a likely
intermediate in the spontaneous formation of the TPQ and LTQ cofactors in both natural8
and fortuitously generated quinoproteins.11
In work concurrent with that reported here, the Schultz group evolved a tRNAaminoacyl tRNA-synthetase pair for in vivo incorporation DOPA into sperm whale
myoglobin revealing limitedly explored changes in the redox chemistry of the DOPA amino
acid and the heme.12 The Stubbe group subsequently reported the semisynthesis of
ribonucleotide reductase (RNR) β2-subunit with a DOPA amino acid incorporated into a
synthetic fragment in the place of a tyrosine suspected of playing a critical role in the
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prevalent radical hoping mechanism.13 Unsurprisingly, they observed that stabilization of a
radical at the tyrosine position quenched nucleotide reduction. In addition, the formation of
the DOPA radical (with concomitant reduction of the crucial diferric-tyrosyl radical
cofactor) was dependent upon the presence of an allosteric effector and/or substrate in the
full α2/β2 complex, and occurred with kinetics similar to that observed in the intein
generated wild type protein. The maintenance of a ligand response and competent kinetics
suggests that the DOPA radical (and presumably the wild type tyrosine radical) is located
along the radical propagation pathway. Stubbe and Schultz then collaborated on the in vivo
incorporation of higher potential DOPA analogs at other sites in RNR providing insights
into a potential hydrogen abstraction mechanism as a basis for catalysis at the nucleotide
reduction active site,14 and other groups followed.15-18 While DOPA provides an important
precedent for both in vivo and semisynthetic incorporation of a redox active quinone amino
acid, its redox potential (~570 mV vs. NHE at pH 7.0)13 places it outside of the useful
biological range for most energy conserving electron transfer reactions. It is also revealing
that later groups used DOPA to allow for site specific redox activated cross linking, a
creative use of the DOPA quinone form’s intrinsic reactivity towards nucleophiles. This high
reactivity in the oxidized form limits the useful lifetime of proteins in which it is
incorporated and further reduces DOPA’s appeal as a candidate for incorporation into
quinone maquettes.
The electrophilicity of quinones arises from the presence of multiple Michael centers
around the quinone ring in addition to the slight tendency for Schiff-base formation at the
quinone carbonyls. In quinones with unsubstituted Michael centers, there is a well-known
reaction that can occur with sufficiently nucleophilic atoms, such as the sulfur of cysteine,
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Scheme 2.1, which results in a covalent bond and preservation of quinone redox function.
This reaction provides the basis for another approach to covalently binding quinones to
proteins. Recent efforts, simultaneous to the work presented here, have extended this
technique to natural19 and synthetic20,21 proteins by reacting a cysteine with quinones having
at least one unsubstituted Michael center. This technique is robust and allows for the
incorporation of a diverse array of quinone head groups at a single cysteine site. The
application of this approach has produced a rudimentary model of early mechanistic stages
of photosynthesis in cytochrome b562, notably a four-helix bundle, demonstrating light
induced electron transfer between a zinc chlorin and a quinone,19 as well as probative studies
on the effects of a protein environment on the incorporated quinone.21,22
Scheme 2.1. Covalent modification of peptide-incorporated cysteine by 1,4-naphthoquinone

The ease of use and expansive opportunities for quinone head group substitutions
makes the cysteine substitution technique quite attractive from a design standpoint, but it is
not without limitations. The need for a covalent linkage between the quinone head group
and cysteine gives the conjugate amino acid a great deal of rotational flexibility due to the
presence of three bonds between the backbone and quinone. The subsequent lack of a welldefined and small set of rotamers may explain the loss of apparent singular structure in a
four-helix bundle modified by a quinone from the work of Haehnel.20 In addition, although
Wydrzynski reports only a small change in midpoint potential (25 mV) of the ubiquinone-0
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head group upon binding and being buried in cytochrome b562 compared to solution,
Haehnel and Tommos observe massive changes in redox potentials (both groups, at least
+110 mV)21,22 and apparent pKas (-3.4 pH units in Tommos’ laboratory).22 Intriguingly, in
both the Haehnel and Tommos proteins there are nearby (i->i+4) positively charged
residues (lysine or arginine) in the primary sequence suggesting that perhaps there are cationpi interactions between the quinone headgroups and the local positively charged residue side
chains. However, the values regularly measured for cation-pi interactions (-0.9 kcal/mol
between a tryptophan and lysine residue in a closely related protein to the one used in
Tommos’ work)23 are not sufficiently energetic to fully account for the changes observed (0.9
kcal/mol is 20 mV for a two electron center). Further, the data for small molecule models of
the cysteine ligation products show either small20 or large22 variations in potentials from the
free quinones. This unanticipated and inexplicable irregularity in the electrochemical
properties of the covalently attached quinones are incredibly interesting, but suggest that this
approach might not be conducive to constructing advanced quinone maquettes where the
redox chemistry of the cofactors is somewhat predictable.

2.2 Design of a New Quinone Cofactor
The work described above provides a general framework for the desired features of a
quinone cofactor whose incorporation into maquettes will allow systematic study of the
effect of protein environment on quinone chemistry. In the need to create functional models
of the critical reactions of photosynthesis and respiration, the primary consideration is the
redox chemistry of the quinone cofactor. The midpoint potentials of the ortho-quinones, like
DOPA, are generally much higher than their para-quinone equivalents. Indeed, in the low
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potential reactions of respiration and photosynthesis, none of the quinone cofactors are
ortho-quinones. In addition to affording redox chemistry closer to that observed in the major
natural quinone oxidoreductases, developing a para-quinone cofactor has the distinct
advantage of implicitly increasing the chemical stability of the oxidized form, thereby
avoiding the cross-linking chemistry demonstrated by DOPA, while providing a functional
group whose redox chemistry is more in line with natural systems.
Nevertheless, para-quinones are quite reactive at their unsubstituted Michael centers,
so it is important that as many of the electrophilic sites around the new cofactor’s quinone
ring are substituted to reduce its reactivity. In the quinones used in respiration and
photosynthesis, both the naphthoquinone core of menaquinone (Vitamin K) and the
benzoquinone core of ubiquinone, Figure 2.2, have all of their Michael centers substituted.
Lacking the methoxy substitutions of ubiquinone, the naphthoquinone head group of
menaquinone is more robust, and in principle, provides an easier synthetic target making it
the obvious choice for the functionality of the new quinone cofactor.

Figure 2.2. Membrane soluble para-quinone cofactors used in respiration and photosynthesis

As previously noted, the Haehnel group has developed a four-helix bundle
containing a naphthoquinone-modified cysteine,20 but this attachment scheme provides
limited control over the position of the quinone head group and lacks consistent
electrochemical behavior.19-22 It seems more prudent to create a naphthoquinone cofactor
17	
  
	
  

	
  

Figure 2.3. Possible backbone connectivity regiomers of the naphthoquinone amino acid (A-C) and the
final design (D); see text for details.

	
  
that is attached to the peptide backbone with a single bridging methylene, much like
tryptophan or tyrosine. The comparison of the double ringed naphthoquinone side chain to
tryptophan is apt, and of the three possible naphthoquinone side chains with methyl
substituted Michael centers, Figure 2.3A-C, the only side chain which closely approximates
the indole ring of tryptophan’s steric bulk is the one in which the backbone is bridged by a
methylene to the quinone side of the naphthalene ring, Figure 2.3C. While the proximity of
the naphthoquinone core to the backbone might prove somewhat disruptive of secondary
structure, its likely benefits are much larger, giving us the opportunity to place the quinone
headgroup with better knowledge of its location relative to the remainder of the protein as
compared to the quinone-modified cysteine cofactors. However, in order to partially address
the possible disruption of secondary structure by reducing the steric volume of the
naphthoquinone amino acid near the backbone and bringing its overall geometry closer to
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that of tryptophan, sacrificing some amount of chemical stability proves necessary.
Unblocking the non-methylene bridged Michael center accomplishes this goal, Figure 2.3D.
The design of the naphthoquinone amino acid, abbreviated Naq or Ϙ, takes into
consideration the likely structural constraints of a protein environment. Trimming the side
chain to give Naq a steric bulk similar to that of tryptophan in theory provides enough
leeway so that the naphthoquinone amino acid can be incorporated into virtually any protein
element which tryptophan can be incorporated. The fact that the target design for Naq is
modeled on a standard aromatic α-amino acid provides it with substantial conformational
rigidity lacking in the cysteine-bridged quinone cofactors, and actually approximates the main
chain side of the natural quinone cofactor amino acid TPQ, Figure 2.1. Finally, the pursuit of
a naphthoquinone amino acid provides the best opportunity for developing a cofactor
whose redox activity and general reactivity fall within the same range as those of natural
quinone cofactors. This is necessary for fully emulating quinone-dependent respiration and
photosynthetic reactions in new quinone maquettes.
The useful monomeric form of the naphthoquinone amino acid, Naq, does not
resemble the image in Figure 2.3D. To fully realize the incorporation of Naq into maquettes,
it is necessary to create a backbone-protected version to be used in peptide synthesis.
Additionally, the primary peptide synthesis chemistry used in the Dutton laboratory is based
upon the base labile 9-fluorenylmetyhyloxycarbonyl (Fmoc) amine-protecting group so the
final desired form of Naq has the main chain amine Fmoc-protected and the carboxylate free
to be activated for peptide chain extension.
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Scheme 2.2. Generic electrophilic aromatic amino acid synthesis (A). The O’Donnell asymmetric amino
acid synthesis (B)

2.3 Synthesis of Naq, the Naphthoquinone Amino Acid
The synthesis of Naq and characterization of heptaNaq found in the remaining
sections of this chapter has been published already by Lichtenstein et al.24
The naphthoquinone amino acid, Naq, in some ways resembles a standard aromatic
amino acid, like tryptophan, tyrosine or phenylalanine. This is especially true in its reduced
form where Naq is nearly isosteric to the artificial amino acid L-2-naphthalanine. The
chemical syntheses of natural and artificial aromatic α-amino acids typically take advantage
of the high electrophilicity of aryl-alkyl halides to form the bond between the final amino
acid’s α-carbon and β-carbon, derived from the formerly halogenated aryl-alkyl methylene,
Scheme 2.2A. The new bond creates a chiral center at the α-carbon, and unless the reaction
is highly asymmetric, the mixture of enantiomers would need to be separated to yield only
the desired L-amino acid. Though synthesis literature abounds with amino acid synthesis
examples dating back to Strecker in the mid-19th century, perhaps the most common
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currently used highly enantioselective amino acid synthesis is based upon work by
O’Donnell et al.25 Reaction of a bulky glycine tert-butyl ester, whose α-protons are rendered
more acidic by the modification of the glycine amine to a benzophenone imine, with an
electrophile in the presence of a base and an alkaloid chiral phase transfer catalyst yields the
electrophile substituted amino acid derivative in high enantiomeric excess, Scheme 2.2B. In
most of the literature using this technique, the free amino acid is released under aqueous
acidic conditions; though unreported, it is in principle also possible to remove both the
benzophenone imine and tert-butyl ester under nucleophilic basic conditions. The simplicity
and scalability of the O’Donnell approach made it an attractive synthetic transformation for
the centerpiece of the synthesis of Naq.

2.3.1 Side Chain Protecting Groups
It was clear that to make use of the O’Donnell amino acid synthesis the desired
naphthoquinone side chain needed to be in an aryl-alkyl halongenated form such as 1,4dihydroxy-2-bromomethylnaphthalene, Figure 2.4, a compound very unlikely to be stable
due to direct conjugation of the 1-position hydroxyl with a hypothetical cation formed from
elimination of the bromide at the 2-position methylene. Indeed, the synthesis of the
naphthoquinone amino acid needed
to be designed around maintenance
of the quinone functionality through
various
	
  

	
  

conditions

the

cofactor was likely to be exposed. In

Figure 2.4. 1,4-Dihydroxy-2-bromomethylnapthalene
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designing Naq, the focus was on

making sure the cofactor had the best possibly chance at demonstrating redox activity over a
useful pH and electrochemical range in aqueous solution. Little, if any, consideration was
made as to how to best effect the final design and the stability of the monomeric cofactor in
non-aqueous environments most often employed during synthetic transformations.
Quinones are notoriously reactive. From uncontrolled polymerization to the
eletrophilicity highlighted in earlier sections of this chapter, the best possible synthetic design
to avoid these issues would take into consideration the fact that the reduced form is more
stable in general, and that if redox cycling between the reduced and oxidized forms can be
limited or stopped, the likelihood of successful synthetic transformations is far higher. The
most straightforward method to obtain a naphthoquinone aryl-alkyl bromide that meets the
above criteria is to acylate reduced 1,4-methylnaphtoquinone with acetic anhydride (Ac2O)
followed by bromination under radical conditions, Scheme 2.3.26 Unfortunately, the acetyl
groups are readily hydrolyzed, and, in considering further transformations, especially during
peptide synthesis, the reactivity of acyl-aryl alcohols towards generic nucleophiles suggested
that the naphthoquinone would not survive the synthesis. Instead, protecting groups that are
more robust are needed.

Scheme 2.3. Synthesis of a naphthoquinone derived aryl-alkyl bromide.
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Initial approaches to generating a protected naphthoquinone side chain capable of
being transformed into an aryl-alkyl bromide focused on acid labile protecting groups that
would remain attached during both the remainder of the amino acid synthesis and peptide
synthesis. Deprotection of the naphthoquinone amino acid side chain could then be effected
under the common acidic trifluoroacetic acid/scavengers conditions used in Fmoc/tBu
peptide synthesis. It was hoped that basic conditions could be used in removing the
benzophenone imine and tert-butyl group needed in the asymmetric O’Donnell synthesis.25
Early attempts to form the tert-butyl ethers, commonly used to protect the tyrosine hydroxyl
in peptide synthesis, proved fruitless and so more readily installed acid labile groups were
pursued. To this end the acid labile methoxymethyl and menthoxymethyl ethers of 1,4dihydroxy-2-metyhlnaphthalene were generated under basic conditions with chloromethyl
methyl ether and (-)-chloromethyl menthyl ether, respectively, Scheme 2.4. It was predicted
that the chiral menthoxymethyl ether could ease separation of the L- and D- amino acids
potentially formed during the amino acid synthesis reaction by merit of creation of nonequivalent diastereomers. Unfortunately, all attempts to brominate the 2-methyl under

Scheme 2.4. Loss of naphthoquinone protecting groups upon oxidation.
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radical conditions with N-bromosuccinamide (NBS) failed to form the desired aryl-alkyl
ether, and resulted in both loss of the protecting groups and re-oxidation of the quinone,
Scheme 2.4. This was due in large part, no doubt, to the oxidative conditions commonly
used for the radical brominations. This observation led to the discovery of a critical literature
report in which the use of moderate hypervalent iodide(III) oxidants allowed the
deprotection/activation of quinones from the methyl ether protected forms.27
The abject failure of the radical bromination to produce useful products for
continued transformations led to a rethinking in the general approach to the aryl-alkyl
bromide. Instead of using a radical-based bromination, it is possible to convert aryl-alkylalcohols to their respective bromides under non-oxidative conditions using phosphorus
tribromide, or equivalent reagent. There are several methods to obtain the arylhydroxymethyl needed for this conversion. There is a literature method in which a methyl
ether protected hydroquinone is reacted with dimethylformamide in the presence of the
dehydrating agent phosphorous oxychloride to yield the formylated quinone, Scheme 2.5.28
Subsequent reduction affords the desired alcohol. However, this transformation actually
involves four steps starting with the highly reactive 1,4-naphthoquinone, and it seemed more
straightforward to start with the natural product, 1,4-dihydroxy-2-naphthoic acid which can
be transformed into the same alcohol in fewer steps and is naturally pre-reduced and air
stable.
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Scheme 2.5. Example synthesis of a protected hydroxymethyl naphthoquinone.

	
  

Early protecting schemes of the 1,4-dihydroxy-2-naphthoic acid proved difficult as

the proton on the 1-hydroxyl group has a very high pKa due to potential bridging to the
carboxylate carbonyl, which is made higher upon deprotonation of the carboxylate. Under
basic conditions, only the carboxylate and the 4-hydroxyl group became protected with the
menthoxymethyl group, Scheme 2.6. Further protection of the 1-hydroxyl with chloromethyl
menthyl ether, using sodium hydride or butyl lithium bases proved inconsistent. It was
believed that by converting the carboxylate to an ester prior to attempting protection of the
hydroxyls, the effective pKa of the 1-hydroxyl could be reduced and full protection would
occur more readily. Surprisingly, under acidic conditions in methanol, the obtained product

Scheme 2.6. Incomplete protection of 1,4-dihydroxynaphthoic acid.
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was not the ester, but rather the doubly methylated methyl 1-hydroxy-4-methoxy-2naphthoate 1, Scheme 2.7, in 93% yield. The addition of two methyl groups under the
conditions used was completely unanticipated, and does not appear in the modern synthetic
literature at all. A single test of the generality of the reaction was preformed using ethanol,
which proved effective.
Having partially accomplished the goal of deactivating the carboxylate, the free
hydroxyl in doubly protected methylnaphthoate 1 was protected as the menthoxymethyl
ether under basic conditions, Scheme 2.7. Reduction with lithium aluminum hydride
afforded the desired alcohol, Scheme 2.7. However, upon treatment of the alcohol with
phosphorous tribromide in carbon tetrachloride to generate the aryl-alkyl bromide, the only
product observed was the alcohol in which the menthoxymethyl ether was deprotected,
Scheme 2.7, with no sign of successful bromination. This surprising result, though similar in

Scheme 2.7. Progress towards a reductive route to a stably protected naphthoquinone aryl alkyl
bromide.
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effect, was not entirely reminiscent of the prior deprotections observed upon attempted
bromination, in that the naphthoquinone remained reduced.
At this point, with seemingly little to gain from the chiral menthoxy methyl or achiral
methoxy methyl protecting groups, especially in light of the previous observation that
quinone methyl ether deprotection can occur under mildly oxidizing conditions, it was
decided to alkylate the 1-hydroxyl with methyl iodide, and continue the synthesis. This
decision bears significant weight on the remainder of this work as will be seen. Effecting the
desired transformation of the methylnaphthoate 1 to methyl-1,4-dimethoxy-2-naphthoate 2
afforded the desired triply methylated product in high yield (90%), Scheme 2.8. Subsequent
reduction with lithium aluminum hydride, and bromination using phosphorous tribromide
yielded the desired aryl-alkyl bromide 1,4-dimethoxy-2-bromomethyl-naphthalene 3 needed

Scheme 2.8. Successful generation of naphthoquinone aryl-alkyl bromide desired for amino acid
synthesis.

	
  

	
  

27	
  

for the O’Donnell amino acid synthesis in nearly quantitative yield.25
The transformations in four steps from 1,4-dihydroxy-2-naphthoic acid to 1,4dimethoxy-2-bromomethyl-naphthalene 3 are high yielding, easily purified and readily scale
to forty grams, the largest reaction size attempted during this work. It is apparent that the
two steps towards the triply methylated methyl 1,4-dimethoxyl-2-naphthoate 2 allows for
different and orthogonal protecting groups on either of the hydroquinone hydroxyls.
However, attempts to silylate or otherwise install non-alkyl orthogonal protecting groups on
the

1-hydroxyl

failed

to

produce

appreciable quantities of the desired
products and these synthetic directions
were abandoned. Given the success of
installing the methyl protecting groups, the
final desired form of Naq, ready for
peptide synthesis can now be drawn,

	
  
Figure 2.5. Final desired structure of FmocNaq(OMe/OMe)-OH.

Figure 2.5.

2.3.2 Completion of the synthesis of Naq
With the 1,4-dimethoxy-2-bromomethyl-naphthalene 3 aryl-alkyl bromide necessary
for the O’Donnell amino acid synthesis in hand, it was combined with N(diphenylmethylene)glycine tert-butyl ester in the presence of cesium hydroxide and the
third-generation asymmetric cinchonidium phase transfer catalyst,29 at -20 °C, Scheme 2.9.
The product, L-N-(diphenylmethylene)-1,4-dimethoxyl-2-naphthalanine tert-butyl ester 4,
was afforded in an 86% yield with a 93% enantiomeric excess, as determined by chiral
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Scheme 2.9. Creation of Cα-Cβ bond in naphthoquinone amino acid.

	
  
HPLC of the free amino acid -- meaning approximately 4% of the product was the
undesired D-enantiomer. Given the high stereochemical enrichment afforded by the
O’Donnell amino acid synthesis, no further separation of the enantiomers was deemed
necessary.
The protected amino acid 4 was committed to standard aqueous acidic conditions
used in removing the diphenylmethylene and tert-butyl moiety protecting the backbone,
rapidly resulting in a black tar. Under suspicions that the acidic water was somehow releasing
the quinone functionality, followed by uncontrolled polymerization, 4 was treated with acidic

Scheme 2.10. Acidic deprotection of naphthoquinone amino acid backbone in methanol.
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Scheme 2.11. Final synthetic steps towards Fmoc-Naq(OMe/OMe)-OH.

	
  
	
  
	
  methanol generated with thionyl chloride, to afford L-1,4-dimethoxy-2-napthalanine methyl
ester hydrochloride 5, Scheme 2.10. While the methyl ester could easily be converted into the
free amino acid, it seemed apparent that anhydrous acidic conditions could afford the
desired free amino acid without the need to purify and deprotect the methyl ester. Using
trifluoroacetic acid (TFA) with ethanedithiol (EDT) as a scavenger for the
diphenylmethylene and tert-butyl cations likely to be released, protected amino acid 4 was
converted to the free side chain protected naphthoquinone amino acid L-1,4-dimethoxy-2naphthalanine hydrochloride salt 6, Scheme 2.11, nearly quantitatively. This reaction darkens
quickly if the scavenger is added after the TFA, suggesting either modification of the amino
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acid by the released protecting groups or, possibly more likely, an oxidation dependent
process which is suppressed by the moderately reducing EDT. Protection of the amine of 6
with Fmoc-OSu in the presence of stoichiometric bicarbonate gives the 9fluorenylmetyhyloxycarbonyl (Fmoc) derived L-Fmoc-Naq(OMe/OMe)-OH 7 desired for
Fmoc peptide synthesis, in an 85% yield, Scheme 2.11. Intriguingly, if the crude reaction
mixture is allowed to sit, the 9-methylfluorene byproduct polymerizes.
The complete synthesis of L-Fmoc-Naq(OMe/OMe)-OH takes seven steps from
the readily available natural product 1,4-dihydroxy-2-naphthoic acid. The key reaction
creating the asymmetric α-carbon-β-carbon bond proceeds in high yield, with high
enantiomeric excess thereby allowing the remainder of the synthesis to proceed without need
for separation of the L- and D- enantiomers. While the methyl protecting groups proved
quite robust in the chemical synthesis, their use in a synthetic peptide requires a separate
deprotection step from the remainder of the peptide side chains. This feature has its
advantages in that peptides containing the protected Naq will be much longer lived than
peptides in which Naq was already deprotected. This simplifies peptide chemistry and allows
peptides incorporating a protected Naq to be treated as any peptide can, without much
consideration for the stability of Naq under various conditions, something that cannot be
done with activated quinones like DOPA. It is important to note that like DOPA, attempts
were made with a collaborator, Ryan Mehl, to integrate Naq into an orthogonal
tRNA/tRNA synthetase pair for expression of proteins incorporating Naq in their primary
sequence. The free amino acid proved somewhat toxic, and no viable hits were obtained
after three attempts, so this aspect of the project was abandoned.
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Scheme 2.12. Synthesis of Ac-Naq-OMe.

	
  

2.4 Initial Electrochemical Studies of Naq in an Ultra-Short Peptide
The free amino acid methyl ester 5, Scheme 2.12, can be readily converted into the
peptide Ac-Naq(OMe/OMe)-OMe, 8, with under standard acetylation conditions with 4dimethylamino pyridine serving as a catalyst. As mentioned in the previous section, methyl
ether protected quinone can be activated by using a hypervalent iodide(III) species like
phenyliodine bis(trifluoroacetate) (PIFA) in nearly quantitative yields,27 and so 8 was treated
with PIFA in a water acetonitrile mixture, giving the hydroquinone product 9 after a
reductive workup, Scheme 2.12.
Cyclic voltammetry studies of a short Naq containing peptide 9, Figure 2.6, showed
very strongly scan-rate dependent waves characteristic of the common ecec protondependent electrochemical mechanisms observed in cyclic voltammetry of quinones in
aqueous solution.30,31 At the slowest scan rate, 1 mV s-1, the half-wave potential, E1/2, is -58
mV vs. NHE, close to the anticipated midpoint of 2-methylnaphthoquinone at pH 8.6 of
approximately -110 mV vs. NHE. Besides obvious differences in local environment between
2-methylnaphthoquinone and Ac-Naq-OMe, the observed difference in midpoint potential
could be do the quasi-reversibility of the quinone electrochemistry in the cyclic voltammetry
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studies.

The

non-ideality

of

the

electrochemistry is such that even at the
slow scan rate of 1 mV s-1, the peak
separation is 115 mV, far from the ideal
diffusion limited 29 mV predicted for a two
electron species at room temperature.
Additionally,

characteristic

of

a

non-

reversible electrochemical process, there is
an observed scan rate dependence of the
measured half-wave potential.
While the cyclic voltammetry of 9
Figure 2.6. Cyclic Voltammetry of Ac-Naq-OMe in 25
mM Na2PO4, 250 mM KCl, pH 8.6 at various scan
rates revealing complex ecec chemistry expected of
quinones. Peak potentials are versus NHE, corrected
from the Ag/AgCl reference used in the experiment.
The working and counter electrodes were Pt.

	
   confirmed

that

Naq

was

indeed

electrochemically active and displayed the
standard suite of proton dependent quinone
electron

transfer

chemistries

when

deprotected using the hypervalent iodide(III) species PIFA, subsequent attempts to use the
hypervalent iodide species with peptides of greater sequence diversity, incorporating the
redox active amino acid tyrosine, proved thoroughly impossible as will be discussed in
greater length in Chapter 3. Since little was known about how Naq would interact within a
peptide containing diverse amino acid functionalities ranging from nucleophilic terminal
amines and lysines, to redox active amino acids like tyrosine, tryptophan, cysteine and
methionine, it became necessary to create a slightly longer model peptide with limited
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functionality that would serve as model system for defining the range of activities likely to be
observed in functionally diverse Naq containing peptide maquettes.

2.5 HeptaNaq
To ease reference to Naq in peptide sequences, it was given the single letter code Ϙ,
which is the archaic Greek letter koppa. With the sequence of PDP-Naq(Ϙ)-PDQ-NH2 and
conceived as an unambiguous Naq containing short peptide, Figure 2.7, heptaNaq was
designed around water solubility, containing both highly water soluble prolines and
aspartates. In addition, the prolines provided structural rigidity thought likely to ease
interpretation of electrochemical behaviors. The sequence acronym PDQ belies its original
purpose as a quick proving
ground

for

deprotection

strategies in peptides of greater
complexity than Ac-Naq-OMe 9
as highly unanticipated problems

Figure 2.7. Cartoon of oxidized heptaNaq in poly-proline II
conformation

	
  

arose

in

the

course

of

attempting to deprotect Naq in
such

environments.

The

problems yielded to neither re-synthesis of Naq using different protecting groups briefly
alluded to before (the observations discussed in Chapter 6, notwithstanding) nor variegation
of deprotection strategies, which will be discussed at greater length in Chapter 3.
HeptaNaq was synthesized using standard Fmoc-solid phase peptide synthesis
procedures and protocols and purified as a single peak on HPLC. There was no evidence of
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Figure 2.8. Average molar absorbance spectrum in 100 mM NaPi, pH 7.4 (A) and normalized
fluorescence excitation (orange, measured at 400 nm) and emission (blue, measured at 329 nm) in 20
mM Pipes, 100 mM KCl, pH 6.57 (B) of heptaNaq(OMe/OMe).

lack of incorporation of Naq into the sequence or of degradation of the amino acid during
peptide cleavage in Reagent R (TFA/thioanisole/EDT/anisole, 95:5:3:2), which like the
cocktail used to deprotect Naq’s backbone during its synthesis contains EDT, suggesting
that Fmoc-Naq(OMe/OMe)-OH behaves appreciably similar to other natural and nonnatural Fmoc amino acids used in peptide synthesis, an important feature needed for FmocNaq(OMe/OMe)-OH’s continued use.

2.5.1 HeptaNaq(OMe/OMe) Spectroscopy and Fluorescence
In the course of studying the deprotection chemistry of Naq(OMe/OMe), it became
necessary to measure the molar absorptivity of heptaNaq to perform reactions with
stoichiometric amounts of deprotecting reagents. Average molar absorptivities were
measured using total Kjedahl nitrogen to determine heptaNaq concentration in solutions
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with known spectra, Figure 2.8A. The molar absorptivity at 301 nm, determined via linear
regression fitting of the Kjedahl and absorbance data as opposed to simply averaging, 5065
M-1 cm-1, is used as a standard value for determining protected Naq-containing peptide
concentrations since no common amino acids have significant absorbances at that
wavelength and the spectrum is not appreciably pH dependent.
HeptaNaq(OMe/OMe), and indeed, seemingly all peptides that contain protected
Naq, has a remarkably bright blue fluorescence observable by eye when taking standard
UV/vis spectra, Figure 2.8B.

2.5.2 HeptaNaq(OMe/OMe) Deprotection
Hypervalent iodide(III) species, such as PIFA, which were successfully used to
deprotect Naq in the peptide Ac-Naq-OMe, react through a covalent intermediate with the
species they are oxidizing. Though never attempted, heptaNaq would likely be efficiently
deprotected by PIFA; however, the covalent intermediate biases the reaction of the
hypervalent iodide(III) species towards reacting with species that have less steric bulk, and in
peptides containing both Naq(OMe/OMe) and tyrosine, the formation of the covalent
intermediate heavily favors oxidation of tyrosine over deprotecting Naq(OMe/OMe).
Nevertheless, use of other non-covalent oxidants might deprotect Naq(OMe/OMe) first,
especially if the redox potential of the reduced protected Naq is lower than the potential of
the tyrosine.
After numerous deprotection attempts with other methodologies, some of which will
be discussed in Chapter 3, a range of single electron oxidants were used to attempt to
deprotect heptaNaq(OMe/OMe); only one, with stoichiometric quantities of cerium
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ammonium nitrate (CAN), was able to completely oxidize heptaNaq(OMe/OMe). The
nominal midpoint potential of CAN is 1.7 V vs. NHE and is likely far more oxidizing than
either tyrosine or Naq(OMe/OMe) are reducing, thereby requiring addition of almost exactly
two equivalents per protected Naq to be selective. Equal concentrations of
heptaNaq(OMe/OMe) and heptaTyr, where the Naq has been mutated to a tyrosine, were
reacted with two Naq(OMe/OMe) equivalents of CAN activating Naq with no major
tyrosine oxidation. This selectivity is enhanced at low pH as the redox chemistry of tyrosine
is pH dependent and the methyl-protected Naq is not anticipated to have a proton
dependent

couple.

As

will

be

discussed

in

Chapter

3,

another

oxidant

dichlorodicyanoquinone (DDQ) that has a lower potential than CAN and is an obligate twoelectron redox center, like Naq, is far more selective; nevertheless, heptaNaq is activated
quantitatively by treatment with stoichiometric amounts of cerium ammonium nitrate.
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2.5.3 HeptaNaq Aqueous Spectroscopy and Potentiometry
The aqueous spectra of 1,4-naphthoquinone and 2-methyl-1,4-naphthoquinone only
differ by the appearance of absorption bands at 262 nm and 268 nm in the latter, attributed
to absorption changes associated with the quinoid ring, Figure 2.9A.32 Activated oxidized
heptaNaq (heptaNaqox)) has a UV/vis spectrum that lies between the two species, although it
is on first glance more similar to 1,4-naphthoquinone than to the more structurally similar 2methyl-1,4-naphthoquinone, Figure 2.9B. The suppression of the bands at 262 nm and 268
nm in heptaNaq may be due to increased structural rigidity of the methylene off of the
quinone in Naq reducing some of the electronic effects of the added methyl in
desymmetrizing the cofactor as seen in 2-methyl-1,4-naphthoquinone. Regardless,
heptaNaq’s UV/vis spectrum is highly characteristic of naphthoquinones, with the broad
moderate band at 239 nm imparting a slight orange tinge to concentrated solutions.

	
  

Figure 2.9. Normalized absorbance spectra of 1,4-naphthoquinone (red) and 2-methyl-1,4naphthoquinone (green) in 25 mM KPi, 100 mM KCl, pH 8.0 (A) and oxidized (orange) and borohydride
reduced (blue) heptaNaq in 20 mM Pipes, 100 mM KCl, pH 6.57.
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Similarly, the reduced spectrum, Figure 2.9B, generated by addition of a slight excess
of borohydride, is also as expected, demonstrating a significant red shift to the absorbance
maximum at 320 nm when compared to the maxima in protected heptaNaq(OMe/OMe) at
301 nm. Excluding the work using a ubiquinone (UQ-0) head group,19,21 it should be noted
that although the various groups that have used cysteine-modified quinones have reported
spectra of peptides incorporating the quinones, none have been so unambiguously the
correct species, perhaps indicating chemical modification of the quinones beyond the
ligation chemistry or showing evidence of aggregation phenomena that could be significantly
altering the quinone environment.20-22
With the spectroscopy of the reduced and oxidized heptaNaq well established, and
with the observation that the erratic electrochemical results observed in the quinonemodified cysteine peptides were all determined using decidedly non-equilibrium cyclic
voltammetry,

heptaNaq’s

aqueous

electrochemistry

was

determined

by

spectroelectrochemistry using a home
built

spectroelectrochemistry

cell

developed by José Cerda. Initial studies
of heptaNaq without redox mediators
and with an unmodified, large surface
area, gold working electrode produced
somewhat non-ideal results. Aggregation
	
  

Figure 2.10. Reduced and oxidized spectra of
heptaNaq (----) and 2-methyl-1,4-naphthoquinone in
the presence of redox mediators. Inset: Redox
difference spectra of the two species.
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of the heptaNaq on unmodified gold
foil spoiled attempts at reversing the
direction of the titration since the

aggregates tended to dislodge during the course of the experiment. Without mediation,
heptaNaq would demonstrate classic two-electron two-proton spectral changes but have an
apparent one-electron Nernst response, yet ultimately displaying the same two-electron
midpoint as determined under more ideal conditions. This is to be expected to some degree,
as there is no physical meaning of a set point redox potential when there are few redox
active charge carriers buffering it, which, in the absence of mediators beyond heptaNaq,
would be the case at the edges of the heptaNaq Nernst curve. However, when the gold
working electrode was modified with a short mercaptoalkylalcohol, and well-spaced
mediators were used, heptaNaq demonstrated ideal redox behavior.
The reduced, oxidized and redox difference spectra observed during the course of
the spectroelectrochemistry titrations matched that of the model compound 2-methyl-1,4naphthoquinone under identical conditions, Figure 2.10. The observed maxima at 243 nm,
and isosbestic point at 252 nm were identical to the values observed for the oxidized and

Figure 2.11. Oxidation-reduction chemistry of heptaNaq. Spectroelectrochemical data fit to the twoelectron Nernst equation (A) from which the values of Em were obtained. The pH dependence of Em is
drawn with line for a two-electron two-proton coupled redox center (slope -58 mV/pH at 20 °C).
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borohydride-reduced species, Figure 2.9B. The pH dependence of the redox midpoint
potential, Em, of heptaNaq was determined spectroelectrochemically. Titrations were
followed by measuring the difference between the absorbance at the maxima and isosbestic
wavelengths as a function of redox potential, Figure 2.11. HeptaNaq’s oxidation-reduction
exhibits classic two-electron reversible Nernst behavior (n = 2.0) over the pH range 5.2-8.3
at 20 °C. The pH dependence of heptaNaq matches the expected two-electron, two-proton
coupled oxidation-reduction of quinones over this pH range., Figure 2.11.33 The Em of
heptaNaq at pH 7.5 is -20 mV, a value comparable to that of the Naq analog 2-methyl-1,4naphthoquinone (Em -47 mV at pH 7.5). The modest difference is similar, albeit smaller, to
that observed in the cyclic voltammetry of Ac-Naq-OMe. Environmental effects caused by
the peptide or more specific hydrogen bond interactions of the Naq side chain with
heptaNaq’s backbone can explain the subtle difference between the model compound and
heptaNaq.
Overall the redox chemistry of heptaNaq is ideal, showing neither a significant
change in the pKa of the hydroquinone hydroxyls as observed by the cysteine coupled
quinone in the work of Hay et al.,22 nor deviating from ideal behavior of known quinone
cofactors in the pH range explored. In addition, the aqueous solution equilibrium
potentiometry confirmed that Naq, as designed, maintains a sufficiently low redox potential
for use in maquettes built to emulate the low potential reactions of respiration and
photosynthesis. However, while confirmation of aqueous electrochemical behavior is
important for establishing the broad utility of Naq in soluble peptides, most of the low
potential chemistry of quinones occurs in environments with low dielectrics and proton
limitation within membranes and membrane protein complexes.
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2.5.4 HeptaNaq Aprotic Cyclic
Voltammetry
It is not surprising that heptaNaq
displays

high

solubility

in

dimethylformamide (DMF), an aprotic
solvent whose dielectric constant is 38.3 D
falling

in-between

the

average

cited

dielectric of between 2.5-4 D for proteins,34
which are of course more heterogeneous
	
  

Figure 2.12. Cyclic voltammetry of heptaNaq in DMF.
Slow (50 mV s-1) and fast (2 V s-1) scan rates redox
couples with different proton dependencies. Peak
potentials are presented relative to NHE using the
ferrocene couple (766 mV versus NHE) as an internal
standard.1

than a solution model would provide, and
80

D

for

water.

Ideally

suited

to

approximate the behavior of some of the
slightly watery active sites of membrane

quinone oxidoreductases, solution cyclic voltammetry in DMF does not suffer from
disruptive IR drops due to high solvent resistance as is observed in low dielectric solvents
like benzene35 making observation of proton-limited heptaNaq electrochemistry readily
accessible.
With cyclic voltammetry using slow scan rates in DMF, heptaNaq oxidationreduction peaks display a clear scan rate dependency not unlike those observed in the cyclic
voltammetry of Ac-Naq-OMe in aqueous buffer. The peaks probably originated with
restricted protonation by protons associated with the peptide itself as HPLC purified
heptaNaq is likely to have at least the N-terminal amine and the two aspartates protonated
due to the presence of trifluoroacetic acid (TFA) in the elution solvent (some mixture of
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water and acetonitrile with 0.1% TFA). Indeed, at 50 mV s-1 a “protonation peak” is
observed indicative of the availability of protons in the DMF solution, Figure 2.12. Further,
although there is a significant depression of the half-wave potential, E1/2 -328 vs. NHE,
compared to the aqueous midpoint, a complex ece(c) electrochemical mechanisms is evident
which is not observed from studies with 2-methyl-1,4-napthoquione under identical
conditions. However, unlike with the aqueous solution cyclic voltammetry of Ac-Naq-OMe,
with increasing scan rates both anodic and cathodic peaks split into two one-electron steps
and approach scan rate independence characteristic of kinetic bypass of protonation and
development of fully reversible redox chemistry. Thus at fast scan rates in the range of 2 V s1

the two proton uncoupled half-wave potentials are -362 mV and -1088 mV vs. NHE. Like

the previously reported redox couples for aqueous cyclic voltammetry and equilibrium
spectroelectrochemistry, these values are modestly positive of the values of 2-methyl-1,4naphthoquinone in anhydrous DMF (-408 mV and -1142 mV vs. NHE). The difference can
once again be explained by interactions with the peptide backbone, or the possible presence
of minute amounts of residual water in the experimental setup.36

2.6 Conclusion
The aprotic cyclic voltammetry of heptaNaq matches very closely that of the model
compound

2-methyl-1,4-naphthoquinone,

suggesting,

with

the

aqueous

spectroelectrochemical behavior, that the overall design of Naq as a cofactor capable of
robustly emulating natural quinone cofactors in respiratory and photosynthetic membrane
oxidoreductases succeeded. In addition, it is clear that considering the range of redox
potentials demonstrated by heptaNaq in both protic and aprotic mediums Naq may be a
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important first step towards creating a family of electron transfer maquettes capable of
demonstrating very low and moderate electrochemical behaviors not unlike the membrane
complexes of photosynthesis. Indeed, since DMF has a significantly higher dielectric
constant than is predicted for the average protein environment and there is a clear presence
of protons in the ‘aprotic’ cyclic voltammetry of heptaNaq, the numbers obtained for the
half-wave potentials represent an upper limit for the real value in the lower dielectric
environment of a protein core. Nevertheless, even if the DMF values are accurate, it is
apparent that Naq may serve as a shuttle for
low potential electrons capable of reducing
hydrogen or other similarly stable highenergy fuels.
With the clear spectroscopy of
freshly prepared Naq established, it is
possible to observe a slow degradation of
the cofactor on the days time scale at room

Figure 2.13. Absorption spectrum and structure of
2-hydroxy-3-methyl-1,4-naphthoquinone.

	
  

temperature. The likely end product is an
analog

of

2-hydroxy-3-methyl-1,4-

naphthoquinone, a species that has a significantly different absorbance spectrum than Naq,
Figure 2.13, with a notable

fairly intense relatively red absorption band at 480 nm.

Unfortunately, there is no good method of avoiding the hydroxylation degradation product
as three distinct routes exist for its formation, namely direct nucleophilic modification of
Naq by hydroxide or water, reaction of oxidized Naq with peroxide followed by a slow
rearrangement (a reaction which was used to produce the reference compound in Figure
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2.13), or reaction of reduced Naq with molecular oxygen reminiscent of the formation of
natural quinoprotein cofactors. Stocks of activated Naq containing peptides are seemingly
stable indefinitely at -80 °C, and last for at least six months at -20 °C; stocks of protected
Naq(OMe/OMe) containing peptides are indefinitely stable under most reasonable
conditions. Fortunately, the distinct spectroscopy of the degradation product allows a quick
check for cofactor purity.
While the studies of heptaNaq confirmed adherence to design principles of the new quinone
cofactor Naq, it should be clear that the choice of methyl protecting groups for the Naq side
chain almost prevented a broad utility of the naphthoquinone amino acid. Ultimately, the
methyl protecting groups allowed the completion of much of this work, though their
deprotection was far less straightforward than initially believed. In the following chapter a
more thorough discussion on the attempts to remove the methyl ether protecting groups will
be presented as it amounted to a major stumbling block. Finally, in Chapter 6, a new,
seemingly completely orthogonal protecting scheme will be presented.
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Chapter 3: Secondary Structure Effects on the
Electrochemistry of the Naphthoquinone Amino Acid, Naq

3.1 Introduction
In the development of the naphthoquinone amino acid Naq the advantages of
creating a quinone α-amino acid that could be installed in a peptide with limited
conformational flexibility outweighed concern of any disruption of that peptide’s secondary
structure (Chapter 2). Care was taken to minimize the likely disruption caused by excessive
steric bulk near the β-carbon by sacrificing some amount of chemical stability, but the
overall design took into little account the need for side chain torsion angles (rotamers) that
were compatible with the major secondary structural elements. Hand modeling of Naq into
idealized and natural alpha helices suggested that while two of the four likely helical χ1/χ2
rotamers would be highly disruptive to the backbone due to steric occlusion with the 1carbonyl (or 1-hydroxyl), the other two rotamers should be tolerated, Figure 3.1. However,
this simple analysis ignores the possibility that Naq could stabilize local non-helical
conformations to such an extent that helix formation would be unlikely, in essence, reducing
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Naq’s alpha helix propensity. For the remainder of the chapter the terms alpha helix and
helix are used interchangeably. Much literature (see Pace and Scholtz’s creation of a
‘universal’ alpha-helix propensity scale based upon prior measurements2 and references
therein), has focused on the establishment of helix propensity scales using an array of
different approaches from early statistical analysis of structures of proteins3 to experimental
systems with synthetic host-guest peptides. The experimental techniques used to ascertain
the helical propensity of natural and artificial amino acids run the gamut from applying
modified Lifson-Roig or ZimmBragg theories in conjunction
with two-state folding models of
monomeric
measurements

helices4-6
of

to
relative

affinities during binding events
to self7 or a metal8,9 that result in
helix stabilization or formation
of helices, respectively.
In one of the more
recent contributions to the body
	
  

Figure 3.1. Likely helix rotamers of Naq. Steric conflicts are
shown as red cylinders as generated by Pymol.

of literature on the measurement
of

helical

propensity,

the

Makhatadze group took advantage of a family of short peptides that demonstrated very
efficient metal dependent helix formation.8-10 This peptide family is based upon the calcium
binding loop III of native rat testis calmodulin.10 The 12-residue peptide, P1 (sequence: Ac	
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DKDGDGYISAAE-NH2), contains a single point mutation that changed the native binding
selectivity from calcium to lanthanide ions, with a binding affinity for the latter of Kd=9.4
µM.8 As with calcium induction of helix formation in EF-hand proteins, in the presence of
saturating lanthanide ion, the final three residues of P1 form a rigid helix due to the terminal
glutamic acid involvement in ligating the metal. Extension of this helix with an additional
four residues (AAAQ) produced the peptide P2; the structure of which at 2 °C confirmed
the helicity of the final seven or eight residues (the terminal glutamine in P2 may be
unstructured), Figure 3.2. Lopez et al. further developed the peptide as a system for
measuring the enthalpy and entropy of helix formation while taking advantage of the
lanthanide induced changes in
CD signal to evaluate the actual
change in helicity upon ligand
binding.9 This formed the basis
for use of the peptide P2 as a
Figure 3.2. Representative solution structure
lanthanide ion in orange, guest site alanine in red.

of

P2A;

host system for measuring the
detailed

thermodynamics

of

helix formation using several different amino acids at position 14, the so called P2X peptides
(sequence: Ac-DKDGDGYISAAEAXAQ-NH2, where X is a guest amino acid under study
and in the lanthanide bound form points away from the peptide ‘core,’ Figure 3.2).8
Using isothermal titration calorimetry (ITC) and fluorescence titrations to follow the
lanthanide binding response of the sole tyrosine residue, Richardson et al. evaluated the
enthalpy and free energy of lanthanide binding for the P2X family (where X= A, F, G, V, L,
I, J, B, N, Q, S, T -- and an observed binding range from 2.4 µM for P2A to 6.5 µM for
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P2G).8 The enthalpy observations surprisingly revealed three distinct classes of amino acids,
which are separated based upon high, intermediate, and low Δhα; it had been previously
believed that the enthalpy of formation of a helix was driven by non-amino acid specific
interactions like the backbone hydrogen bonds and van der Waals contacts. The classes
follow two empirical rules, namely, if the amino acid is β-branched or can hydrogen bond to
the backbone it belongs in class two. Non- β-branched aliphatic residues make up class one,
and glycine is the sole member of class three. There does not appear to be a single
explanation for the observed classes of amino acids. Hydration and the nature of the
unfolded state are surely components, but the clear-cut observation of the significance of
varying amino acid-specific enthalpic effects on helix formation is an important discovery in
itself. More importantly, however, for the purposes of this work, was the observation that
the ‘site-specific’ free energy (ΔΔG) values obtained from the P2X peptides and the
compiled propensity scale created by Pace and Scholtz2 matched. This realization proved the
utility of P2X as a straightforward thermodynamic host-guest system for accessing the helical
propensity of artificial amino acids, including Naq.
In the work of the Makhatadze group, their treatment of the thermodynamic data
played a critical role in the success of the P2X peptide as a system for measuring the energies
of helical propensity and so it will be briefly summarized here with modification. The
fluorescence titrations of the P2X peptides showed tighter binding affinities for the
lanthanide ion than that of the lanthanide binding loop peptide P1. The energy difference
between the P2X and P1 is the effective energy of helix formation in the last three or four
residues of P2X
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⎛ K (P 2X ) ⎞
ΔG(P 2X ) = −RT ln ⎜ d
⎟
⎝ K d (P1) ⎠

Eq. 1

where Kd(P2X) is the measured dissociation constant of lanthanide ion for P2X, and Kd(P1)
is the measured dissociation constant for P1, 9.4 µM. Since the P2X peptides demonstrated
some amount of helicity in the absence of lanthanide, this energy is corrected to account for
the changes in helicity, assuming the lanthanide bound form is fully helical

ΔGO (P 2X ) =

ΔG(P 2X )
1 − Fα− (P 2X )

Eq. 2

where Fα− (P 2X ) is the fraction helical in the unbound peptide derived from ellipticies of
experimental and reference states

Fα− =

[Θ(P 2X )]c − [Θ − (P 2X )]
.
[Θ(P 2X )]c − [Θ(P 2X )]h

Eq. 3

The value for [Θ(P 2X )]h represents the ellipticity of a fully helical control, in this case the
lanthanide bound form which is assumed to be >95% helical, and [Θ − (P 2X )] is the
measured ellipticity for the lanthanide unbound form. [Θ(P 2X )]c is
[Θ(P 2X )]c =

13 ⋅[Θ − (P1)] + 4 ⋅[Θ(RCC )]
17

Eq. 4

where [Θ − (P1)] is the ellipticity of P1 in the absence of lanthanide, and [Θ(RCC )] is the
ellipticity of a random coil control peptide designated P6N5 in Makhatadze’s group that
represents the final four residues in P2X. The weights (13, 4 and 17) arise from the circular
dichroism formalism of counting backbone peptide units including the N-terminal acetyl and
C-terminal amide. [Θ(P 2X )]c can be thought to represent a mean molar residue ellipticity
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spectrum of an idealized random coil form of the P2X peptide and thus Fα− (P 2X ) is an
accurate measure of the fraction of helix in the lanthanide unbound form assuming the
lanthanide bound form actually represents [Θ(P 2X )]h . In the Makhatadze group’s treatment
of their P2X titration data, it was assumed that the globally responsive circular dichroism
spectrum giving the fractional helicity in the unbound form adequately represented the local
properties of the amino acid in the guest site, an assertion they defended by matching the
measured fractional helicity with that calculated using AGADIR, a program based upon
empirical derived helix formation energies refined using observed fractional helicities
obtained from CD spectra.8,11 In any case, it is clear that if the lanthanide bound form does
not represent the true measure of full helicity then it is necessary to find an alternative
measure of [Θ(P 2X )]h and the equation for ΔGO (P 2X ) must be modified

ΔGO (P 2X ) =

ΔG(P 2X )
F (P 2X ) − Fα− (P 2X )
+
α

Eq. 5

where Fα+ (P 2X ) is the fractional helicity of the lanthanum bound form. Considerations
such as these were used by the Bierzynski group12 in explaining slight disparities being their
observations of the enthalpy of helix formation and those of the Makhatadze group in the
same peptide family.9
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Figure 3.3. The lanthanide binding coupled electrochemistry of P2Naq

	
  

3.2 P2Naq Thermodynamics
The discussion thus far has ignored that Naq has two stable thermodynamic states at
neutral pH. In essence, P2Naq, the P2X peptide with Naq substituted into the guest site,
actually allows the measurement of the helical propensity of both forms of the amino acid,
and there is reason to believe they may be different as their abilities to hydrogen bond the
backbone are distinct. The binding of lanthanum to reduced and oxidized P2Naq (P2Naqred
and P2Naqox, respectively) is thermodynamically coupled to the midpoint potentials of the
bound and unbound forms of P2Naq, generating a thermodynamic box, Figure 3.3. The
P2Naq system actually allows the measurement of the change in redox potential associated
with a change in secondary structure of Naq. In an ideal system, where the lanthanide bound
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form of the peptide is fully helical and the unbound form has no helical character, the
measure of this value is straightforward

ΔΔGα c = −nFΔEm,α c = −nFEm+ + nFEm− = ΔG(P2Naqred ) − ΔG(P2Naqox ) Eq. 6
where ΔΔGα c is the free energy change from coil to helix, n is the number of electrons
associated with Naq reduction (n = 2), F is Faraday’s constant (23.06 kcal mol-1 V-1), ΔEm ,α c
is the redox midpoint change of Naq going from coil to helix, Em+ and Em− represent the
lanthanide bound and unbound forms assumed to represent fully helical and fully coil,
respectively, and ΔG(P2Naqox ) and ΔG(P2Naqred ) represent the lanthanide binding
energies of the oxidized and reduced form of P2Naq corrected for the binding energy of P1
to lanthanide as in Eq. 1. Unfortunately, the system is not ideal and the need to correct the
thermodynamic values to account for fractional helicity would prevent direct use of
measured redox midpoints. Combining fractional helicities with experimentally determined
midpoints makes little thermodynamic sense since midpoint potentials represent the energy
of a half-cell and are meaningless without a coupled redox reaction. Nevertheless, assuming
a two-state model, the expected change in midpoint potential for the coil to helix transition
can be calculated via binding affinity differences

ΔΔGα c = −nFΔEm ,α c =

ΔG(P 2Naq )red
Fα+ (P 2X )red − Fα− (P 2X )red

−

ΔG(P 2Naq )ox
Fα+ (P 2X )ox − Fα− (P 2X )ox

Eq. 7

where Fα+ (P 2X )ox and Fα− (P 2X )ox represent the fractional helicity in the oxidized
lanthanide bound and unbound forms, respectively, and Fα+ (P 2X )red and Fα− (P 2X )red
represent the fractional helicity in the reduced lanthanide bound and unbound forms,
respectively. ΔΔGα c and ΔEm,α c calculated as such serve as global measures of helical
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propensity for both forms of Naq. These values are not directly comparable to the values of
helical propensity, which are generally standardized using helix formation energies of
peptides with alanine in the guest site; yet it is an effective measure of the energetic coupling
of the coil to helix transition to electrochemical changes in Naq and should represent an
energy of disruption or stabilization of a helix that would occur on changing Naq’s redox
state. The closest observation of a change in an independently measurable physical property
with natural amino acids would be the observed rotamer dependent fluorescence lifetimes of
tryptophan and tyrosine.13-15
Without making a large number of assumptions, there is perhaps no good way to
adequately measure the lanthanide bound fraction helicity, Fα+ (P 2X )ox , and similar values
site-specifically with circular dichroism, with single site aromatic amino acid dichroism being
a possible and noteworthy exception. Model states and thermal unfolding assumptions are
perhaps good enough for a global estimate, but to determine site-specific probabilities
another technique is needed. The chemical shifts of the 1Hα, 13Cα, 13Cβ, and 13CO atoms in
amino acids have long been known to be responsive to secondary structure.16,17 With
selective labeling, it is therefore possible to obtain an unbiased measure of helical content in
a site-specific manner by observing the corresponding chemical shifts of the amino acid in
question

Fα =

δ obs − δ c
δh − δc

Eq. 8

where δ obs is the observed chemical shift for the atom in question in the experimental
peptide, and δ h and δ c are the reference chemical shifts for helix and coil form of the same
atom, respectively. As with the circular dichroism based fraction helicities, the choice in helix
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and coil controls is vitally important. Fortunately, under most circumstances the long
distance effects on chemical shifts in NMR are minimal, and the local environment can be
approximated or even copied by directly repeating the local sequence of the experimental
system into controls designed to take on the helix and coil geometries. This technique, for
instance, has been used to great effect by the Waters’ lab in their thermodynamic studies of
cation-pi interactions in β-hairpins.18

3.3 Synthesis, Deprotection and Initial Characterization of P2Naq
As previously mentioned, P2Naq is based upon the P2X peptide family used by the
Makhatadze group to measure the enthalpic contributions of various amino acids at a guest
site

in

the

formation

of

a

helix.8

Its

synthetic

sequence

is

Ac-

DKDGDGYISAAEAϘ(OMe/OMe)AQ-NH2, where Ϙ once again represents Naq. Fmocsolid phase peptide synthesis was once again straightforward; an increased yield was obtained
by synthesizing the isoleucine-serine sequence into the growing peptide chain using a Fmocprotected pseudo-proline derivative, where the serine residue side chain hydroxyl is
reversibly bound to its own amine with an acid labile dimethylacetal group thereby reducing
the likelihood of premature termination of chain extension. Additionally, when synthesized
on a CEM Liberty microwave synthesizer, it was necessary to switch from the common
piperidine Fmoc deprotection reagent to the less basic piperazine to circumvent succinimide
formation between Asp5 and Gly6, increasing the overall yield of the peptide substantially.
Peptide identity was confirmed via MALDI-TOF-MS. It is of note that purified and
lyophilized P2Naq(OMe/OMe) is more or less completely insoluble in any solution besides
at least 4 M GdnHCl or neat TFA, or mixtures of the two (high concentrations of urea is
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possibly effective, but it was not tested). When added to aqueous solutions that do not
contain high denaturant concentrations, the peptide forms hard, millimeter scale gel-like
aggregates that are transparent with no apparent scattering from the bulk solution. They can,
however, be recovered quickly using neat TFA or slowly adding >4 M GdnHCl solutions. In
addition to P2Naq(OMe/OMe), peptides P1 and P2A, as described above, were synthesized
under the same conditions.

3.3.1 Deprotection/Activation of
P2Naq(OMe/OMe)
Despite the success of using the
hypervalent iodide(III) oxidant PIFA to
activate Naq in Ac-Naq(OMe/OMe)OMe, all attempts to similarly deprotect
P2Naq(OMe/OMe)
Figure 3.4. Titration of P2Naq(OMe/OMe) with
substoichiometric aliquots of PIFA. One equivalent is
added before oxidation of Naq(OMe/OMe) is evident
as observed at 340 nm. The lines are drawn to guide
the eye.

while

initial

failed.

Indeed,

experiments

were

performed with blind excess of the
PIFA reagent resulting in indistinct

products, none of which had an obvious, non-aggregate naphthoquinone spectrum, even
careful titrations of PIFA into a solution of P2Naq(OMe/OMe) showed an unexpected one
equivalent lag of in the formation of an activated Naq product, Figure 3.4. The best
explanation

was

that

another

species

in

solution,

presumably

the

Tyr7

of

P2Naq(OMe/OMe), was reacting significantly faster with PIFA than Naq(OMe/OMe) since
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oxidation is effected through a covalent adduct between the oxidant and its target and
tyrosine is less sterically occluded than Naq(OMe/OMe).
Since it was unknown at the time whether the observed phenomena was going to be
true for all oxidants commonly used to activate methyl-ether protected quinones suggesting
that the tyrosine is far more reductive than Naq(OMe/OMe) is, other common methods of
removing methyl-ether protecting groups were explored, all of which can be described as
push-pull nucleophilic displacement reagents, where an oxophilic Lewis acid activates the
methoxy sufficiently to allow a nucleophile to displace the methyl group freeing the
hydroxyl. The vast majority of the reagents attempted, from BF3-methylsulfide or
AlCl3/EDT in CH2Cl2, both of which only partially deprotected Naq(OMe/OMe) even
though they were in vast excess, to TMSBr/EDT/thioanisole/m-cresol, which showed no
appreciable deprotection, were completely unsatisfactory. There were two exceptions to this
observation. In the case of triflic acid/thioanisole in TFA, there was clear removal of the
methyl protecting groups from Naq(OMe/OMe), but it was met with a mixture of backbone
hydrolysis products around Naq; as if Naq, once deprotected, was involved in the pseudocatalytic hydrolysis of peptide bonds before and after itself. On the other hand, using
TMSI/EDT/thioanisole in TFA to deprotect P2Naq(OMe/OMe) gave a single
predominant product with a very clear reduced spectrum not unlike that of the protected
Naq(OMe/OMe). Mass spectroscopy, both MALDI-TOF-MS and ESI-MS, revealed a
dehydration reaction had occurred, but this was not all together unexpected given the
number of amides in the peptide. However, the product was not redox active as purified,
and only displayed redox activity after being accidentally exposed to a highly acidic aqueous
solution. Given the observations, it is believed that the dehydration product was actually a
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cyclization of reduced Naq to the peptide backbone, Scheme 3.1. The heptaNaq project
described in Chapter 2 was conceived to untangle the various reactions that were
complicating the selective deprotection of Naq in P2Naq. Subsequent attempts to further
fine-tune the reactivity of the push-pull systems proved difficult; the use of TMS-triflate in
TFA, for instance, generated both presumptive backbone cyclization and hydrolysis
products, while using B(OTFA)3 in TFA in a large excess seemingly hydrolyzed the
backbone of an extended helix from the N- and C- terminals and, though interpretation of
the MALDI-TOF spectra of the HPLC purified products was difficulty, did not appear to
deprotect Naq(OMe/OMe).
Scheme 3.1. Backbone cyclization of Naq when treated with TMSI.

	
  

The success of using stoichiometric amounts of cerium ammonium nitrate (CAN) to

deprotect heptaNaq(OMe/OMe) in the presence of heptaTyr (Chapter 2), provided the basis
for successfully deprotecting P2Naq(OMe/OMe). Treatment of P2Naq(OMe/OMe) in 8 M
GdnHCl with 100 mM TFA, see discussion above concerning the solubility of
P2Naq(OMe/OMe), with 2-3 equivalents of CAN at room temperature for twenty minutes
yields deprotected P2Naqox in a ~60% overall HPLC yield; the remaining 40% is made up of
~20% unactivated P2Naq(OMe/OMe) and ~20% unidentified peptide byproducts. Above 3
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equivalents and the reaction specificity for Naq(OMe/OMe) declined rapidly. It was
observed that the unidentified byproduct percentage tracked with the amount of
unconverted starting material depending upon how quickly the CAN was added to the
solution, which flashes brown after CAN addition, suggesting that a slightly less reactive
oxidant might be effective in increasing the yield and specificity.
Having exhausted the readily available or easily produced single electron moderate
oxidants and found none to be sufficient, it was discovered that there is a commonly used
obligate two-electron quinone, dichlorodicyanoquinone (DDQ), in organic synthesis whose
redox potential was sufficiently above that of the single electron oxidants attempted.
Unfortunately, DDQ is not long lived in aqueous solutions, but it does dissolve in
acetonitrile (MeCN) and is stable in TFA; thus, reaction of P2Naq(OMe/OMe) in neat TFA
with precisely one equivalent of DDQ afforded the deprotected P2Naqox in ~80% yield after
purification by HPLC. The yield was increased to be effectively quantitative when the
reaction is kept at 0 °C for at least 30 minutes. Slight excess DDQ does not appear to
oxidize the peptide further, but rather, appears to form a covalent adduct to the peptide and
makes purification significantly more difficult. The reaction of Naq(OMe/OMe) with DDQ
is notably slower than the reaction with CAN and stays brown for tens of minutes before
becoming slightly yellow, indicating long lived formation of semiquinones or charge transfer
complex between DDQ and Naq. Some amount of the selectivity can probably be explained
by the much reduced effective redox potential of DDQ compared to CAN, but in addition,
it seems apparent that the two-electron nature of DDQ oxidation may actually bias reaction
towards Naq(OMe/OMe) over Tyr7, which is significantly less likely to be doubly oxidized.
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3.3.2 Spectroscopy of P2Naq
Like protected heptaNaq(OMe/OMe), it became necessary in the course of study to
determine the molar absorptivity of P2Naqox to make possible the determination of
concentrations of experimental solutions. The Kjedahl total nitrogen of solutions of
P2Naq(OMe/OMe) with known spectra were determined and the molar absorptivity
spectrum calculated, Figure 3.5. As with the spectroscopy of heptaNaq (Chapter 2), the
spectrum is does not deviate from
the

spectroscopy

of

known

naphthoquinones, with features lying
between

those

of

naphthoquinone
naphthoquinone.

2-methyl-1,4and

As

1,4-

anticipated,

there is only slight evidence that the
tyrosine chromophore is present.
The molar absorptivity at 252 nm is
Figure 3.5. Molar absorptivity of P2Naq in 8 M GdnHCl, 100
mM TFA. See text for details.

	
  

12700 M-1 cm-1, and at 340 nm is
1840 M-1 cm-1. The band at 340 nm is

sufficient to measure the concentration of most peptides containing activated Naq since it
does not overlap with any natural amino acids. In situations where the peptide concentration
is too low to measure the 340 nm band reliably, the tyrosine absorbance at 252 nm is 316 M-1
cm-1,19 which represents an insignificant 2.4% adjustment so the value 12700 M-1 cm-1 can be
used without modification.
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3.3.3 Borohydride Oxidase Activity of P2Naq
Like most natural quinones and
the peptide heptaNaq, Naq in P2Naqox
can

be

reversibly

reduced

by

borohydride; oxidation of P2Naqred by
molecular oxygen reverses the process
effectively making P2Naq a catalyst for
the oxygen dependent oxidation of
borohydride, Figure 3.6. Depending
upon the steric occlusion of the Naq
cofactor, the reaction is likely to be
slightly

irreversible

as

	
  

Figure 3.6. Borohydride reduction of 28 µM P2Naq in
20 mM Cacodylate, 100 mM KCl, pH 6.9, followed by
reoxidation of P2Naq red by O2. Black spectra are of initial
oxidized and reduced samples. Red to yellow spectra
were taken at various time points after reduction.

covalent

modification of reduced Naq by molecular oxygen is a possible path given the biologically
important reaction of reduced naphthoquinone vitamin K with molecular oxygen in the
cross linking of interstitial tissue.20,21

3.4 Synthesis of Nitrogen Labeled Peptides for Site-Specific Helicity by NMR
As described in the Section 3.2 on P2Naq thermodynamics, it is possible to use
chemical shift measurements to ascertain the fraction helicity in a site-specific manner.
Unfortunately, while highly desirable for a full description of the conformation of Naq in
any peptide, a full labeling the backbone and Cβ is not possible in any cost effective manner,
rather a choice must be made between 15N labeling the amine or 13C labeling the Cα, both of
which provide convenient handles with which to determine the chemical shifts of 13Cα and
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1

Hα through selective pulse sequences. These chemical shift values can then be used calculate

Fα , the fractional helicity. It is also clear that focusing on Naq alone in the guest site of
P2Naq might not provide enough information about the general conformation of the
peptide around Naq to give a clear gauge of what is actually happening in Naq’s local
environment. Therefore, it seemed prudent to label the preceding and following residues as
well, both alanines in P2Naq. The importance of tracking the identity of the amino acids as
their chemical shifts change from experimental peptide to experimental peptide cannot be
overstated. While intuitive tracking of the chemical shifts is possible in the absence of clear
connectivity data,

15

N labeling the amine provides the best experimental route to not

depending upon inference in that it is possible to use a nitrogen filtered HNCA experiment
to get backbone connectivities in generic peptides by revealing cross peaks not only between
the amide proton and the Cα of a residue but also between the amide proton and the Cα of
the i-1 residue. Additionally, with 15N labeling, a nitrogen filtered NOESY allows walking the
backbone amides in helices. Pulse sequences that provide the same information do not
readily exist for peptides incorporating 13Cα labeling alone. 15N labeling also provides an
opportunity to use the nitrogen filtered HNHA for measuring J-coupling between the amide
proton and 1Hα and, thus, the φ, CO-N-Cα-CO, dihedral angle giving another physical
parameter about the nature of the peptide backbone in the environment around Naq.

3.4.1 Synthesis of 15N labeled Fmoc-Naq(OMe/OMe)-OH
In synthesizing either 15N or 13Cα labeled Naq, no major changes in the synthetic
route need to be considered. The ease of synthesis of the 15N or 13Cα labeled backbone
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precursor N-(diphenylmethylene)glycine tert-butyl ester from

15

N or

13

Cα labeled glycine

allows direct incorporation of the labels into the synthesis as it currently exists, Scheme 3.2.22
Thus

15

N Fmoc-Naq(OMe/OMe)-OH was synthesized by incorporating the

15

N-

(diphenylmethylene)glycine tert-butyl ester into the synthesis reported23 and described in
Chapter 2.
Scheme 3.2. 22 Synthesis route to 15N labeled intermediate needed to make backbone labeled Naq.

	
  

3.4.2 Synthesis of 15N labeled P2Naq(OMe/OMe), Random Coil Control and Helical Control
As described above, the sequence of

15

N labeled Ala13, Naq14 and Ala15 were

incorporated into P2Naq as well as controls for random coil and helical conformation; the
sequences of the three peptides are shown in Table 3.1.

15

N labeled P2Naq (sequence Ac-

DKDGDGYISAAEAϘAQ-NH2, where the emboldened amino acids are 15N labeled) was
synthesized and deprotected with DDQ as described above. Unlike the Makhatadze random
coil control P6N6, which had very little sequence similarity to the terminal sequence of
P2A,9 the random coil control (RCCNaq) was designed to be a nearly one-for-one
duplication of the terminal six amino acids (sequence Ac-AEAϘAE-NH2). The mutation of
the terminal glutamine residue to a glutamate was made to increase solubility of the resulting
peptide and decrease the likelihood of any short helix formation as there should be an i	
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>i+4 side chain charge-charge repulsion. Deprotection of RCCNaq(OMe/OMe) with DDQ
as described proceeded smoothly producing a peptide with a very clean characteristic
oxidized Naq spectrum.
Table 3.1. Primary sequence of peptides under study. Amino acids in bold are to be labeled for NMR
studies; the numbering scheme for those amino acids is preserved from the longer peptides in the
shorter RCCNaq.

Peptide
P2Naq

Sequence
Ac-DKDGDGYISAAEA13Ϙ14A15Q-NH2

RCCNaq
P2NaqExt

Ac-AEA13Ϙ14A15E-NH2
Ac-DKDGDGYISAAEA13Ϙ14A15QAAAAEAAAAEAAAAE-NH2

Richardson et al. assumed that the lanthanide ion bound P2X peptides were fully
helical,8 arguing that given the strength of helix formation in the P2A peptide upon
lanthanide binding as evidenced by both NMR and CD experiments, the P2X peptides
should have similarly efficient structural transitions. Unfortunately, with the concern that
Naq in both its reduced and oxidized forms might significantly cap helix formation through
hydrogen bonds between the backbone amides and side chain hydroxyls and carbonyls,
respectively, this assumption appeared illegitimate. In designing a better representation of
the helical conformation, sequence identity was preserved beyond the terminal six amino
acids as in the random coil peptide. Indeed, the entire sequence of P2Naq was copied
wholesale and appended to 15 residues of one of Baldwin’s ‘unusually stable’ monomeric
alanine-based alpha-helical peptides.24 Although only sixteen residues in length, the Baldwin
peptides displayed upwards of 80% helicity under ideal conditions (low temperature, high
ionic strength). The best designs had a pentameric repeating unit of four alanines and a
single charged residue. This design assured that the helices did not aggregate in solution
since the charged residues would be almost evenly dispersed around the helix (every 140°,
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assuming 100° per residue). Since P2Naq is highly negatively charged without a ligand, the
Baldwin helix chosen to append for the helical control peptide was similarly charged giving
the

sequence

of

the

helical

control

termed

P2NaqExt

as

Ac-

DKDGDGYISAAEAϘAQAAAAEAAAAEAAAAE-NH2. With the added extended helical
sequence, it was hoped that this peptide would be sufficient to induce Naq into a helical
conformation, if possible. P2NaqExt was readily synthesized with acetic anhydride capping
after each amino acid and deprotected with DDQ. Again, spectroscopy revealed a clear
unambiguous Naq signal.

3.5 Circular Dichroism of P2Naq, RCCNaq, and P2NaqExt
The P2X family of proteins demonstrates clear lanthanide ion dependent circular
dichroism (CD) changes in the amide region associated with helix formation. This fact was
used by Richardson et al. to measure fractional helicity in lanthanide free P2X to correct the
measured ‘helix formation’ energies for calculation of the site-specific enthalpy and free
energy contributions to helix formation for the guest amino acid according to Eq. 2. In
addition to providing one measure of alpha-helical content in the lanthanum unbound state,
circular dichroism provides a convenient method form confirming gross properties of
P2Naq, RCCNaq and P2NaqExt.
While it is certainly clear that the CD spectroscopy of the oxidized peptides should
be straightforward, the CD spectroscopy of the reduced peptides presents somewhat more
of a challenge. As will be discussed in greater detail in Section 3.6, the choice in reductants is
not obvious. The standard reductant dithionite is known to extensive modify quinones, and
indeed, there is evidence that Naq becomes sulfonated in the presence of dithionite.
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Although as noted above, borohydride or related borane compounds function reasonably
well, it is all but impossible use sufficient quantities of excess borohydride in high
concentration samples to assure maintenance of complete reduction. In the work on
developing methods for measuring the binding constant of P2Naqred to lanthanide ion, it was
discovered that hydrogen gas (H2) can be used in association with platinum nanoparticles to
reduce both P2Naq and the benzyl viologen redox dye, which serves as both a redox buffer
and a convenient visible measure of the redox state of P2Naq since it is significantly more
reducing than Naq is likely to be. One drawback of using benzyl viologen is that it has a high
molar absorptivity in the far-UV region used to observe protein amide CD signals, so there
is a small decrease in the quality of the spectra for the reduced samples because of this. All
samples were measured on an Aviv 410 Circular Dichroism Spectrometer in triplicate at 25
°C from 200 nm to 260 nm. The wavelength was limited to this range because of technical
challenges of acquiring data below 200 nm.

3.5.1 Circular Dichroism of P2Naqox and La3+- Bound P2Naqox
The circular dichroism spectrum of P2Naqox was measured in the far-UV at a variety
of concentrations averaged, Figure 3.7A. The spectrum appears to be a mixture of a small
amount of helix in a random coil background; not qualitatively different than that reported
for P2A.10 There was no observed concentration dependence on the mean residue molar
ellipticity of P2Naqox at 217 nm, -1930 mdeg cm2 dmol-1, Figure 3.7. The averaged CD
spectrum of lanthanide ion bound P2Naqox shows a dramatic shift towards a slightly more
alpha helical spectrum with a significant increase in the mean residue molar ellipticity at 217
nm to -6800 mdeg cm2 dmol-1, Figure 3.7A. However, when this mean residue molar
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Figure 3.7. CD spectra of apo and holo P2Naq ox (A). Concentration dependence of CD signal at 217 nm
for apo and holo P2Naq ox shown with experimental errors and lines drawn through the average (B). CD
spectra were taken at 25 °C in 20 mM Cacodylate, 100 mM KCl, pH 6.9.

	
  

ellipticity is compared to the reported values for the P2A peptide, approximately -11000
mdeg cm2 dmol-1,9,12 it is evident that the helix is not forming entirely upon lanthanide ion
binding. Qualitatively, when compared to the spectrum of lanthanide bound P2Naqox, the
spectrum of lanthanide bound P2A9,12 appears to have significantly less of the strong random
coil-associated signal near 200 nm. These observations lend credence to the idea that
lanthanide bound P2Naq might not be fully helical. No concentration dependence of the
mean residue molar ellipticity of lanthanide bound P2Naqox was found, Figure 3.7B.

3.5.2 Circular Dichroism of P2Naqred and La3+- Bound P2Naqred
As above, CD spectra were measured of the ligand free P2Naqred and lanthanide ion
bound P2Naqred. In the absence of lanthanide the CD spectrum of P2Naqred appears similar
to that of unbound P2Naqox, but with a notable decrease in the signal at 217 nm, Figure
3.8A, -1200 mdeg cm2 dmol-1. While there may be a slight concentration dependence at 217
nm, the values measured for the mean residue molar ellipticity of P2Naqred are within error
68	
  
	
  

of each other, Figure 3.8B. Upon being saturated with lanthanide ion, the CD spectrum of
P2Naqred changes radically as with P2Naqox, Figure 3.8A. Similar to P2Naqox the mean molar
residue ellipticity at 217 nm is -6920 mdeg cm2 dmol-1 suggesting that although the Cterminals of both peptides may not becoming entirely helical the same fraction of helix is
forming. With the exception of an anomalously low measured mean residue molar ellipticity
for the sample at 50 µM, there does not appear to be a concentration dependence of the CD
signal for lanthanide bound P2Naqred, Figure 3.8B. If investigated closely, there is an
apparent positive signal present at ~245 nm in the lanthanide bound P2Naqred CD spectrum
that is not present in the spectrum of lanthanide bound P2Naqox or in the spectrum of ligand
free P2Naqred. The correlation of this observed band’s maxima with the approximate
absorption maxima of the reduced Naq did not go unnoticed.

Figure 3.8. CD spectra of apo and holo P2Naq red (A). Concentration dependence of CD signal at 217 nm
for apo and holo P2Naq red shown with experimental errors and lines drawn through the average (B). CD
spectra were taken at 25 °C in 20 mM Cacodylate, 100 mM KCl, pH 6.9.
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3.5.3 Circular Dichroism of RCCNaqox and RCCNaqred
The CD spectrum of RCCNaqox confirms its design as a random coil standard,
revealing no clear conformational bias, Figure 3.9A; and while the signals were smaller than
the noise especially at the lower concentrations of peptide, there was no clear concentration
dependence of the CD signal at 217 nm, Figure 3.9B. On the other hand, the CD spectrum
of RCCNaqred is even more featureless, Figure 3.9A; and increased noise is apparent in the
plotting the concentration dependence, Figure 3.9B. With such small signals, it appears that
the addition of benzyl-viologen to the sample, coupled with the higher molar absorptivity of
the reduced Naq cofactor and the presence of amides in the protective polymer of the
colloidal platinum, may have significantly decreased sample quality; yet the differences
between the two samples at wavelengths associated with coil-to-helix transition in the P2Naq
peptides are small (at 217 nm, ~370 mdeg cm2 dmol-1, which is approximately the average
error for the two samples).

Figure 3.9. CD spectra of RCCNaq ox and RCCNaq red (A). Concentration dependence of CD signal at 217
nm for RCCNaq ox and RCCNaq red shown with experimental errors and lines drawn through the average
(B). CD spectra were taken at 25 °C in 20 mM Cacodylate, 100 mM KCl, pH 6.9.
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Figure 3.10. CD spectra of P2NaqExtox and P2NaqExtred (A). Concentration dependence of CD signal at
217 nm for P2NaqExtox and P2NaqExtred shown with experimental errors and lines drawn through the
average (B). CD spectra were taken at 25 °C in 20 mM Cacodylate, 100 mM KCl, pH 6.9.

3.5.4 Circular Dichroism of P2NaqExtox and P2NaqExtred
In designing the helical control peptide P2NaqExt, a length of a free helix stable in
solution was appended to the P2Naq sequence. It is clear that to effect the desired result of
forcing Naq into a helical conformation, this peptide, which presumably still binds
lanthanide, should have its physical properties measured in saturating lanthanide ion; thus in
all studies with P2NaqExt, saturating lanthanide is present. The CD spectra of P2NaqExtox
and P2NaqExtred can be seen in Figure 3.10A. The two peptides are clearly helical. Modifying
Eq. 4 we can obtain an anticipated value for the mean residue molar ellipticity for a
P2NaqExt assuming it is simply a combined species
[Θ + (P 2NaqExt )] =

17 ⋅[Θ(Baldwin )] + 17 ⋅[Θ + (P 2X )]
32

Eq. 9

where [Θ + (P 2NaqExt )] is the predicted ellipticity of P2NaqExt, [Θ(Baldwin )] is the
ellipticity of one of the Baldwin24 peptides related to the sequence added to P2Naq, and
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[Θ + (P 2X )] is either [Θ + (P 2Naq )] or [Θ + (P 2 A)] , the ellipticities of the P2Naq or the
idealized ellipticies of P2A, respectively. The scaling numbers come from the backbone
peptide lengths of the individual species. This calculation allows us to gauge how
successfully the addition of the Baldwin peptide to P2Naq increased the helicity of joint
product. For the purposes of this calculation, it is assume that due to the relative flatness of
the P2X peptide’s mean residue molar ellipticity from 217 nm to 222 nm the value at 217 nm
is equal to the value at 222 nm. The mean residue molar ellipticity of Baldwin’s peptide is
taken as -11000 mdeg cm2 dmol-1,24 and that of P2A is taken as -11000 mdeg cm2 dmol-1.9,12
In the case of P2NaqExtox, using the ellipticity of lanthanide bound P2Naqox for

[Θ + (P 2X )] , [Θ(P 2NaqExt )] is predicted to be ~-9500 mdeg cm2 dmol-1, in comparison to
the observed -14500 mdeg cm2 dmol-1. In the case of P2NaqExtred, using ellipticity of
lanthanide bound P2Naqred for [Θ + (P 2X )] , [Θ(P 2NaqExt )] is predicted to be -9520 mdeg
cm2 dmol-1, in comparison to the observed -11500 mdeg cm2 dmol-1. For both redox states
of P2NaqExt, the predicted value assuming [Θ + (P 2X )] is the ellipticity of lanthanide bound
P2A is -11700 mdeg cm2 dmol-1. The observed ellipticities compared to the predicted
ellipticities strongly support the conclusion that the P2NaqExt control is helical. Using P2A
as a proxy for a fully helical P2Naq unit, both P2NaqExtox and P2NaqExtred compare
favorably suggesting that in the absence of two helix nucleation events, the amino acids
around Naq are, in fact, helical. It is not surprising that P2NaqExtox proves significantly
more helical than predicted since without the need to overcome the barrier for or probability
of nucleation, the helix would be likely to extend much further. However, it is surprising that
P2NaqExtred is not significantly different than that predicted in the idealized case, suggesting
something else might be going on.
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The cause of the observed significant difference between the oxidized and reduced
forms of P2NaqExt is not immediately obvious. It may be possible that due to the
experimental setup for the reduced peptides, the concentrations were significantly off, and
this difference is amplified in the P2NaqExt experimental results. In addition, benzyl
viologen, the dye added as a redox indicator in the reduced samples, is a dication in its
oxidized form and was observed to cause the precipitation of P2NaqExt when both species
were in high (~1 mM) concentrations, suggesting the presence of intermolecular interactions
that might affect CD signals. Finally, it is entirely possible that reduced Naq completely
disrupts or caps any helix formed nearby; however, NMR results of P2NaqExtred discussed
below will show that this is not likely to be the case and that the significant difference in the
CD signal between the oxidized and reduced P2NaqExt is probably due to experimental
parameters that were not ideal.
As with the samples of P2Naq and RCCNaq, there is no observed concentration
dependence of the CD signal with either P2NaqExtox or P2NaqExtred, Figure 3.10B. It is of
note, that once again, in the reduced 50 µM sample there is an anomalously low measured
mean residue molar ellipticity at 217 nm.

3.5.5 Naq specific CD signals in P2Naq and P2NaqExt
The observation of a slightly different CD spectrum in the 240 nm-260 nm region
for lanthanide bound P2Naqox and P2Naqred, Figure 3.11B, was further confirmed with
P2NaqExtox and P2NaqExtred, Figure 3.11C. In the helical control peptides, the spectral
features are more clearly those of the oxidized and reduced Naq. On closer inspection of the
P2Naqox and P2Naqred samples, only P2Naqox shows any sort of identifiable spectral features,
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Figure 3.11A. The CD signals of the
RCCNaq random coil peptides do not show
any discernible spectral feature relating to
either form of the amino acid. The CD
signal of aromatic amino acids in the nearUV is known to be responsive to local
protein environment like the net-dipole
moment, which affect the symmetry of the
chromophore’s environment and thus the
CD

signal

through

changes

in

the

chromophore’s polarizability. The apparent
tracking of Naq’s chromophore CD signal
with helicity in these peptides, with no
apparent response in random coil peptides
and the strongest response in the helical
control peptides, can serve as an additional
approximate ‘site-specific’ measure of the
fraction helicity of Naq in the apo and holo,
reduced and oxidized P2Naq peptides. By
Figure 3.11. Naq chromophore specific molar
ellipticities in P2Naq ox (A), and both redox states of
holo P2Naq (B) and P2NaqExt (C). N preptide is the
number of backbone peptide units. Data fit with
cubic spline. See text for details.

using non-residue averaged redox difference
CD spectra to remove the effects of the
remainder of the peptide backbone from the

analysis, the observed changes in this region of the CD spectrum can be tied directly to the
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Naq chromophore. Use of the relevant calculated redox difference ellipticities in Eq. 3
allows an average measure of the fraction helicity of Naq in the reduced and oxidized
peptides in question. While this method might suffer somewhat from low signal strength,
this is not anticipated to prevent the use of the approach as an approximation of the real
value as a method to confirm the results obtained as described above by CD or NMR.
Additionally, non-identical CD signals of the reduced and oxidized peptides due to structural
differences are not expected to be particularly strong in the relevant region between 240-260
nm, especially since neither amides nor tyrosine absorb appreciably in this region. Finally,
while it is not clear if the Naq chromophore’s CD signal is linearly responsive to the helicity
of its environment or how this might occur, a possible explanation for the observed
response is that it is dependent on the strength of the local helix dipole which should scale
with length of the helix.

3.6 Measurement of Lanthanide Ion Binding Affinity of P2Naqox and P2Naqred
The CD response of the P2Naq peptides to saturating lanthanide confirmed that
ligand binding induced helix formation. In previous reports with the P2X peptides,8 binding
affinities were measured using changes in Tyr7’s fluorescence intensity. Initial attempts to use
fluorescence to measure P2Naqox’s lanthanide binding affinity failed, possibly due to charge
transfer between Tyr7 and Naq14 suppressing tyrosine’s natural fluorescence. This left circular
dichroism as the only spectroscopic technique capable of being used to measure lanthanide
binding. The CD titrations were significantly eased using an automated titration apparatus,
which eliminated the significant variability associated with manual measurements. Data
collected at 25 °C was fit to the tight binding equation
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CDsignal

−A − A 2 − 4[P2Naq]tot [La 3+ ]tot
= ε apo [P2Naq]tot + (ε holo − ε apo )
Eq. 10
2

where CDsignal is the measured CD signal at a chosen wavelength, ε apo and ε holo are
uncorrected ellipticities of the ligand free and bound peptides,

A is (Kd +

[La 3+ ]tot + [P2Naq]tot ), Kd is the dissociation constant, [La 3+ ]tot is the total concentration

of lanthanide ion, and [P2Naq]tot is the total concentration of P2Naq. Lanthanum chloride
stocks were made by dissolving solid LaCl3 in the titration buffer to approximately 10 mM,
making aliquots and snap freezing. The stocks were kept at -20 °C to prevent precipitation
of lanthanum carbonate formed from lanthanide ion and dissolved carbon dioxide. Stock
concentration was determined using a spectrophotometric end point titration of a lanthanide
ion stock/xylenol orange solution with a calibrated EDTA solution.25 The EDTA solution
was calibrated with a standardized zinc solution with xylenol orange. This calibration scheme
varies markedly from the method used by Richardson et al.,8 who made their lanthanide ion
stocks by mass, a technique that proved unreliable for the titrations. In the titrations, the
peptide concentration was always approximately 5 µM, as determined by UV/vis
spectroscopy using the molar absorptivities determined as described above.
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3.6.1 Lanthanide Binding of P2Naqox
The
P2Naqox

lanthanide

observed

with

titration
CD

of
was

relatively straightforward. Five identical
titrations were simultaneously fit to the
tight binding Eq. 10 at 217 nm after
their initial CD signal was zeroed due to
significant variance, Figure 3.12. The
dilution effect was accounted for by
discreetly

fitting

concentrations

of

P2Naqox, giving a Kd of 3.2 µM ± 0.4

	
  

Figure 3.12. Simultaneous fit of five identical
lanthanide ion titrations of P2Naq ox with errors in 20 mM
Cacodylate, 100 mM KCl, pH 6.9. Data was fit to the tight
binding equation Eq. 10. See text for details.

µM. This Kd is the tightest non-alanine
dissociation constant measured for the P2X peptide family.8

3.6.2 Lanthanide Binding of P2Naqred
Measuring lanthanide binding to P2Naqred proved problematic. It was determined
early that large excesses (>100 eq) of the water stable ammonia borane (NH3BH3) complex
could reduce Naq at neutral pH without the concomitant production of hydrogen gas seen
with borohydride reagents. Unfortunately, it appeared that the product borate, from the
oxidation of the borane, bound lanthanide very tightly; causing the titrations to have both a
lag before binding to P2Naqred began and, since there was likely continued oxidation of the

	
  

77	
  

borane during the course of the titration, the effective Kd measured was not accurate given
that the exchangeable lanthanide was not equal to the total lanthanide added.
Both

the

common

catalytic

oxygen

scrubbing

system

of

glucose

oxidase/glucose/catalase and the less common xanthine oxidase/xanthine/methyl viologen
interfered with lanthanum binding. Spectroscopic considerations made it clear that by adding
sufficient quantities of any of the available, non-metal binding, redox mediators to reduce
P2Naq and maintain a scrubbed sample, the absorbance in 200-260 nm range would far
exceed that needed for good CD measurements. The need for a spectroscopically silent
reductant led to consideration of the use of hydrogen gas, H2. The only literature report
known to employ hydrogen gas directly to reduce a redox active protein used a natural
hydrogenase to effect reduction.26 While an attempt was made to find sources of natural
hydrogenases, a brief literature search made it clear that although seemingly never attempted
before, the use of platinum nanoparticles could facilitate reduction of P2Naq with H2. It was
observed that at a high, but unbuffered, pH, platinum nanoparticles could reduce methyl
viologen in the presence of hydrogen.27 Since the viologen redox dyes do not have pH
dependent redox couples, a quick back of the envelope calculation suggested that the
platinum nanoparticles could conceivably reduce the higher potential benzyl viologen at the
titration pH 6.9 (the potential of hydrogen gas at pH 6.9 is -414 mV; benzyl viologen is -311
mV). Nanoparticles with a 40 kD polyvinylpyrrolidinone protective polymer in a 40:1
monomer/platinum ratio generated under standard conditions28 were capable of mediating
H2 reduction of a benzyl viologen solution at pH 6.9 as indicated by the appearance of the
blue-purple viologen radical in less than 30 s. To ensure there was no interference of
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lanthanide binding by free platinum ions,
the

colloidal

platinum

was

dialyzed

extensively in pure water.
In the reduced titrations, platinum
nanoparticles were kept at a platinum atom
concentration within an order of magnitude
below the concentrations of the peptides
being studied. Additionally, benzyl viologen
was 50 µM, a concentration not anticipated
to interfere with CD signals but enough that
it might serve as a redox buffer. Under these
conditions, in the absence of positive
pressure hydrogen, P2A, the reference
peptide from the work of Richardson et al.,8
bound lanthanide ions with the same
affinity, within error, as that reported, 2.4
µM.8 However, under positive pressure
hydrogen gas, with the sample reduced as
observed by the blue-purple of the benzyl
viologen radical, the P2A titration gave a
much higher Kd, 4.4 µM, Figure 3.13A.
Figure 3.13. P2A titration under reducing
conditions; fit with Eq. 10 as measured (A),
ignoring first point (B), and making a linear
adjustment to the data (C). See text for details.

	
  

While this type of variance might be
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anticipated from one titration to another, the lack of this significant variability in the
P2Naqox titration data gave pause. It was also clear that the difference between the
experimental value and the reported value was solely due to what appeared to be an
incomplete addition of the first aliquot of lanthanide. This seeming incomplete addition of
the first aliquot was also observed under similar conditions for titrations of P2Naqred. In
some of these titrations, there was no observable change in CD signal after the initial 5 µL
aliquot. Changing the concentration of the platinum nanoparticles did not change the
stoichiometry of the apparent pause, and since the pause was observed in both P2Naqred and
P2A under similar conditions, it was not a peptide specific problem. It is possible that when
under positive pressure, even at the lowest over pressure setting possible, there is significant
compression of the fluid line (of a bubble, for instance) from the titration apparatus to the
sample cuvette. If this were the case or if there was an exogenous lanthanide binder in
solution, the data could be corrected by assuming linearity in the concentration dependence
of the CD signal change for the first two responsive aliquots. The lanthanide concentrations
for all aliquots could then be corrected by subtracting the concentration of lanthanide that
was apparently not added in the initial partial aliquots. The other possibility is that the
lanthanide solution is being partially added to the cuvette during manipulation of the titrant
line in setting up the titration. The correction for this would simply be to ignore the first,
‘without-lanthanide’ point. This second possible cause for the observed delay in response is
unlikely to be the case since there were titrations in which the pause lasted for two aliquots,
thus suggesting that greater than 5 µL of the lanthanide solution was added before the
titration began. 5 µL represents the volume contained in 2 cm of the steel transfer tubing
and it is highly improbable that much compression occurred during manipulation. In
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addition, when fitting the data using the assumption that the first point is to be ignored, the
fit predicts an experimental change in CD signal for P2Naqred (and P2A) that is much larger
than the signal change observed when the titrant tube is added to the sample after the first
CD signal is recorded. In any event, correcting the P2A titration as described by assuming
the first point is in error, Kd 1.8 µM ± 0.4 µM as seen in Figure 3.13B, and by assuming the
first aliquot is partially consumed, Kd 2.7 µM ± 0.4 µM as seen in Figure 3.13C, reveals that
the fitted Kd’s become significantly closer to the reported value. The assumption that the
first aliquot is only partially added matches the expected value more closely, and because of
the reasons outlined above this method was chosen for correcting the titration data observed
with P2Naqred.
Unlike P2Naqox, five identical experiments were not preformed with P2Naqred;
however, five experiments, two in duplicate, were fit as with Eq. 10; no correction for
dilution was needed since the lanthanum titrant solution had P2Naqred at the same
concentration as the sample. This procedural adjustment was made to ensure a good
endpoint was reached, as opposed to the trailing upward endpoint of the P2Naqox titrations,
and so that the sample would remain reduced while the titrant was being added. Both the
titrant and the sample contained benzyl viologen as a redox indicator and buffer to ensure
maintenance of a reduced sample during the experiment. The five values for the measured
lanthanide binding Kd of P2Naqred were in the range between 4.5 µM and 4.6 µM with an
average of 4.6 µM ± 0.1 µM, where the reported error is propagated from the error
associated with each measurement (σ=0.04 µM). If the method of correcting for the
apparent pause in the titration data were in error, it is unclear how such disparate titrations
(varying by the concentrations of peptide, lanthanide in the titrant solution and colloidal
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platinum, wavelengths of observation and methods for degassing the solutions), would
produce nearly identical measures of binding affinity.

3.6.3 Completing the Thermodynamic Box
With the measurement of the two lanthanide ion binding affinities corresponding to

ΔG(P 2Naqox ) and ΔG(P 2Naqred ) complete, a measure of the difference between the
midpoint potentials of the lanthanide bound and unbound P2Naq can be made.

E

m

holo P2Naq
-0.23 mV ± 1 mV

Fraction Reduced

1

ΔG(P 2Naqox ) , as defined by Eq. 1
and using the reported value of
Kd(P1) of 9.4 µM, is -0.64 kcal mol-1;

ΔG(P 2Naqred ) is -0.42 kcal mol-1.

0.5

Using Eq. 6 this gives a ΔG+ − , the
change in free energy between the

0
E

m

apo P2Naq
-13 mV ± 2 mV

-180

-90

bound and unbound P2Naq, of 0.22
0

90

180

E (vs. NHE)

kcal mol-1 and a ΔEm ,+ − , the change

h

Figure 3.14. Spectroelectrochemical titration of both apo
(red) and holo (blue) P2Naq in 20 mM Cacodylate, 100 mM
KCl, pH 6.9 fit to the two electron Nernst equation. The
change in measured midpoint is of the opposite sign and
of a larger magnitude than measured with the lanthanide
titrations.

in P2Naq’s midpoint with and
without lanthanum, of -5 mV. A
change in midpoint of 5 mV is not

reliably measurable by any electrochemical technique available in the Dutton Laboratory.
Early redox titrations of P2Naq with and without lanthanide indicated as much with the
measured potentials for lanthanum bound and unbound forms orbiting each other, Figure
3.14 (José Cerda, personal communication). The electrochemistry is very much similar to
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that of heptaNaq showing clear two-electron Nernst behavior in the presence of mediators
for both lanthanide bound, Em -0.23 mV ± 1 mV, and unbound forms, Em -13 mV ± 2 mV.
The ΔEm,+- is 13.2 mV, which is of the opposite sign and of a larger magnitude than the
lanthanide binding data would suggest. It is illuminating to consider that this measured
difference in energy would predict a difference in lanthanide affinities between P2Naqred and
P2Naqox on the same order as that seen between alanine and glycine in P2X, the largest
difference measured by Richardson et al.8 In the attempt to better measure the redox
difference between the lanthanum bound and unbound forms, a new spectroelectrochemical
cell is being developed which will be described in a section in Appendix A.

3.7 Backbone Chemical Shift
Determination for P2Naq, RCCNaq,
and P2NaqExt
The

nitrogen

labeled

peptides

P2Naq, RCCNaq, and P2NaqExt were
created

to

allow

the

unambiguous

measurement of site-specific helicities of
Figure 3.15. Backbone 15N labeling of the amino
acid sequence A13Ϙ14A15. The amide proton, 15N
amide nitrogen, Cα and H α are indicated for clarity.
NMR data was collected to observe the chemical
shifts of these four nuclei.

Naq and the two adjacent alanines to Naq,
Figure 3.15. In all three peptides, the
A13Ϙ14A15 (the numbering is preserved from

P2Naq and P2NaqExt, even in the case of RCCNaq) amino acid sequence was uniformly
15

N labeled to provide for a full description of the local conformation of Naq in the various

forms of the test peptide P2Naq. Circular dichroism as discussed above confirmed the
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success of the designs of the control peptides RCCNaq and P2NaqExt as models of random
coil and helical conformations, respectively. In addition, the lack of concentration
dependence of the CD signals for all of the peptides in both reduced and oxidized forms
further suggests that any NMR results observed with peptides in the low mM range should
be applicable to the thermodynamics measured with peptides in the low µM range. All NMR
data was collected with Veronica Moorman in the laboratory of A. Joshua Wand.
In the initial design and selection of

15

N labeling, it was thought that three

experiments (the 15N filtered HNHA, NOESY and HNCA) would sufficiently describe the
backbone chemical shifts,

13

Cα and Hα, the dihedral angle φ via J-coupling and the

connectivity between the side chains; ensuring identity of compared nuclei was preserved
across the various samples. For practical reasons the length of data collection was a concern
given the slow hydroxylation of oxidized Naq in solution. In trial experiments, it was evident
that the HNCA was not going to give sufficient signal strength to allow full data collection in
a reasonable (<12 hours) amount of time. To obtain 13Cα chemical shifts, a 13C-HSQC was
needed, and a 15N-HSQC was also added to the experiment list. In all, 13C-HSQC, 15NHSQC, and 15N filtered HNHA and NOESY spectra were taken of each peptide, excluding
the P2NaqExt peptides, which were not observed with 13C-HSQC due to the supposition
that the alanine chemical shifts for the residues adjacent to Naq would be indistinguishable
from the background of 16 hypothetically helical alanines. In addition, no 13Cα chemical shift
data for Naq was obtained since in the

13

C-HSQC the chemical shift of Naq’s 1Hα

overlapped with the H2O proton peak, even in a D2O sample. 13C labeling is a potential
route to obtaining these values, and given the lack of success in obtaining data from the
HNCA experiment, 13C labeling might have been more advantageous. Nevertheless, full 1Hα
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data was obtained for all of the peptides; tracking the identities of the nuclei and their amino
acids by inference proved slightly easier than expected since the chemical shift behaviors of
the two alanines across the peptides were very different. The NOESY spectra were not
entirely useful for identifying amino acids as NOE peaks only appeared in some samples,
notably only in the lanthanide containing P2NaqExt and P2Naq samples. It is also
noteworthy that due to degeneracy of the amide proton chemical shifts in some of the
samples, J-coupling values and hence values for φ are unreliable, but this is a minor point.
All data was collected at 25 °C with temperature calibrated to methanol, 15N, 13C, and
1

H chemical shifts were standardized to the 1H chemical shift of DSS by IUPAC

recommendations.29 Concentrations of the peptides ranged from 1 mM-2.6 mM; samples
were adjusted to pH 6.9 ± 0.1 as measured by a micro pH electrode. Samples which
contained lanthanide had approximately 10 mM LaCl3 added prior to pH calibration.
Measurements were performed on a Brucker 500 MHz Advance II Spectrophotometer
equipped with a cold probe. All of the reduced samples had 11 µM colloidal platinum
prepared as described above and in most cases, 100 µM benzyl viologen. Samples to be
reduced were stirred in a small pear shaped round bottom under a fast flow of H2 for at least
15 minutes before colloidal platinum was added. Reduction took ~5 minutes as indicated by
the solutions developing a blue-purple color characteristic of the benzyl-viologen radical.
After reduction was observed the samples were quickly cannulated into a clean NMR tube
that had been purged with H2 through a rubber septum. Attempts to conventionally flame
seal the NMR tubes were unsuccessful, so after sample transfer the rubber septum of the
NMR tube was dipped in a quick setting epoxy and allowed to harden for an hour before
NMR experiments were undertaken. In all cases, the epoxy sealed septum held for the
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course of the experiments, with very little evidence of oxidation of the benzyl viologen (loss
of blue-purple color) at the top of the NMR sample. Intriguingly, a sample prepared in this
way oscillated in the apparent deepness of the blue-purple color over the course of months;
a phenomenon that cannot be explained by oxygen leakage into the tube nor a simple two
component reaction. It is likely, given the complex redox active nature of the cacodylate
buffer that a complex oscillatory reaction has accidently been established in this sample.

Table 3.2. Chemical shifts of backbone atoms of 15N labeled Ala13, Naq 14 and Ala15 in P2Naq, RCCNaq
and P2NaqExt under a variety of conditions. Chemical shifts are in ppm and referenced to DSS. The 1H α
and 13Cα chemical shifts in bold were used in calculating site-specific fraction helicity see text for details.
Nuclei have same naming convention as in Figure 3.15.

3.7.1 Chemical Shifts
The measured chemical shifts for the various backbone atoms indicated in Figure
3.15 can be found in Table 3.2. The chemical shifts of the 13Cα of Naq in all peptides and in
alanines of the P2NaqExt peptides are absent for the reasons described above. The chemical
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shift values for 1Hα of Naq14 show some
trends, Figure 3.16, with the values of
the experimental P2Naq peptides for
the most part falling in between the
values obtained for RCCNaq and
P2NaqExt. On the other hand, while
there are significant differences between
the RCCNaq and P2NaqExt chemical

Figure 3.16. Graphical representation of the H α
chemical shift data in Table 3.2. P2Naq δHα (outlined
boxes) and lanthanide-bound P2Naq δHα (red boxes).
Redox dependent chemical shifts for random coil
(circle) and helical controls (box) are shown with their
corresponding atom in P2Naq. See text for details.

	
  

values for the 1Hα of Ala15 in both redox
states, Figure 3.16, the chemicals shift
for these atoms and the corresponding
13

Cα’s in the experimental P2Naq

peptides all lie very close to the random coil peptide (towards higher ppm values in Figure
3.16, e.g.), giving more evidence that as suggested by CD, the helix is not fully formed in
P2Naq even in the presence of lanthanide. This contrasts nicely with the chemical shifts of
Ala13, Figure 3.16, which like Naq14, has values of 1Hα that are well dispersed and show clear
variance between the apo and holo P2Naq peptides. In addition, the 13Cα for Ala13 values
have a much larger range than those of Ala15 suggesting the clear conformational change
implicated by the 1Hα chemical shift changes is real. The chemical shift values suggest quite
strongly that upon lanthanide binding in the P2Naq peptides Ala13 becomes significantly
helical, Naq14 becomes slightly more helical, and Ala15 does not change. This further suggests
that Naq14 is a distinct ‘helix breaker,’ and that there is possibly not enough energy in helix
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formation from the last two residues to drive it into a fully helical conformation. These
results will be discussed more quantitatively when considered with the results of the CD
studies in the next section.

3.7.2 Quantitative J-Correlation and Measures of φ
J-coupling is a direct consequence of nuclei being bound together as magnetization is
transfer from nuclei to bonded nuclei through the intervening electrons that make up the
bond(s) between them. The efficiency of this transfer is highly dependent on the relative
orientation of the bonds, which when part of a three-bond system describes a dihedral angle
according to the Karplus equation, Figure 3.17
J(θ ) = A cos 2 (θ ) + B cos(θ ) + C

Eq. 11

where J(θ ) is the measured J-coupling
between bonded nuclei, θ is the dihedral
angle between the first and third bond
defined physically, and A, B and C are
empirically derived parameters dependent
on the identities of the bonds in the dihedral
angle.1 In the case of the backbone dihedral

Figure 3.17. Karplus curve described by Eq. 11
calibrated to φ (φ = θ + 60°). The empirically
derived values A, 7.09; B, -1.42; C, 1.55 are from
reference1 and were used in the calculation of φ
from experimentally determined J HαHN.

	
   φ, φ = θ + 60 due to convention. J-coupling
is most commonly manifest as a splitting of
peaks in 1D 1H NMR. Measurement of
splitting parameters in the 1D or 2D NMR
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spectra of proteins and peptides is made more difficult due to the large amount of overlap
between nearly chemically identical nuclei. Quantitative measurement in experiments like the
HNHA take advantage of dephasing effects associated with J-coupling dependent
magnetization transfer observed in the cross and diagonal peaks

Scross
= − tan 2 (2π J H α H N ζ )
Sdiagonal

Eq. 12

where Scross and Sdiagnal are the peak volumes of the amide correlated cross (1Hα-amide 1H)
and (amide 1H) diagonal peaks, respectively, J H α H N is the measured J-coupling between the
1

Hα and amide 1HN, and ζ is a pulse delay during which J-coupling dephasing occurs.30 An
example of a nitrogen filtered HNHA
spectrum from this experimental set is
seen in Figure 3.18.
While Eq. 11 describes four
potential dihedral angles, three of the
angles described are unlikely since they
are either positive or very near to -180°.
To clarify analysis these values were
ignored, Table 3.3. Excluding values of
	
  

Figure 3.18. 15N-filtered HNHA of RCCNaq ox showing
characteristic peaks with positive intensity along the
amide proton diagonal (red) and negative cross peaks
correlated to the amide proton and H α (green).
Measurement of the relative volumes of the peaks
gives J HαHN according to Eq. 12. The J-coupling values
can then be used to calculate the backbone dihedral
φ. Data was collected as described in the text with
ζ =13.05 and 128 transients in the indirect dimension.
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φ that were determined from nearly
degenerate amide protons, lightened in
the table, there is an overall trend
towards more positive φ values as

peptides become more helical. Comparing the φ for all P2NaqExt and RCCNaq, the
reported values of φ for the helical control are closest to the idealized helical value of ~-58°
for an alpha helix. Other trends are harder to distinguish given a lack of credible data, and
the measured angles in the reduced P2NaqExt peptide are significantly higher than in the
oxidized peptide. This may have been a result of an accidental excess of benzyl viologen
radical in this particular sample, with the radical causing differential relaxation of the
transitions that lead to the cross and diagonal peaks.32 In any event, the HNHA J-coupling
experiments are not sufficient to identify the conformation of the backbone since lacking the
ϕ angle prevents full attribution. Indeed, the measured φ angles for the RCCNaq peptides
could very well be found in a naturally occurring helix.

Table 3.3. The backbone J HαHN scalar coupling constants as measured using volumes of cross and
diagonal peaks from HNHA experiments with ζ =13.05 ms as proscribed by Eq. 12. Volumes were
measured by Gaussian integration in Sparky.31 φ was subsequently calculated using Eq. 11 with values
of A, B and C from reference1 (A 7.09; B -1.42; C 1.55). Values in grey were obtained from degenerate
diagonal peaks and are unreliable, but included for completeness.
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Figure 3.19. 15N-filtered NOESY spectra of lanthanide bound P2Naq ox (A) and P2NaqExtox (B). Black bars
overlaying spectra track NOE cross peak correlations. The correlation observed in lanthanide bound
P2Naq ox suggests some presence of helicity; however, the slight correlation compares unfavorably to the
clear backbone walk from the bottom left peak of (B) corresponding to Ala13 to Naq 14 and finally to Ala15.
Data was collected as described in the text with 128 transients collected in the indirect dimension.

	
  

3.7.3 Walking the Backbone with a 15N Filtered NOESY
In proteins with well-defined alpha helices, it is possible to walk the backbone from
amide i->i+1. This is true because of the close proximity in space of the amide protons of
adjacent residues allowing efficient NOE magnetization transfer. The NOESY spectra of the
P2Naq and RCCNaq peptides were mostly devoid of such NOE signals, Figure 3.19A, even
in the lanthanide bound P2Naq samples. However, in the P2NaqExt helical control samples,
it became possible to observe a very clear backbone-amide to backbone-amide in the
NOESY spectra, Figure 3.19B, adding further evidence of helicity of these controls, and the
lack of full helicity of lanthanide bound and unbound P2Naq.
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Figure 3.20. Chemical exchange in mix redox state sample of holo P2Naq. 15N-HSQC overlay of pure
lanthanide bound P2Naq ox (orange) and P2Naq red (blue) (A); and mixed lanthanide bound P2Naq ox
and P2Naq red in an approximate 60:40 ratio. The appearance of two additional Naq 14 ‘cross peaks’ in the
mixed sample along with observations of chemical exchange in the sample’s NOESY spectrum suggests
that electron transfer was occurring between P2Naq ox and P2Naq red. The chemical shifts in (B) are
uncorrected. See text for details.

	
  

3.7.4 Measuring Electron Transfer Rates Between Lanthanide-Bound P2Naqox and P2Naqred
While most samples were prepared fully oxidized or fully reduced, two partially
reduced lanthanide bound P2Naq samples were prepared accidentally. The NOESY of both
samples indicated some amount of slow chemical exchange was occurring between the
oxidized and reduced forms of the peptide. However, this process was more clearly observed
in the 15N-HSQC spectrum, Figure 3.20B. In comparing to the 15N-HSQC of pure oxidized
and pure reduced samples, combined in Figure 3.20A, it is clear that in the mixed sample
two additional ‘cross peaks’ arise at the intersection of the reduced amide proton and
oxidized amide nitrogen chemical shifts, and vice versa. It appears that chemical exchange is
manifest in the proton dimension alone based upon the fact that the peaks begin to merge
only parallel to the proton axis; the asymmetry of the exchanging peaks is further evidence
that the exchange process is fairly slow, since in the absence of exchange, peaks should be
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found only at the pure oxidized and reduced positions. It may be that exchange is manifest
in the nitrogen dimension as well, but the overall exchange is so slow that the length of the
15

N chemical shift evolution period in the pulse sequence is insufficient to fully observe line

broadening associated with the exchange process. The rate of the slow chemical exchange
process can be measured by
k = π (hex − ho )

Eq. 13

where k is the apparent rate constant, hex and ho are the peak widths at half max (FWHM)
of the exchanging peak and a non-exchanging peak, respectively. Using the program Sparky31
peak widths were measured in both the 1H and 15N dimension for the four peaks of Naq
observed for the exchange process and four peaks of significantly lower intensity seemingly
unassociated with either the predominant P2Naq species or the exchange process. Averages
of the observed peak widths were used in the calculation of k as described in Eq. 13. The
value of k measured in the proton dimension is 14 s-1; that for the nitrogen dimension was
2.5 s-1. The range for the FWHM values for the 15N dimension for both the exchanging
peaks and non-exchanging peaks overlapped significantly so the value is quite likely zero.
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Scheme 3.3. After Rich,33 the major route of equilibration between quinones and hydroquinones in
aqueous media at neutral to acidic pH, where proton transfer is faster than electron transfer. NQH 2 and
NQH - are the doubly protonated and singly protonated forms of the naphthohydroquinone,
respectively, NQH • and NQ•- are the singly and fully deprotonated forms of the naphthosemiquinone,
respectively, and NQ is naphthoquinone.

	
  

A major route of the equilibration between reduced and oxidized quinones in

aqueous solution reaction is well established,33 Scheme 3.3; the rate limiting step is the
bimolecular reaction between a deprotonated hydroquinone and a quinone forming a pair of
unstable semiquinones which after proton exchange react with each other in a diffusion
controlled manner producing a new quinone and hydroquinone. Rich33 determined the rate
of electron transfer between quinones of known midpoint and semiquinone potential
differences, which provide a good benchmark to compare the observed electron transfer rate
in the mixed P2Naq NMR sample. It was observed that the logarithm of the rate scaled
linearly with the driving force for the rate-limiting step creating the pair of unstable
semiquinones

ΔGo = Em (QH − / QH • ) − Em (Q•− / Q)
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Eq. 14

where ΔGo is the driving force for the rate limiting step, and Em (QH − / QH • ) and

Em (Q•− / Q) are the midpoint potentials for the single electron oxidation of signally
deprotonated hydroquinone and the single electron reduction of quinone to the anionic
semiquinone, respectively. The rate calculated from the observed line broadening is a first
order rate, which must be converted to an effective second order rate by dividing by the
concentration of the interacting species. The sample from which the rate was calculated was
approximately 1.6 mM total lanthanide bound P2Naq, and by NMR, approximately 40% was
reduced. Using the lesser concentration species as the entity which is getting reduced, since
in effect the 20% excess oxidized P2Naq is not involved in the reaction, 0.64 mM of each
species was reacting in solution giving a second order rate constant of 2.2 x 104 M-1 s-1 using
the value of the exchange rate obtained from line broadening in the proton dimension.
Using the values for Em (QH − / QH • ) and Em (Q •− / Q) for 2-methyl-1,4-naphthoquinone
calculated from reference34 and assuming approximate the pKa, 12 of the hydroquinone
dianion, ΔGo is -370 mV, which according to the studies by Rich33 corresponds to a rate of
approximately 105 M-1 s-1, which is reasonably close to the measured second order rate
constant given the need to estimate the pKa and the likelihood that fewer collisions are
productive when the quinone is attached to a peptide chain. It should be noted that this
might be the first time that a self-quinone redox reaction was observed, since NMR is the
only technique suited for its measurement.
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3.8 Measurement of the Change in Midpoint of Naq from Coil to Helix
All of the data presented thus far was collected with the goal of measuring ΔEm,α c ,
the change in Naq’s midpoint potential from coil to helix; a value that would represent the
difference in helical propensity of the two forms of the amino acid in an ideal system. Yet
P2Naq is not ideal. The fraction helicity from the CD data calculated with the assumption
that RCCNaq is a random and lanthanide bound P2Naq is fully helical using Eq. 3, Figure
3.21A, is compared to that of the NMR data using Eq. 8 with the same assumptions, Figure
3.21B, or assuming that P2NaqExt is fully helical at Naq14, Figure 3.21C. The results are also
tabulated in Table 3.4, and additionally compared to the results of calculations considering
the observed Naq chromophore CD signature as discussed in Section 3.5.5.
It is apparent that the assumption of full helicity for lanthanide bound P2Naq is
erroneous. While this was somewhat clear from the discussion of the CD data, it is made
especially clear when considering that using the same assumptions with the NMR data, in

Table 3.4. Computed fractional helicities.
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effect ignoring the P2NaqExt control, Figure 3.21B, wildly disparate results are observed for
Ala15. In addition, under these assumptions with the NMR 1Hα chemical shifts, the projected
percent helicity of Naq14 in apo P2Naq is well above the values reported for any amino acids
in the studies of the Makhatadze group,8 and seemingly significantly different (NMR 53%
versus 22% CD for P2Naqox, and 60% NMR versus 6% CD for P2Naqred) than the values
obtained by the CD data itself. This later disparity strikes at the core argument made by
Richardson et al. that the measured CD helicities are good proxies for the helicity at the guest
site in the P2X peptides. This is clearly not a universal rule. In addition, since lanthanide
bound P2Naq in both redox states does not become fully helical, it is impossible to ascertain
the helical propensity of Naq in both redox state with respect to alanine in P2A; such a
comparison would ignore the effects of helix breaking and capping that are at work in the
P2Naq peptides.

Figure 3.21. Fractional helicities calculated using CD and NMR data as described in the text. Gradients
are to guide the eye between the fractional helicities of apo (outlined white boxes) and lanthanide
bound P2Naq (filled red boxes). In (A) and (B), lanthanide bound P2Naq are assumed fully helical; in (C)
the NMR helical control P2NaqExt is taken as the helical reference state.
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On the other hand, while the data set is not complete due to the absence of the
fractional helicity from the 13Cα values, with the assumption that the P2NaqExt are fully
helical, the 1Hα numbers provide a clearer description of what is happening in the peptides.
It appears that there is limited if any helicity in Ala15 even with saturating lanthanide in the
P2Naq peptides. Ala13 behaves as expected, going from approximately 50% helical in both
redox states of P2Naq to fully helical upon saturating lanthanide. The exceptionally high
134% helicity for Ala13 the lanthanide bound P2Naqred appears to be due to a slightly higher
than anticipated Ala13 1Hα chemical shift in P2NaqExtred as is evident in Figure 3.16. A small
adjustment of the chemical shift by 0.03 ppm, the width of the peak in the HNHA
spectrum, brings the value down to a more reasonable 107% helicity. Naq14 in both oxidized
and reduced P2Naq increases in total fractional helicity upon lanthanide binding, while not
becoming fully helical. The redox average values for fraction helicity obtained by NMR in
both the lanthanide unbound (25%) and bound forms (43%), are close to the values
calculated by using the redox difference CD signal of the Naq chromophore at 243 nm (8%
and 36%). The better match to the lanthanide bound peptides might be attributable to better
signal-to-noise in significantly helical samples. Nevertheless, it is a nice confirmation that the
NMR results are somewhat correlative to more global measures of helical content, since the
CD signal of the chromophore is reporting on much larger scale environmental effects.
Finally, using the fractional helicities determined by 1Hα NMR using RCCNaq as a
random coil control and P2NaqExt as a helical control, a measure of ΔEm,α c can be made
using the lanthanide binding affinities corrected by the lanthanide affinity of P1 as described
above and Eq. 7. Without any further assumptions, ΔEm,α c is measured to be -16 mV.
Assuming that the NMR fractional helicities can be better represented by averages between
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the values of the two redox states, ΔEm,α c is -13 mV. These are not large numbers, roughly
0.7 kcal mol-1, which alone is not likely to destabilize a long helix upon a redox change (to
some degree evidenced by the P2NaqExt control). However, it is possible that by placing
multiple Naq’s along a helix, it might be possible to create a redox sensitive conformational
switch. The switch may be highly cooperative depending upon whether nearby Naq’s affect
each other’s midpoint potentials. Without such cross talk, it is anticipated that by reducing
one Naq and partially destabilizing the helix, the remainder will follow more readily.

3.9 Conclusion
A fundamental assumption in this analysis has been that in P2Naq the only major
difference in structure in the two different redox states is associated with Naq, that is, that all
of the other amino acids adopt the same conformation and interact with each other in the
same way. While this may be true for amino acids prior to Naq, namely the preceding alanine
and the entire lanthanide ion binding motif represented by P1, given both the NMR
observations of Ala13 and the fact that the peptides both still bind lanthanide ions in an
expected range, the residues following Naq are clearly unstructured and may be adopting
different unstructured states. However, it is not anticipated that the last two residues of
P2Naq will vary from either their random coil state, suggested to be true by the NMR of
Ala15, or, perhaps more significantly, between reduced and oxidized P2Naq thus allowing
their energetic contributions to be balanced upon subtracting the corrected free energies of
binding.
The final result of this work is a measure of the change in midpoint potential of Naq
on going from a coil state to a helical state. The determined ΔEm,α c is not large,
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approximately -16 mV or 0.7 kcal mol-1, a pittance compared to the general stability of most
proteins (on the order of 7 kcal mol-1 for example, for the holo four-helix bundle
cytochrome b562).35 It is difficult to say exactly what the source of the 16 mV difference is.
The value of ΔEm,α c is approximately on the order of a hydrogen bond, and while it is
certainly likely that the ability for the side chain to hydrogen bond in the helical state is
reduced in comparison to the random coil state, it is difficult to ascertain how this might
effect differentiation between the two states. The change in midpoint might also arise from
other sources, like the presence of a helix dipole perturbing, however incrementally, the pKa
of the reduced amino acid, or perhaps it is even more directly related to the helical
rotamer(s) of Naq and the ability of the methylene protons to hyperconjugate into the ring
system. Regardless, it is clear that in short helices or near the end of long helices Naq is quite
likely a helix breaker in both redox states. While this certainly limits the range of structural
environments Naq can be placed, it might be possible to design around the helix-breaking
tendency by introducing competitive hydrogen bonding partners that selectively stabilize
Naq’s helical rotamer(s). It may be possible to do this in a catholic manner, using side chain
amides of asparagine and glutamine or the hydroxyls of threonine and serine to serve as
hydrogen bond donors and acceptors for the carbonyls of the oxidized form or the
hydroxyls of the reduced form, respectively. It is important to realize, however, that in the
P2NaqExt peptides, without any designed interaction, Naq was integrated into a stretch of
helix which had all of the hallmarks of a natural helix, ranging from the CD spectrum to the
observation of backbone amide to backbone amide NOE’s to the measure of φ, which in the
case of P2NaqExtox was nearly ideal for the stretch of AϘA. However, in the future care will
certainly need to be taken on incorporating Naq near the end of helices.
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Chapter 4: Differentiating Oxidized and Reduced Naq in
Designed Protein

4.1 Introduction
The projects described in Chapters 2 and 3 establish Naq as a well-defined new
quinone cofactor demonstrating the full range of quinone electrochemical properties
observed in natural system with real, but perhaps limited, perturbation of short helices. An
observed moderate change in midpoint potential upon going from a random coil state to a
helix is tantalizing evidence that Naq’s environment may have larger measurable
electrochemical effects. Indeed, it may be possible to design two structurally identical
peptides that separately tune the environment around Naq to selectively stabilize the neutral
oxidized (quinone) or neutral reduced (hydroquinone) redox states. The measured midpoint
potentials of Naq in peptides designed with such differentiation in mind should separate
according to the redox state that was stabilized in the design process. So in considering a
design that stabilizes the introduction of an oxidized Naq cofactor, the midpoint potential
should become more negative compared to an undersigned reference state, in essence,
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making it more energetically costly to introduce the reduced ‘mutation.’ The opposite should
hold true for a peptide designed to stabilize the hydroquinone for the same reasons. In
effect, by driving the design of the peptides towards stabilizing particular redox states there
should be a measurable difference in their respective midpoint potentials, Figure 4.1. The
likely order of this difference is unknown, but given that the two forms of the amino acid are
neutral under most pH conditions,
perturbation is likely to be manifest by
either the significant differences in
hydrogen bonding geometry preferred by
the two forms of Naq’s side chain, or via
more generic and possibly less energetic
interactions affected by the difference in
electron density of the two redox states.
Figure 4.1. The effect of progressively and
independently designing proteins to stabilize only
one of two different redox states of Naq. As designs
separately become more stable through specific
interactions with Naq in its different redox states, a
difference in midpoint potential between the peptides
will develop. This cannot progress indefinitely; rather,
there is an unknown limit where the design scaffold
reaches its maximal differential stabilization of the two
redox states. This is true even if negative design is
introduced to destabilize the opposing redox state. In
nature, however, evolution is not limited to considering
only two forms of a quinone. At least six quinone states
are at play in natural systems, each with their own
evolving axis of stabilization.

The largest differentiating electrostatic
effects might be driven by cation-pi
interactions,1,2 but contacts such as these
would also include pi-pi interactions as
well as subtle changes in van der Waals
(vdW)

forces

due

to

polarizability

changes between the two redox states. It
should be clear that if the design process works, the observed differentiation will provide
new information with respect to the extent and ability of natural systems to modify the
electrochemistry of generic quinone cofactors.3,4
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The typical approach towards maquette design in the Dutton laboratory is to start
with a candidate sequence that is likely to adopt a particular structural fold and iterate over
several generations until the desired properties are obtained.5 While this approach has
succeeded primarily because it is an evidence based design process,6 it is not likely to provide
enough structural resolution and global consideration of the energy landscape of a peptide to
allow the development of two structurally similar peptides designed to selectively stabilize
different redox states of Naq. On the other hand, a variety of computational protein design
approaches7,8 exist that might be able to address this question. The choice of the Saven
laboratory’s statistical computationally assisted design strategy (SCADS) is obvious since,
while it requires the input of initial backbone coordinates for a target design, it is not
exclusively dependent upon natural structures to generate pair-wise interaction energies
between amino acids, is fast and it generates a testable number of possible designs which can
be further optimized in an iterative computational approach not unlike the hand-designed
maquette approach. In addition, as will be discussed below, SCADS has been used in the
redesign of a short miniprotein which is an ideal starting point for a structural scaffold
incorporating Naq.9
SCADS uses an informational entropy approach to generate site-specific and amino
acid-specific probabilities of stabilizing mutations.10 The sequence entropy derived directly
from these probabilities is constrained using mean-field energy terms that are dependent
upon the amino acid probabilities, allowed rotamers, pair-wise interactions with nearby
residues and backbone geometry. Numerically maximizing the sequence entropy subject to
these constraints using Lagrange multipliers gives a list of site-specific probabilities for the
ensemble of amino acids considered. This approach allows sequence optimization from
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single sites and a handful of amino acids to an entire protein considering all amino acids. In
addition, non-bonding energies are pre-calculated in a pair-wise manner using the AMBER
force field so the algorithm is not computationally taxing. One advantage that this approach
allows is that the energetic constraints can implicitly incorporate the energies of an ensemble
of unfolded states.
One of the concerns with any design process is blindly destabilizing the protein
target through a build up of subtly destabilizing mutations. This is particularly true when the
target protein is small enough to be produced on a peptide synthesizer, as is the case with
any simple design incorporating the Naq cofactor. Fortuitously, SCADS has been used to
stabilize the smallest known independently folding protein.9 At 20 amino acids, the Andersen
group’s wtTrpCage is structured, cooperatively folds and consists of an N-terminal helix, 310
helical loop, followed by a proline rich C-terminal tail, Figure 4.2.11 It folds around a centrally
buried tryptophan, which additionally makes a stabilizing hydrogen bond to the amide
backbone of a C-terminal Arg16, thereby ‘stapling’ the structure together.11,12 In mutagenesis
studies, the wtTrp6 was found to be essential;
significantly,

in

mutants

that

showed

significant ‘cage’ structure, the only other
amino acids tolerated at position 6 were
naphthalanine residues, which are structural
homologs to Naq, suggesting that burial of
	
  

Figure 4.2. A representative NMR structure of the
TrpCage. Primary sequence shown at top for
reference; buried wtTrp 6 is shown in spheres.

	
  

the large planar hydrophobic ring system of
tryptophan drives protein folding.13 In
addition, there is evidence for stabilizing salt
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bridges between wtAsp9 and wtArg16, and the N-terminal amine and C-terminal carboxylate.11,12
A second helix stabilizing interaction exists between wtAsp9 and wtGln5.12,14 In a subsequent
paper published after the initiation of this work, the Andersen group used alanine scanning
mutagenesis to optimize the stability of the wtTrpCage fold finding an approximately 14 °C
increase in melting temperature in a protein that had two alanine mutations (L2A and I4A),
and an N1D capping mutation in the N-terminal helix.12 The stability of the helix and the
van der Waals interaction of wtTrp6 with wtPro19 proved above all else to be essential for the
miniprotein to both cooperatively fold and achieve the TrpCage structure.
Given the wtTrpCage’s small size, which eases synthesis and structural studies, the
relatively high contact order of the buried tryptophan, partial tolerance of insertion of the
Naq homolog 2-naphthalanine at the site of the tryptophan and the successful use of
SCADS in redesigning the protein, it is the natural choice for a structural framework for
separately stabilizing reduced and oxidized Naq in a peptide. In addition, since the Naq6 site
would likely be partially buried, it would provide an opportunity to observe how changes in
protein environmental hydrophobicity affect Naq’s redox properties, an environmental
constraint that was not adjustable in heptaNaq (Chapter 2) or the P2Naq (Chapter 3)
peptides. Selectively redesigning the wtTrpCage to incorporate either Naqox or Naqred should
produce so-called NaqCages with different electrochemical midpoints.

4.2 SCADS Redesign of wt TrpCage into Redox State Specific NaqCages
Initial attempts to generate usable SCADS output by the author were unsuccessful
and as the collaboration developed with the Saven laboratory, Seung-gu Kang took the
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initiative to generate the designs discussed below. The work described in this section is that
of Seung-gu Kang, a graduate student in Jeff Saven’s laboratory.

4.2.1 Optimizing wtTrpCage Scaffold
The NMR structure of the wtTrpCage11 consists of the top 38 models that matched
the NMR constraints. However, SCADS requires the input of a single backbone pdb
structure for mutagenic optimization. The individual structure which showed the lowest
overall z-value (deviation from the mean) for the structural parameters (φ, ϕ, χ1, χ2) defining
the local geometry of Trpg and which visually confirmed the known stabilization wtAsp9wt

Arg16 salt bridge was intact was selected for use as a starting backbone (model 34 in

1L2Y.pdb). Unfavorable van der Waals contacts in the chosen structure were eliminated by
minimizing the energy of the structure using the AMBER potential parameters with the
secondary structures constrained.

4.2.2 Incorporating Naq into SCADS Amino Acid Library
To make good functional use of the Saven group’s design algorithm SCADS, it is
necessary to supply both forms of the non-natural naphthoquinone amino acid, Naq,
structural details that that readily exist for natural amino acids including calculating the
partial charges on the atoms for AMBER force field calculations, generation of rotamer
families, one-body backbone interactions, and pre-calculating two-body interactions with the
rotamers of other amino acids. This process begins with the calculation of the structure of
the amino acid using geometry optimization in Gaussian03 with the HF/6-31G* quantum
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Figure 4.3. Optimized scaffold for SCADS. Optimized geometry for oxNaqCage backbone overlaid upon
TrpCage model 34 from NMR structure (r.m.s.d 0.880 Å from wildtype) (A). Optimized geometry for
redNaqCage backbone overlaid upon TrpCage model 34 from NMR structure (r.m.s.d 0.289 Å from
wildtype) (B). Images created by Seung-gu Kang. See text for details.

basis sets. van der Waals parameters were obtained from the AMBER force field. Partial
charges were calculated by fitting the Gaussian generated surface electrostatic potential with
restrained electrostatic potential (RESP) charge fitting using the RED II tool. This process
generates values for point charges at the sites of atoms, which are needed for AMBER force
field calculations. For Naqred, since the hydroxyl protons on the side chain can adopt several
conformations, the side chain protons were discreetly modeled and the partial charges
assigned to the atoms in Naqred were Boltzmann weighted averages of the atomic charges
obtained from each possible conformation.
The values derived for the partial charges of both redox states of Naq were used in
defining the scaffold to be given to SCADS. Separately Naqox and Naqred were substituted
into the wtTrp6 site of the optimized wtTrpCage described above. In both cases, the geometry
of the backbone was further optimized using AMBER to accommodate the Naq side chain.
The end structures were verified by φ -ϕ analysis, with all but wtGly15 in the favored regions
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of the Ramachandran plot; it is notable that

wt

Gly15 in the wild type TrpCage can be

substituted with D-Ala in a strongly stabilizing mutation.15 R.m.s deviations from the
backbone of the

wt

TrpCage starting structure were computed: 0.880 Å between the

NaqCageox and the wtTrpCage, and 0.289 Å between NaqCagered and the wtTrpCage, Figure
4.3. Several interesting features were observed in these geometry optimized initial states. In
the case of the NaqCageox, though not observed, the Naq side chain carbonyls can possibly
hydrogen bond to the backbone amide proton of wtLeu7 (a likely helix breaking interaction)
and the amide proton of a residue at position 18 (in the case of the starting structure, a
wt

Pro18 which does not have an amide). In the case of NaqCagered, due to the hydroxyls of

the side chain being hydrogen bond donors and acceptors, possible backbone interactions
exist with the carbonyl of wtTyr3 and the amide of wtLeu7 (both helix breaking), and the
carbonyl of wtArg16, a possibly stabilizing long distance buried polar contact.
Although it is possible to force the Naq side chains to take the geometry proscribed
in the optimized scaffolds seen in Figure 4.3, to further expand the capabilities of SCADS
with respect to Naq side chain flexibility, rotamer families were generated. Using the
backbone geometry defined by the optimization procedure, a rotamer (χ1, χ2 in five degree
increments) potential energy surface of Ac-Naq-NHMe in both redox was determined,
Figure 4.4. Rotamer libraries were built from rotamers within 1.0 kT above the local minima,
giving 38 rotamers for Naqox and 22 rotamers for Naqred. While this procedure is slightly
biasing towards the backbone geometry calculated in the optimization procedure, without an
actual structure of Naq in a helix, this is the only method available to provide Naq with side
chain flexibility. It is notable that the rotamer adopted by wtTrp6 in the wild type protein is
near one of the local minima for both redox states of Naq. Finally, one-body interactions of
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the rotamers in the library with the backbone were calculated, as were the two-body
interactions between these rotamers and the rotamers of natural amino acids from Roland
Dunbrack’s library.16
!1

!2

	
  

	
  

!

!2

!2

!1
!1
	
  
! Potential energy surface of side chain dihedral angles χ 1 and χ 2 of Ac-Naq ox-NHMe (left)
Figure 4.4.
and Ac-Naq red-NHMe (right). The image at top is of Ac-Naq-NHMe. The yellow circle in either potential
energy surface indicates the local minima in which the wtTrp 6 conformation resides in model 34 of the
TrpCage structure. Images and figure layout created by Seung-gu Kang. See text for details.

	
  

4.2.3 Identification of Mutation Sites
SCADS was run incorporating Naqox and Naqred as described above. The mutNaq6 site
was left unvaried but allowed to adopt rotamers as determined above, generating
probabilities for each rotamer as a natural result of the SCADS algorithm. All other 19 sites
were individually allowed to mutate to all natural amino acids except Cys. This procedure
allowed the calculation of site specific frustration values defined as ln(wimp/wiwt), where wimp
is the site specific SCADS generated probability of finding the most probable amino acid at
site i, and wiwt is the same for the ‘wild-type’ amino acid. This procedure was preformed at
two ‘temperatures’ represented by β = 1/kT values of 0.5 mol kcal-1 and 2 mol kcal-1.
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Frustration values so defined represent a measure of the comparative stabilization of
mutations made against a wild type background. To gauge the selective effects of mutations
on the stability of one redox state versus the other an average, site-specific, relative entropy
was calculated
Srel,i = 1

2 ∑ α =1
19

(w

ox
i

) (

)

(α ) − w ired (α ) ln w iox (α ) w ired (α )

where w iox (α ) and w ired (α ) are the probabilities of finding amino acid α at site i in the Naqox
stabilizing design (oxNaqCage) or Naqred stabilizing design (redNaqCage), respectively. The
Srel,i value gives a measure of the importance of a specific site with regards to stabilizing one

form of the amino acid versus the other, thereby allowing a selection of mutants based upon
both the broad stabilization of the fold, high frustration, low Srel,i , and redox-specific
interactions, moderate to high frustration, high Srel,i . Selection of globally stabilizing
mutations and redox state differentiating mutations can then be made.
The top eight frustration sites were selected for inspection. This was more than
simply a practical measure, as beyond about eight sites conservative mutations began to
dominate suggesting that no further useful information was to be derived from analysis. Of
the eight sites, five were eliminated from consideration. Mutations at wtLys8, wtSer13, wtGly15
and wtPro17 were eliminated since they were highly solvent accessible and therefore had little
interaction with

mut

Naq6. In addition,

wt

Gln5 and

wt

Ser13 were targeted for conservative

mutations at moderate temperature. While wtGln5 was suggested to mutate to either Asn or
Asp at moderate or low temperature, respectively, this site was left un-mutated given its role
in the QXXXD helix stabilization motif. Finally, with wtLys8 it was clear that mutation might
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locally stabilize the helix but long distance interactions with other mutant sites, I4D for
instance, appeared to be probable, something the single site analysis would miss.

Figure 4.5. Identification of SCADS mutation sites. Orange (top) sites correspond to mutations selected
for stabilization of oxNaqCage. Blue (bottom) sites correspond to mutations selected for stabilization of
redNaqCage. Black (middle) site corresponds to identical mutation suggested to stabilize the fold of both
peptides. Red sites (bottom-center) correspond to sites known for their stabilizing or potentially
stabilizing interactions in the wtTrpCage. Structures were generated by Seung-gu Kang as output from
SCADS.

Three sites were ultimately chosen for mutation: the aforementioned wtIle4 which is
highly frustrated in both redox states, and wtTyr3 and wtPro18 which are frustrated but also
have a significant Srel,i , Figure 4.5. Mutation of Pro18 is absolutely required due to significant
steric contact between

mut

Naq6 and the rigid

wt

Pro18 potentially disrupting stabilizing

interactions required for maintenance of the wtTrpCage fold; in both redesigned proteins site
18 showed the highest Srel,i . The Naqox stabilizing design incorporates either a oxTyr18 or
ox

His18. In both cases the residues make good aromatic vdW contact with the oxidized

mut

Naq6. The suggestion of a mutation of the wtTyr3 to oxGlu3 is somewhat surprising given

the conservation of the wtTyr3 in the mutants generated by Andersen’s lab and its pivotal role
in establishing the fold.11,12,15 However, long-range electrostatic interactions appear to be
113	
  
	
  

Table 4.1. Sequence for the wtTrpCage and SCADS target sequences for oxNaqCage and redNaqCage
miniproteins. Ϙ is the one letter code for Naq. Sites of mutation are indicated with subscript site
numbering. GN is generational number.

Peptide
wt

GN

TrpCage
NaqCage

ox

red

Sequence
NLY3 I4 QW6LKDGGPSSGRP P18 PS
NLE3D4Q Ϙ6 LKDGGPSSGRP Y18 PS
NLE3D4Q Ϙ6 LKDGGPSSGRPH18PS
NLE3D4Q Ϙ6 LKDGGPSSGRPN18PS

1

NaqCage

	
  
driving SCADS’s selection of this mutation. The Naqred stabilizing design incorporates an
red

Asn18 residue that makes good vdW contacts and electrostatic interactions with the

hydrophobic core of the redesigned protein. The mutation at wtTyr3 is the only mutation
seemingly taking advantage of differential hydrogen bonding abilities of the two forms of the
amino acid with a

red

His3 mutation capable of hydrogen bonding to the hydroxyls on the

reduced mutNaq6 residue. One common mutation was the mentioned I4D, which makes good
stabilizing electrostatic intrahelical contacts with wtLys8. Table 4.1 summarizes the suggested
mutations from SCADS output.

4.3 Synthesis and Redesign of ox NaqCage
With three mutant sequences identified as potentially uniquely stabilizing Naqox and
Naqred in the

wt

TrpCage fold, it was decided to initially focus on testing the

ox

NaqCage

mutants; in particular, the mutant GN 1, Table 4.1, which had a oxTyr18 mutation and showed
excellent hydrophobic burial of the Naq side chain. There was also some concern, though
unfounded, that the oxHis18 mutation might covalently modify Naq. In addition, at the time
of this early work there was no convenient way to keep the NaqCages reduced during the
course of a CD or NMR experiment, precluding rapid testing of design sequences. Peptide
concentrations were determined by absorbance spectra using the molar absorptivity of the
oxidized Naq cofactor determined in Chapter 3.
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4.3.1 Synthesis and Deprotection of oxNaqCage Target Sequences
All oxNaqCage peptides discussed in this section were synthesized using standard
Fmoc-SPPS on Fmoc-Serine Wang resin on a CEM synthesizer ensuring that the C-terminal
was a carboxylate and not the more typical amides. This was essential since there is evidence
that a stabilizing interaction between the N-terminal amine and C-terminal carboxylate.
Fmoc deblock was effected using piperazine instead of the more typical piperidine to avoid
succinimide formation in the DG sequence of some of the peptides. Deprotection of the
natural amino acids using a standard TFA/scavenger cocktail mix and Naq(OMe/OMe)
using the DDQ procedure described in Chapter 3 proceeded without issue. As with all other
peptides discussed in the preceding chapters, the UV/vis spectrum of the deprotected Naq
containing peptides were unambiguously naphthoquinone. All peptide identities were
confirmed by MALDI-MS.

Table 4.2. Sequences for the wtTrpCage, optimized mutTrpCage, initial SCADS target sequence 1 for
oz NaqCage, and sequences of iteratively redesigned ox NaqCage. Ϙ is the one letter code for Naq. Sites of
mutation are indicated with subscript site numbering. Lower case q is the residue dGln GN is
generational number. GN 7c was selected on the basis of CD spectral analysis as a NMR structure target.

Peptide

GN

wt

TrpCage
TrpCage
ox
NaqCage
mut

	
  
	
  

1
2
3a
3b
4
5
6a
6b
7a
7b
7c
8

Sequence
N1 L2 Y3 I4 QW6 L7 KD9G10GP S13 SGRP P18 PS
D1A2Y3 A4 QW6 L7 KD9G10GP S13 SGRP P18 PS
N1 L2 E3D4Q Ϙ6 L7 KD9G10GP S13 SGRP Y18 PS
D1A2E3 E4 Q Ϙ6 L7 KD9G10GPA13SGRP Y18 PS
N1A2E3 E4 Q Ϙ6 L7 KD9G10GPA13SGRP Y18 PS
N1A2E3 E4 Q Ϙ6 L7 KD9G10GPA13SGRPH18PS
N1A2E3 E4 Q Ϙ6 L7 KD9 q10 GPA13SGRP Y18 PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 L7 KD9G10GPA13SGRP Y18 PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 L7 KD9 q10 GPA13SGRP Y18 PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 L7 KD9 q10 GPA13SGRPH18PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 T7 KD9 q10 GPA13SGRP Y18 PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 N7KD9 q10 GPA13SGRP Y18 PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 Q7KD9 q10 GPA13SGRP Y18 PS
T-3P-2E-1Q1A2E3 E4 Q Ϙ6 Q7K E9 q10 GPA13SGRP Y18 PS
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Figure 4.6. CD spectral data of the iteratively redesigned oxNaqCages and the mutTrpCage, the primary
sequence of which most of the mutant sequences are based. CD spectra were collected at 2 °C in 50 mM
K2PO4, pH 7 buffer. Samples were equilibrated at 2 °C for 30 min prior to acquisition of data.

	
  

4.3.2 Iterative Redesign of oxNaqCage
The CD spectrum, taken at 2 °C, of target 1, Figure 4.6A, in the absence of TFE is
characteristic of a random coil peptide, with perhaps a small amount of alpha-helical
character. It compares unfavorably to the CD spectrum of
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opt

TrpCage (mutant 10b, in the

Andersen naming scheme),12 Figure 4.6B, which shows a more classical alpha-helix CD
response. The strength of the optTrpCage CD signal cannot be compared directly since there
is evidence that because the chromophore’s CD signal at 226 nm becomes negative and
intensifies in helices, the magnitude of the 222 nm band associated with helices projects
higher helical content than is actually in the structure.11 In the presences of 30%
trifluoroethanol (TFE), a secondary structure stabilizing reagent which acts to lower the
barrier to desolvation of the peptide backbone,17 the CD spectrum appears to indicate the
protein is more helical, but still has significant random coil character. The difference CD
spectrum shows that TFE did effect a coil-to-helix transition, but it was a small change. This
is perhaps not surprising given the results discussed in Chapter 3 that suggest that Naq in
both redox states is significantly helix destabilizing, but these results were actually the first
indication that Naq might disrupt helices.
The lack of helical CD spectrum was an sign that the fold was not forming properly,
and rather than focus on obtaining melting and thermodynamic data for what little fold
might have been present, it was decided that it might be better to attempt to get to a peptide
that appeared significantly folded (as measured by an alpha-helical CD response) in the
presence or absence of TFE. Obtaining an NMR structure of this peptide would then guide
further design efforts, including recommitting the obtained structure back into SCADS.
While this initial work was underway, Andersen’s group published another paper on
the TrpCage detailing the results of alanine scanning the protein sequence and identifying
several stabilizing mutations that increased the melting point of the mutant protein by 14
°C.12 After some discussion with Seung-gu Kang, it was decided that it would not likely
change the SCADS results if the three most stabilizing mutations (N1D, L2A and S13A)
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identified by this paper.12 were incorporated into the target sequence. Additionally, the I4D
mutation that SCADS recommended was once again changed to oxGlu4 since SCADS had
also recommended this mutation to some degree and it would eliminate the potentially helix
breaking residue Asp from the N-terminal of the helix, Table 4.2, GN 2. The CD spectra of
this second generational

ox

NaqCage design, Figure 4.6C, varied significantly from the

preceding GN 1, indicating that stabilization of the N-terminal helix effected similar
responses in the oxNaqCage as in the mutTrpCage.
The two GN 3 mutants (3a and 3b), Table 4.2 and Figure 4.6D, reverted the N1D
mutation since it was apparent that the different capping strength of the Asp and Asn
residues was not significant. Mutant 3b with a oxHis18 residue further tested whether the
choice of the P18Y (3a) mutation over the P18H was at fault for the non-ideal CD spectral
response. Neither mutant was much of an improvement over previous generations, and
further confirmed that something specifically related to Naq could be disrupting the fold. In
addition, it appeared that the oxTyr18 mutant was slightly more helical even in the CD sample
lacking TFE, suggesting that the choice of target 1 as a starting point was not an issue.
The significant increase in melting temperature of the mutationally optimized
opt

TrpCage over the original

wt

TrpCage paled in comparison to the ΔTm caused by

introducing a dGln (lower case q) at the wtGly10 site (Vikas Nanda, personal communication).
It was believed that this mutation would not only be tolerated, since achiral wtGly10 adopts a
right handed backbone conformation, but actively stabilize the short 310-helix by effectively
capping it. This confirms the later findings by Andersen’s group that by introducing dAla at
both wtGly10 and wtGly15, they could get a mutTrpCage that would only partially melt at 83 °C.
Thinking that perhaps by stabilizing the fold outside of the helix might encourage the
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protein to become structured, a dGln residue was introduced into site 10, produced GN 4,
Table 4.2. The CD spectrum of GN 4 without TFE showed the largest deviation from the
previous generations, appearing significantly less random coil, but not comparably helical,
Figure 4.6E. In the presence of TFE, the CD spectrum looks appreciably identical to all
previous generations of the oxNaqCage under similar conditions. It would appear, then, that
the method of stabilization found with the dGln10 residue in the wtTrpCage is somewhat
independent of helix formation, presumably acting mostly on the 310-helix. In directing
further efforts, it became clear that the dGln residue was possibly important for the overall
topology of the protein; in addition, coming at the end of the helix it would guarantee that in
TFE the alpha-helix would not continue unabated through the 310-helix since it would be
incompatible with right handed alpha-helix propagation.
The need to stabilize the alpha helix of the oxNaqCage mutants, drove the design of
GN 5, Table 4.2. The replacement of the N-terminal Asn1 residue with the strong helix
capping motif TPEQ,18 afforded a slight increase in the amount of helix in the absence of
TFE, Figure 4.6F. However, in the presence of TFE, the spectrum takes on a much more
notable alpha-helical character, suggesting that significantly more stabilization of the helix
has occurred. It is particularly telling that in the with and without TFE difference CD
spectrum, the apparent change occurs mostly at the alpha-helix associated 222 nm band,
suggesting that elimination of the random coil, whose CD signal overlaps with the 208 nm
helical band, is more complete than in the previous mutant generations.
Combining the successful TPEQ helix cap and the dGln10 mutation allowed the
comparison of the site 18 mutants (P18Y (6a) and P18H (6b)) in a more structured context,
GN 6 in Table 4.2. Both peptides demonstrated increased helicity in their CD spectra with
	
  

119	
  

and without TFE compared to previous generations, Figure 4.6G. Once again it appeared
that the P18H mutant was slightly less helical, so for the remainder of the mutants, the P18Y
mutation was kept.
Hand modeling of the oxNaqCage using the published structure of the wtTrpCage and
editing in Naqox at site 6 suggested that if Naq was disrupting the helical fold, it could be
doing so by hydrogen bonding to the backbone of the helix and prematurely capping it, an
effect that would likely be minimized in the presence of TFE because of improved
competition between solvent hydrogen bonding contacts and disruptive peptide hydrogen
bond contacts. Further modeling suggested that incorporating a hydrogen bond donor at site
7 (wtLeu7), a hydrogen bond between Naq’s side chain 1-position carbonyl could be
effectively competed off and the helix stabilized further. Three mutant GN 7, Table 4.2,
were synthesized with hydrogen bond donating residues at site 7 in the background of GN
6a. GN 7a, with a L7T mutation, and GN 7b, with a L7N, mutation were highly disruptive
of whatever helical content was observed in the absence of TFE, Figure 4.6H compared to
Figure 4.6H. In the presence of TFE both mutants behaved identically to the previous
generation, suggesting that instead of interacting with Naq’s carbonyl, these two helix
disrupting residues were breaking an insipient helix near Naq; perhaps also suggesting that
that there might be other, unknown, structural perturbations occurring in the protein. On
the other hand GN 7c, with a L7Q mutation did not behave appreciably different than the
previous generation of peptides under either condition in CD suggesting at the very least
that the mutation was not particularly disruptive to the overall structure.
Finally, SCADS also suggested that a functionally conservative mutation (D9E) of
the Asp9 residue involved in a critical salt bridge with Arg16 might help stabilize the fold by
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allowing the salt bridge to occur over longer distances that might be necessary with Naq
incorporated at site 6. Mutating Asp9 to Glu9 in the background of GN 7c afforded GN 8,
Table 4.2. Qualitatively, the CD spectra of 8 in the absence and presence of TFE look
appreciably identical to that of 7c, though perhaps 7c is a bit more convincingly helical in
the absence of TFE, Figure 4.6I. The nearly 1.5 fold increase in signal intensity of both the
TFE-free and TFE containing sample cannot be explained by any structural consideration,
and is likely due to the fact that the measured sample concentration was probably wrong.
Regardless, the D9E mutation does not appear to significantly change the CD properties of
the parent peptide 7c.
Qualitatively, the two best peptides from this iterative design process are 6b and 7c,
and their CD spectra are nearly identical in the absence and presence of TFE. Given the
possible hydrogen bond contact between the Gln7 residue of 7c, this peptide was selected
for further study using NMR.

4.4 NMR of ox NaqCage 7c
Without any tertiary structural data provided by CD directed mutagenesis, it was
prudent to select the best candidate mutant from the iterative redesign cycle to determine, if
possible, an NMR structure. This has two advantages. First, while gross changes in CD
spectra were observed over the course of the iterative redesign cycle which tracked with an
intuitive understanding of the anticipated effects of the mutations, CD gives no real tertiary
structural information, and the stabilization of the helix afforded by the iterative redesign
could be significantly disruptive to the fold as a whole, however unlikely. Second, if a
structure is obtained by collection of relevant NMR data, this structure can guide both hand
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and SCADS redesign efforts. This would aid the process immensely since it would allow
SCADS to mutate a backbone with a structure based upon NMR obtained physical
constraints as opposed to relying on the AMBER force-field minimization that was
performed in generating the original

ox

NaqCage target backbone. The NMR determined

backbone could be used for both forms of the amino acid and thus aid the overall progress
of the project towards maximal Em separation between oxNaqCage and redNaqCage.
A set of 1H NMR data sufficient to determine the structure of 7c was collected and
processed at CCNY with Ronald Koder, Hsin Wang and Lei Zhang; a graduate student in
Ronald Koder’s laboratory. Data was collected on a 600 MHz Varian Inova
spectrophotometer equipped with a cold probe In particular, 2D TOCSY, 2D NOESY,
natural abundance 13C-HSQC, and 3D NOESY-TOCSY data were collected at 2 °C. An 80
ms DIPSY spin lock was used for the TOCSY experiments, and NOESY data were
collected at 100 ms, 150 ms, and 200 ms mixing times. Natural abundance 13C-HSQC data
was collected with signal enhancement. The 3D TOCSY-NOESY was collected with an 80
ms spin lock and 100 ms NOE mixing time. The samples were at 1.2 mM peptide, in a 50
mM K2PO4 buffer, pH 7, containing 10% D2O and 33% deuterated TFE. pH was
uncorrected after addition to peptide. Solvent suppression was accomplished with a presat
on water. Spectra were standardized to the residual TFE resonance at 3.919 ppm.
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Figure 4.7. H α region of natural abundance 13C-HSQC (A) and 1H TOCSY (B) spectra of oxNaqCage 7c. It
is possible to count nearly the correct number of H α-Cα correlations in the 13C-HSQC. The TOCSY spectrum
shows decent dispersion of the Glx residue spin systems, but suffers, like the 13C-HSQC and NOESY (not
shown), from a large streak corresponding to the residual protons on the deuterated TFE used in the
sample. Positive peaks are in red, negative in green. See text for details.

	
  
On first glance the NMR data looked incredibly promising. The natural abundance
13

C-HSQC had 20 of the expected 23 Hσ-Cα correlations, Figure 4.7A. This chemical

dispersion suggested that the various, and chemically identical amino acids were in different
structural environments which would not be true if the protein was either unfolded or
particularly dynamic. The TOCSY, which reveals covalently bonded spin systems through
scalar (J) coupling, also appeared to be particularly clean given the number of repetitive
residues (7 Glx, 4 Pro, 2 Ser, 2 Ala, 2 Gly). In particular, it was possible to count all seven
Glx spin systems in the Hα correlated part of the spectrum, Figure 4.7B, and identify the
spin systems of every residue except for one proline and one glycine. The aromatic spin
systems of Tyr18 and Naq6 overlapped significantly but were clearly observed in the TOCSY.
However, using the NOESY to walk the backbone proved to be quite limited. While the
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missing proline’s side chain became apparent in the NOESY, unfortunately, there is an
unknown TOCSY spin system on top of the region of amide-amide correlations that would
ordinarily be used for tracing the backbone of a helix. While some such correlations are
observed, there are just few enough that the helix of the

ox

NaqCage cannot be

unambiguously pieced together. For instance, Ala2, which is surrounded by two stretches
(two, and three residues) of Glx residues, would in the best case show identical helical amide
proton-amide proton NOEs in both directions. This sequence homogeneity is complicated
by the fact that there are a number of degenerate amide proton chemical shifts. The NOESY
data, unfortunately, does not allow long runs of assignments, and thus it is somewhat
difficult to identify long (sequence) range NOEs; none had been identified when
assignments were stopped.
The 3D NOESY-TOCSY was acquired to address some of the degeneracy seen in
the 2D NMR; although its value was somewhat limited due to the need to keep experiment
time under 5 days, which is about the length of time it takes Naqox to get modified
appreciably enough to see peaks growing in even at 2 °C. New peaks observed in the 3D
NOESY-TOCSY merely confirmed what was known from the 2Ds. Finally, the need for
33% TFE removes a significant portion of all of the spectra from analysis and introduces
streaks of NOE peaks that could either be due to NOE contact to TFE or the few Hα
protons that lie close to its chemical shift. It is unclear whether the missing glycine
resonances are coincident with the TFE or presat water peak. Use of a different solvent
suppression pulse sequence may have significantly reduced the size of the residual TFE
proton peaks. In particular, the WET pulse sequence uses shaped gradients to target specific
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proton chemical shift regions of the spectra thus allowing multiple solvent peaks to be
suppressed, but it was not used at the time of time of data collection.
All told, while 20 out of 23 spin systems could be clearly identified, only the
backbone protons of 16 residues could be assigned, Table 4.3. It is somewhat telling that the
majority of the residues without definite backbone assignments are the Glx residues of the
helix, where assignment was slowed by the lack of unambiguous amide proton-amide proton
NOEs. The remaining Gly and Ser resonances might be coincident with the TFE peak. It is
possible, with continued effort, that the NMR data collected would be sufficient to complete
the assignments. The well-dispersed spin systems are evidence enough for this, but without
long distance NOE contacts the structure is not solvable. With the current level of
assignments complete and without any obvious long range NOEs observable, it may not be
possible to obtain a structure without recollection of data with better solvent suppression
and higher resolution in the indirect dimensions.

Table 4.3. Backbone assignments. Sequence of the iterative redesigned oxNaqCage GN 7c; amino acids
in red indicate backbone assignments of both the amide proton, where applicable, and H α can be made.
Ϙ is the one letter code for Naq. Sites changed during the iterative redesign are indicated with subscript
site numbering. Lower case q is the residue dGln GN is generational number. GN 7c was selected on the
basis of CD spectral analysis as a NMR structure target. See text for details.

ox

Peptide

GN

NaqCage

7c

NMR Backbone Assignments (in Red)
T-3P-2E-1Q1A2E3E4Q Ϙ6 Q7KD9q10GPA13SGRP Y18 PS
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4.5 Conclusion
There is sufficient evidence to suggest that the oxNaqCage GN 7c mutant has the
approximate arrangement of secondary structures found in the original TrpCage fold.
However, it is difficult to address how compactly folded mutant 7c actually is. The CD data
suggests that in the presence of TFE, mutant 7c becomes largely helical; at least significantly
better than previous generations of the

ox

NaqCage. While the NMR confirms this

observation showing significant, but overlapping, amide proton-amide proton NOE
contacts signifying a helical conformation, there is little in the way of long sequence distance
NOE contacts suggesting a compact fold. However, this may simply be due to the fact that
the long distance contacts that are likely to occur are between side chains that have not been
either found (like Ser14) or ambiguously assigned (like the majority of the Glx residues in the
helix). In fact, the 28 long range (i->i+n, n>=5) contacts observed in the NMR of the
optimized12

mut

TrpCage almost all occur between residues at equivalent positions that have

either ambiguous side chain resonances (like Naq’s aromatics) or are not assigned in the
NMR of oxNaqCage. At the same time, large scale chemical shift deviations that Andersen’s
group observed in the TrpCages, which was attributed to the aromatic ring of Trp6 shielding
or deshielding nearby protons, were similarly observed to a lesser degree as far away as Pro19
in the NMR of 7c. These effects, indicating close proximity to the Naqox cofactor, suggest
that the oxNaqCage 7c may be adopting a compact fold, but without full assignment it is
difficult to know whether the effects are truly due to a unique structure being adopted.
It remains to be seen whether Naq can be incorporated into a folded protein of 20
residues, and whether through differential design the midpoint potential of the cofactor can
be driven high or lower at will. The SCADS output was an essential component to laying the
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groundwork for the CD data driven redesigns. This should be clear since the only SCADS
directed mutant site that was different in the final mutant 7c was a functionally conservative
D4E mutation that SCADS also picked up. The remaining mutations that progressed the
design were outside of the functional sphere of SCADS; namely, adding the sequence TPE
to the backbone, and use of a dGln residue in the 310-helix. These were perhaps the only real
inputs the hand re-design process added to the SCADS design, but they were possibly as
essential to obtaining a peptide that significantly folded in the presence of TFE. It is
noteworthy that although the fraction folded was not determined, the CD spectrum of
mutant 7c in the absence and presence of TFE appears qualitatively more helical than the
Trp6 to 2-naphthalanine mutant under the same conditions that Barua and Andersen
generated in studying the importance of the Trp6 hydrogen bond.13 In effect, the design
process to the oxNaqCage 7c created a mutant protein that represents the first apparently
successful replacement of the centrally buried tryptophan in a TrpCage-like protein. It is an
open question whether 7c or a subsequent mutant are properly structured.
On a more philosophical note, the project, as conceived, limits the design to only
two redox states of Naq when a full six are hypothetically available at neutral pH. The
electrostatic effects on the redox chemistry of neutral oxidized to neutral reduced are likely
to be somewhat minimized compared to the same effects on negatively charged
deprotonation states. In fact, the biggest effect of varying the electrostatic environment
around Naq is likely to be seen in the relative stability of the single electron semiquinone
state with little to no effect on the midpoint potential. This is perhaps why natural quinone
redox sites fall into three families related to the availability of protons with little known
changes to the midpoint of the neutral hydroquinone to neutral quinone redox couple. This
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is one of the reasons why this project was initiated to begin with, natural systems may not
have found a method to stably (in the evolutionary sense) take advantage of electrostatic
effects on the midpoint potential of neutral cofactors, but protein designers are not limited
to the survivability of a bug harboring their protein, at least not in most cases. Of course it is
also clear that selective hydrogen bonding can effect changes in redox midpoints, perhaps
evidenced by the observed change in midpoint of Naq going from random coil to helix,
hence the focus of the initial designs and subsequent mutations (see for instance between
GN 6 and GN 7) on finding good specific hydrogen bonding interactions in a structured
protein environment. These effects can be substantial – typical hydrogen bond energies of a
few kcal mol-1 can produce a substantial 65 mV change in the midpoint of Naq, especially if
the hydrogen bond is allowed to one redox state but not the other. Finally, just burying Naq
into a well packed hydrophobic environment would represent not only a first for Naq, but
also possibly restrict both water and proton access enough to change the kinetics of Naq’s
reduction and possibly its semiquinone stability through pKa effects. It is perhaps clear,
then, why it might be too early to give up on getting a structure of a

ox

NaqCage and

restarting the SCADS design process with backbone coordinates of a protein already
incorporating Naq.
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Chapter 5: Design and Properties of a Single-Chain Four-Helix
Bundle Maquette

5.1 Introduction
With perhaps the exception of a few of the soluble quinoproteins and the vitamin K
dependent carboxylases, most proteins that use a quinone cofactor bind more than one
redox cofactor. In some sense this confirms general concepts about the ability for natural
quinone cofactors to do substrate level redox chemistry, which in the case of the respiratory
and photosynthetic membrane complex para-quinone cofactors is limited to the occasional
reduction of the quinone by a hydride source like tetrahydrobiopterin1 or borohydride. Indeed,
given their biological role as membrane soluble proton and electron transport cofactors, it is
not surprising that the active sites of the membrane complexes have multiple different redox
cofactors capable of processing electrons to and from the substrate quinones. This presents
a glaring omission in the work described thus far with Naq; if the biological role of paraquinone cofactors is to predominantly act as an electron source or repository, then focusing
on the subtle effects of helix-coil transitions on the midpoint potential of Naq (Chapter 3) or
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on the possibility of differentiating between the reduced and oxidized state in a pair of
designed scaffolds (Chapter 4) completely misses the broad need for better descriptions of
active site chemistry and the natural engineering principles that guide quinone
oxidoreductases. Indeed, while most of the work that has been presented focuses on setting
Naq on a firm chemical, physical and design basis, the long term goal in the development of
Naq has been the creation of maquettes which emulate natural function. This topic will be
addressed specifically in the Future Directions section of Chapter 6. However, to jump from
simple peptide systems, the longest of which was 31 residues (P2NaqExt, Chapter 3), to a
protein that contains a single Naq residue and can bind multiple other natural cofactors
requires a significant enhancement from the designs of almost all previously reported
cofactor binding maquettes.
A maquette, in the biochemical sense, is a protein or peptide that functions to
emulate natural biological cofactor binding proteins. The maquette is further differentiated
in a strict sense from de novo designed cofactor binding proteins through the observation that
all true maquettes have had each of their amino acids selected for a particular reason.2 This
differentiation is critical to the entire maquette design process, in that because amino acids
are placed with clear intensions in each iterative round of redesign, interpretation of the
overall success of the design process is much easier than when designing a protein wholesale.
Each step and mutation can be judged according to its designed purpose. This pseudo-site
specific (not entirely specific due to the symmetry of most of the designs) knowledge of
amino acid function is perhaps best thought of as a mutational scanning of a natural protein
in reverse; each step of the iterative process of redesign introduces more complexity leading
to more native-like sequences to the point, in theory, where given the end result maquette
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designed in such a manner it would be almost impossible for the roles of the individual
amino acids to be determined by inspection. However, because of the process, the
individuals who designed the maquette would know each reason why every amino acid was
placed, and presumably the linear effects of each mutation. This process mirrors evolution
and is always dependent upon the starting point. It must be made clear, however, that the
loosest definition of maquette, which broadly incorporates both de novo designed cofactor
binding proteins and those natural proteins whose function was extended through novel
cofactor addition is perfectly legitimate and perhaps closer to the way the term is used in the
Dutton laboratory.
The earliest maquette was designed to emulate the
function of the bH and bL bis-histidine heme binding sites in the
respiratory bc1 complex.3 Based upon earlier work by Regan
and DeGrado,4 the peptide H10H24, named for the sites of
heme-ligating histidines, Table 5.1, adopted into a four helix
bundle tertiary structure characterized as a noncovalent
homodimer of cystine-crosslinked monomer helices. Sequence
design was quite minimal, based upon binary pattering of
hydrophobic and hydrophilic residues around a heptad repeat
with the heme-ligating histidines located along the hydrophobic
helix interface. The original designs were highly successful in
	
  

Figure 5.1. Crystal Structure
of apo H10H24-L6I-L13FL31M from end (top) and
side (bottom), with hemeligating
histidines
highlighted in red.

	
  

creating a multi-heme binding protein that was capable of
differentiating the redox midpoints of the bound hemes.
However, unlike natural proteins, these maquettes proved not
132	
  

to have a singular structure in either apo or holo form.5-7 Iterative redesign produced a
mutant protein, H10H24-L6I-L13F, Table 5.1, which increased the steric bulk of the
interhelix volume and allowed both NMR6 and crystal structures7 to be determined of the
apoprotein, Figure 5.1. The apoprotein structure revealed that the non-covalent monomers
naturally aligned in anti-topology, Figure 5.2A. Subsequent redesign of the sequence focused
upon producing a protein that was uniquely structured in the holo form. Several mutations
were made which eliminated one of the heme binding sites on each helix, reduced the steric
bulk near the remaining heme binding site, introduced non-ionic polar residues at sites which
become exposed to solvent upon heme binding, and lastly, deleted a critical arginine which
was responsible for heme differentiation in the original maquette design but was disrupting
the helical register, HP1, Table 5.1.8 HP1 proved to have a singular structure upon heme
binding and, while losing the midpoint potential differentiation between the two anticooperatively binding heme sites, HP1 maintained the binding affinity of heme.
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Table 5.1. Sequences of maquettes discussed in text showing evolution of design. Proteins are
separated by covalent architecture. – indicates a deletion of a residue. Ϙ represents the position of Naq
in a semisynthetic maquette (see text and Chapter 6). C is highlighted to show the site of covalent
linkage between the two chemically ligated parts of BT3Naq. Histidine heme ligation sites are indicated
in bold. Naming scheme for peptides follows laboratory convention; literature names may be different or
non-existent.
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HP1 was the first of a series of proteins designed to increase the likelihood of
obtaining a solution structure of a heme-bound maquette.2 While eliminating the sequence
homogeneity by introducing diversified surface residues was critical for NMR analysis, the
most significant advance was the conversion of the anti-oriented homodimer of cystinecrosslinked helical monomers structure of HP1, Figure 5.2A, into the syn-oriented cystinecrosslinked homodimer of helix-loop-helix monomers of HP7, Figure 5.2B. As described by
Gibney et al. with the H10H24 protein,9 this conversion only required the elimination of the

	
  

Figure 5.2. Protein topologies of multichain heme-binding maquettes HP1 (A) and HP7 (B), and single
chain heme-binding maquette BT6 with hypothetical Naq residue to demonstrate the effect of adding a
desymmetrizing cross-bundle loop (C), see text for details. Helices in vary in color by whether they have
their N-termini (blue) or C-termini (pink) pointed towards the viewer (top) or up (bottom). Loop
rearrangement was the most significant change in topology between HP1 and HP7 as orientation of
helices and heme binding site sequence did not vary significantly. Similarly between HP7 and BT6, the
most major topology changes involve the construction of a cross-bundle loop between helices 2 and 3
and elimination of the disulfide bridge found between the loops of HP7.
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CGGG sequence from the N-terminus of the helical monomers of HP1 and the addition of
two loops (sequence GGSGCGSGG) between the anti-oriented helices, Table 5.1. The
loops, which incorporated central cysteine residues, allowed the creation of a covalent
‘candelabra’ geometry via disulfide formation, though this proved unnecessary for
maintenance HP7’s properties.2 Once again, HP7 demonstrated nearly identical properties to
HP1 while allowing full NMR backbone assignments to be completed.10 Unfortunately, due
to the redundancy of the protein sequence and, hence, overlap of sidechain chemical shifts,
NOE-based distance measurements needed to define the structure were impossible to obtain
(Ron Koder, personal communication). Holo-HP7 proved to have very similar properties to
holo-HP1 with the added feature of being able to form a transient, but observable, oxyferrous state, intriguingly having a slightly higher ferrous affinity for O2 than CO.2 The
determined midpoint of HP7 was approximately -300 mV (Ronald Koder, personal
communication).

5.2 Design of BT3
The work described in this section is the result of collaboration between Tammer
Farid and the author.
HP7 advanced the groundwork set by the uniquely structured holo-HP1. It not only
represented an advance in the topological construction of the primary sequence, but, in
addition, represented the first four-helix bundle maquette in the Dutton lab to be solely
produced by expression given the length of the individual monomers (though more recent
maquettes of similar length have been synthesized). However, for all of its benefits, HP7
cannot be used directly for incorporating a single site mutation or covalent modification due
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to the homodimeric nature of its structure, and this certainly precludes, without resorting to
heterodimeric disulfide bridged helix-loop-helix monomers, incorporation of a single Naq
residue. Rather, if possible, it would be much preferable to have a single chain variant of
HP7. In work undertaken simultaneously as that presented here, Bender et al. describe the
creation of a single chain dual iron(III) porphyrin binding de novo designed four-helix bundle
protein with a significantly different cofactor binding architecture, though nearly identical
topology, than HP7.11

5.2.1 N-Cap design
In the NMR of HP7, it was clear that the N-termini of the monomers were not
structured. The same sequence on the N-terminal end of the second helix in the helix-loophelix monomer was however structured (Ron Koder, personal communication). To further
advance solution structure determination by clarifying the NOE constraints of the Nterminal residues, Ron Koder added a non-ideal Ser-Pro sequence to the beginning of the
HP7 sequence producing HP8 (Ron Koder, personal communication), Table 5.1. This had
the undesired effect of eliminating one of the heme binding sites (data not shown, collected
by T. Farid). To test the more ideal N-capping motif TPEQ,12 BT2 was synthesized as a
single helix of HP7 with this N-capping motif in place, Table 5.1, and a C-terminal loop
ending at a Cys for covalent cross linking. Presumably forming dimers of cystine-crosslinked
dimers BT2 demonstrated full two-heme binding, suggesting the ideal capping sequence
TPEQ would not interfere with heme binding in a single chain HP7 variant. Since it was
observed that the glycine-serine loops in HP7 were sufficient to cap and stabilize the N-
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terminal end of the second helix in the monomer, only one N-terminal TPEQ sequence was
needed in the single chain variant.

5.2.2 Cross Bundle Loop Design
The nine residue loops of HP7 are much longer than would be expected to link two
adjacent helices.13-15 However, in the development of HP7 it became clear that shorter loops
increased the amount of higher order oligomeric states of heme bound maquettes as
observed by size-exclusion chromatography (Ron Koder, personal communication), which
confirmed an earlier report that suggested shorter loops would be disruptive to the fourhelix bundle fold,15 although in that case the variation observed was in loops 3-5 residues
long. The need for loops of nine residues belies the fact that the N-terminal and C-terminal
ends of the Dutton Laboratory maquettes are still very much identical to the original design
and have not been optimized for linking via loops in this manner, especially considering the
need to not interfere with cofactor binding. Indeed, the glycine-serine loops in HP7 were
designed to be as minimally perturbing as possible so as not to develop a set structure that
might interfere with assembly or cofactor binding. Since there was no need to keep the
cystine-crosslinks in the single chain HP7 variant, the central cysteine in the found in the
HP7 loops was replaced by a homologous serine residue that had been previously found not
to globally change the properties of the heme bound HP7C38S.2 Additionally, it was
envisioned that the cross-bundle loop (from helices 2 to 3), Figure 5.2C, would need to be
longer than the loops found in HP7 so the cross-bundle loop length was increased to eleven
residues by the addition of two glycines around the central serine in the HP7C38S loop,
Table 5.1. This design process contrasts with that used by Bender et al. in the de novo redesign
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of a dual iron(III) porphyrin binding single chain four-helix bundle.11 Using a database of
natural interhelical loop structures, the DeGrado group were able to find a loop that best
matched (r.m.s.d.) the positioning of at least five Cα backbone atoms at the loop-helix
interface of a computationally optimized backbone. This reveals an advantage that de novo
design methods has over the maquette iterative design procedure in that computational
approaches do not depend upon the determination of a protein structure when a backbone
target is produced during the design process, thus making it easier to systematically design
loops and other structures to stabilize a goal structure.

5.2.3 Addition of an N-Terminal Methionine
To allow direct expression of the new single chain maquette in E. coli for use in the
intein work detailed in Chapter 6, an N-terminal methionine was appended, giving the final
sequence of the single chain HP7 variant, BT3, Table 5.1.

5.2.3 Breaking the Symmetry of HP7
Addition of the cross-bundle loop between helix 2 and helix 3, Figure 5.2C,
generates the possibility of two topologically distinct, but nearly structurally identical BT3
conformations. The same conformational rearrangement in HP7 is possible, but it produces
a protein that has an indistinguishable topology. This level of symmetry is broken by the
addition of the cross-bundle loop. It is anticipated that at least with early BTX designs, this
new asymmetry will have limited effects on heme cofactor chemistry since no difference in
properties was observed between the non-identical sites in HP7 with histidine knockout
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mutants. However, it should be clear from Figure 5.2C that positioning an amino acid like
Naq that introduces further asymmetry into BT3 can cause some differentiation between the
symmetric pair in a manner that may complicate analysis. To avoid significantly different
behavior from the two topological arrangements of helices in such pseudo-symmetric
bundles, mutations are effectively limited to pseudo-symmetric positions that are not in
different environments with heme bound. Essentially, until one topology can be forced to be
favored this requires placement of single site mutations at positions that should remain
solvent exposed regardless of topology. The caveat to this design consideration is that
mutations that are designed to break the remaining symmetry and effect differentiation of
the heme sites will more than likely be found at positions that vary significantly in their
environments between the two topologies.

5.3 Confirmation of General Properties of Heme Binding Maquette BT3
The work presented in this section and subsequent sections is based upon data
collected by Ross Anderson and Tammer Farid. The author was actively involved in the
design process of the maquettes described below, which was mirrored in the work presented
in Chapter 6; however, for the sake of brevity, this work will be discussed in the context of
the BT3 maquette because the advances of BT3 are not exclusively in the domain of Naq
incorporation. While incorporation of Naq into a single site in a four-helix bundle maquette
was the original motivation for developing the BT3 protein, it was also evident that the
natural advantage of being able to introduce mutations truly site-specifically in a single chain
protein would greatly enhance the structural, cofactor and environmental control possible in
the maquettes. It is believed that the long term benefits of the development of the BT family
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of single chain four helix bundles will be in the diversity that this structural change allows,
including the incorporation of one or more Naqs.
All BT proteins were expressed in E. coli BL21(DE3)-RIL as a C-terminal fusion to
GST. Purification on a nickel column, followed by cleavage from the fusion via a TEV cut
site afforded BT3 with an additional N-terminal glycine residue.

5.3.1 Heme Binding
BT3 was designed as a single chain
variant of HP7, which unambiguously binds
two hemes.10 End point heme titrations at
high and low concentrations of BT3
universally showed that BT3 binds only one
heme; thus, failing to match the design
Figure 5.3. Iron(III) protoporphyrin IX (PPIX)
endpoint titrations of BT3 at 1.88 µM showing
unanticipated one-heme binding in a protein
designed with two binding sites. Lines through
data and drop line from equivalency point are
meant to guide the eye. The titration was followed
at 412 nm, the peak position of the bound heme
Soret. Filled dots represent titrations in which heme
binding was observed; open dots represent those
in which heme aliquots contributed to free heme
spectra. Equivalents bound is calculated at 0.98
hemes/bundle. Data collected by Tammer Farid.

	
  

criteria, Figure 5.3 (Tammer Farid, personal
communication). It was apparent that either
the cross-bundle loop or the N-cap was
interfering with heme binding since no
other

major

structural

changes

were

incorporated in the step from HP7 to BT3.

While this result was surprising, the iterative design process limits the number of factors that
needed to be tested to identify the root causes of the property change, something that would
be difficult to do in a protein designed from scratch.
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5.3.2 Molecular Oxygen Binding
Perhaps not surprisingly
given that one site of BT3
binds heme and both sites of
HP7 independently (and jointly)
bind molecular oxygen, ferrous
heme
Figure 5.4. Formation of oxy-ferrous state in hemin bound BT3 in
a stopped-flow experiment. Spectral panels show Soret (left) and
alpha-beta bands (right) of intermediates determined by SVD
analysis of the full spectral kinetic traces. Oxidized (blue), reduced
(black) and oxy-ferrous (red) states are distinctly visible. Data
collected by Ross Anderson.

holo

BT3

binds

molecular oxygen with similar,
or

perhaps

slightly

better,

kinetics as HP7, Figure 5.4.

This suggests that the molecular rate constants involved in this unique property are
appreciably maintained even though the protein does not have two functional heme binding
sites.

5.3.3 Redesign
The observation that either the loop or the N-cap, or both, were interfering with
heme binding at one of the sites was confirmed in an early chemical ligation maquette based
upon BT3 that incorporated Naq(OMe/OMe) in the forth helix, BT3Naq(OMe/OMe),
Table 5.1. Incomplete histidine knockout mutagenesis studies appeared to indicate that the
N-terminal heme binding site (Site 1) was not binding heme. This weakly suggested that the
N-cap, which had not interfered with heme binding in BT2 was the cause of the loss of twoheme binding, however, the histidine knockout studies could not completely exclude the
loop from potential interference. Mutagenesis of the N-cap to the simpler and less bulky
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Asp, BT4, Table 5.1, produced no further changes in heme binding behavior. Further
mutagenesis of the Asp residue to a Gly was underway when two laboratories working on
related proteins revealed that a cross-bundle loop length of nine residues identical to the
loops found in HP7 was sufficient to maintain heme-binding behavior (Dror Noy and Ron
Koder, personal communications). This was quickly confirmed, Figure 5.5, with a new
mutant BT6, Table 5.1, which also completely eliminated the N-cap (though it proved
unnecessary, mutant BT5, Table 5.1, which maintained the TPEQ N-cap and had shorter
loops bound two hemes, Tammer Farid, personal communication).
Surprisingly, the exceeding long
cross-bundle loop somehow interfered with
two-heme binding. It is possible that a loop
of such length allows the protein to adopt a
lower energy heme binding topology that
excludes a second heme-binding event.
While the loop is certainly long enough
(extended length approximately 37 Å) to
Figure 5.5. ‘Two-heme’ binding restored in the BT6
single chain heme-binding maquette. Iron(III)
protoporphyrin IX (PPIX) endpoint titrations of BT6
at 5.16 µM showing a closer to ideal 1.8 equivalents
heme bound per bundle. Lines through data and
drop line from equivalency point are meant to
guide the eye. The titration was followed at 412 nm,
the peak position of the bound heme Soret. Filled
dots represent titrations in which heme binding was
observed; open dots represent those in which heme
aliquots contributed to free heme spectra. See text
for details and discussion of deviation from
optimum 2 equivalents. Data collected by Tammer
Farid.

span most of the entire helix (~43 Å), it is
unclear if this is the cause of the observed
properties. As will be discussed below, there
is evidence that by forcing BT3 into proper
orientation two heme-binding can be
restored. More sophisticated loop design
will need to be addressed at some point, but
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the current generation of maquettes will likely continue to function without intensive loop
redesign. It should be noted that although the maquettes have shown unambiguous twoheme binding by NMR,10 the stoichiometry obtained during a titration is invariably lower.
Some amount of this may be due to overestimation of the concentration of the protein or
under estimation of the heme stock (determined with pyridine hemochrome16), but these
corrections are not perfectly in line with the data for proteins that only bind one heme. In
those cases, the amount of heme bound is nearly exactly one. What this might be suggesting
is that in at least all of the recent maquettes the first heme binding mostly occurs at one site
with a minority binding in a topology or higher order protein aggregate that prevents a
second heme binding. This minority binding site would have to be of a low enough fraction
that it is not apparent in NMR studies. It could be that the failure of BT3 to bind two hemes
was just an extreme example of this sort of behavior. Unfortunately, without a means to
detect such minority binding events, it may not be possible to fully describe this slight
deviation from integer binding in the second heme site. It is likely that NMR on heme
binding in BT3 would be revelatory.

5.4 cBT3
The work described in this section is almost entirely that of Ross Anderson. While
the author was engaged in the protein design process and some of the experimental designs,
it is included to further emphasize the long-term benefits of the single chain BT3 family of
proteins.
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5.4.1 In vivo c-Type Maturation
The

heme

and

iron(III)

porphyrin binding maquettes developed
thus far have been mostly focused on the
non-covalent attachment of the cofactor
	
  

Figure 5.6. Spectra of ferrous Heme A (green), Heme
B (red) and Heme C (blue) bound to protein
maquettes. With the advent of the BTX family of
single chain heme-binding maquettes a c-type heme
can be incorporated into the maquette family with
single site specificity. Data collected and figure
generated by Ross Anderson.

ligand in the holo proteins. A notable
exception is the work by Ishida et al. in
which a helix-loop-helix version of
H10H24 was converted from a b-heme

binding maquette into a covalent c-heme binding maquette using the conserved c-type
binding motif CXXCH.17 Reaction with iron(III) protoporphyrin IX in vitro afforded an
undisclosed amount of a singly thioether linked c-type monomer creating a dimeric double ctype protein.17 Under similar conditions, cBT3, Table 5.1, with a CXXCH motif at the
second helix’s heme binding site (Site 2), c-type incorporation was minimal (Ross Anderson,
personal communication). However, expressing cBT3 with an periplasmic export tag in
BL21(DE3) constitutively expressing a c-type maturation operon on the pEC86 vector
generates a majority of the desired dithioether modified c-type, Figure 5.6. Such in vivo
incorporation of a cofactor at a single site in BT3 represents a critical advance in the
maquette family design.
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Figure 5.7. Potentiometry of cBT3. Spectra acquired during potentiometry of cBT3 (left) showing classing
c-type heme responses and reversible one-electron Nernst redox behavior (right) with an Em of -232 mV,
slightly more positive than b-hemes in similar constructs. Data collected and figures generated by Ross
Anderson.

5.4.2 Potentiometry and Molecular Oxygen Binding
Potentiometric titration of cBT3 was typical, Figure 5.7, with an expected slightly
more positive midpoint potential compared to the b-type maquette, Em -232 mV at pH 9.0.
Like ferrous BT3 and HP7, fully matured ferrous cBT3 also binds molecular oxygen, Figure
5.8. Intriguingly, when titrated with iron(III) protoporphyrin IX, the c-type incorporated
cBT3 bound an additional one equivalent of heme, suggesting that the binding of a c-type
heme covalently at the more C-terminal heme site (Site 2) returns typical two-heme binding
properties (Ross Anderson, personal communication). Since the c-type is on the second helix
which ideally bis-histidine ligates an iron(III) porphyrin as a partner with the forth helix, it is
possible that c-type heme binding serves to eliminate the flexibility imparted upon the bundle
by the long cross-bundle loop by preventing the forth helix from adopting a topology that
allows it to improperly histidine ligate an iron(III) porphyrin co-ligated with the first helix.
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Figure 5.8. Formation of oxy-ferrous cBT3 in a stopped-flow experiment. Soret peak (A) and alpha-beta
band (B) absorbance spectra of four forms of cBT3. Reduced (blue), oxidized (green) and oxy (red) were
determined by SVD analysis on full spectral kinetic data from the experiment and match literature
spectra for the species. Carboxy (black) was determined in a separate experiment. Kinetic trace (C) shows
auto-oxidation of oxy-ferrous heme. Data collected and figure generated by Ross Anderson.

	
  

5.5 Conclusion
The development of the two-heme binding single chain maquettes BT5, BT6 and
cBT3 from the homodimeric HP7 represent a new range of opportunities that have thus far
been absent from the heme maquettes. cBT3 is the first direct example of this development
showing that in vivo incorporation of a redox cofactor in a site specific manner can be fully
realized. This also completes one aspect of the long story of natural heme cofactor binding
in the maquettes as all three of the most common hemes, heme a, heme b and heme c, have
now been shown to bind in a single protein, Figure 5.6. It is now almost trivial to generate a
maquette that binds any two of these natural heme cofactors, a feat that was not possible
before the development of the single chain maquette family. On a more practical note, the
preservation of the critical properties observed in the previous generation maquette HP7
means that differentiation and selection of a subset of properties can be held off for at least
another generation. The advancement to a single chain maquette also makes it more practical
to introduce mutations that would ease solution structure determination by eliminating the
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hurdle of sequence homogeneity. Finally, the BT series of proteins represent the first time
that advances in the generation of semisynthetic proteins can be applied to the maquettes, a
distinction that allows the incorporation of Naq into designed protein scaffolds capable of
emulating natural redox electron transport proteins.
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Chapter 6: Incorporation and Deprotection of Naq in a FourHelix Bundle Maquette

6.1 Introduction
The single chain BTX heme-binding four-helix bundle maquette family (Chapter 5)
was conceived as a way to produce four-helix bundle maquettes that permitted single sitespecific mutations free from the pseudo-symmetry of all previous generations of maquettes.
As was seen in Chapter 5, this allowed the single-site incorporation of a c-type heme in the
progenitor single chain maquette BT3. Yet the advantages of the BTX maquettes are not
limited to single-site mutagenesis. Indeed, by taking advantage of expressed protein ligation
techniques,1 a single chain BTX mutant can be created with synthetic fragment containing
any number of functional moieties not available in vivo.
Expressed protein ligation (EPL)1 built upon the already established native chemical
ligation (NCL), in which a synthetic fragment having a C-terminal thioester and a peptide
with an N-terminal cysteine are initially coupled via thioester exchange, Scheme 6.1.2 A
subsequent rearrangement of the crosslink affords a native peptide bond between the two
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synthetic fragments. There is a similar system in nature, wherein a protein domain efficiently
excises itself post-translationally, leaving intact the functions of the remainder of the protein
via cross coupling the N-terminal and C-terminal fragments at the site of excision. In
recognizing that these so-called intein domains catalyze their reactions through a thioester
intermediate, using a commercially available intein based protein purification vector Muir et
al. were able to capture the thioester of an expressed fragment of Csk. Through native
chemical ligation they then attached a synthetic fragment containing a phosphorylated
tyrosine residue thought to be important for the self-inhibition of the related kinase Src, but
absent from wild type Csk, thus generating a full length phosphorylated-Src analog that
lacked self-inhibition.1 Like native chemical ligation, expressed protein ligation results in the
incorporation of a cysteine residue at the site of cross-linking. While a full review of the use
of native chemical ligation and expressed protein ligation is beyond the scope of this chapter,
these techniques have been used to create a sizable number of previously impossible or very
difficult proteins from the total synthesis of all D-amino acid proteins,3-5 to construction a
three segment piecewise MBP expression system that allowed selective 15N labeling of each
segment.6 The biology of inteins themselves is fascinating – the intein domain is an
expressed part of a parasitic genetic element and in most cases serves as a homing
endonuclease for propagation of the gene that encodes it. Because the intein splices out of

Scheme 6.1. Native chemical ligation between two peptide fragments. See text for details.
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the gene product that it has infected, it minimally perturbs the normal biological function of
its host.7 Regardless, it is clear that by using expressed protein ligation of the single chain
BTX maquette family with a synthetic fragment, it should be possible to incorporate Naq
into a semi-synthetic four-helix bundle maquette.

6.2 Building a Maquette Competent
Expressed Protein Ligation Vector
In some ways the single chain BTX
maquettes are the ideal starting point for use
in expressed protein ligation (EPL) system
since they have both long loops between the
helices and those loops have virtually no
functional requirements in terms of amino
acid content. This makes the fact that the
expressed

protein

ligation

and

native

chemical ligation methodologies leave a
	
  

Figure 6.1. Diagram of possible intein joint sites in
BT3.

cysteine at the site of the coupling of
minimal concern. There are then three

convenient sites to covalently link synthetic and expressed fragments at each of the three
loops in the single chain BT3 maquette, Table 6.1 and Figure 6.1. To minimize the number
of fragments needing to be coupled, although there are methods that allow several fragments
to be coupled,3-6 only two of these joint sites are synthetically practical since coupling at the
loop between helix 2 and 3 would require chemical synthesis of a 70+ residue fragment.
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Both of the two remaining sites of attachment are similar but not identical in the details of
the fragments needed to perform EPL. Chemical ligation between a synthetic helix 1 and
expressed helices 3-4 requires a synthetic C-terminal thioester of helix 1 and an expressed Nterminal cysteine fragment of helices 3-4. Expression of an N-terminal cysteine fragment is
made possible by the fact that the cleavage of the thioester intermediate generated by an
intein produces a fragment with an N-terminal cysteine in the absence of cross coupling. On
the other hand, chemical ligation of expressed helices 1-3 and synthetic helix 4 requires an
expressed thioester fragment and a synthetic helix with an N-terminal cysteine. The second
method was arbitrarily chosen, though it is likely in retrospect that the first method is slightly
less work since a number of purification steps would be eliminated and excess N-terminal
cysteine containing fragments would be easier to produce. The site of chemical ligation in
the loop between helices 3 and 4 was the central serine, which in the dimeric HP7 was a
cysteine suggesting that the requisite mutation of this residue to cysteine for EPL would
likely be minimally perturbing. The cysteine could be blocked with bromoacetamide, or
otherwise modified to, for instance, covalently incorporate another cofactor.
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Table 6.1. Sequences of maquettes discussed in text. Ϙ represents the position of Naq in a
semisynthetic maquette. C is highlighted to show the cysteine site required for and preserved during
chemical ligation.
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6.2.1 Constructing a BT3-Intein Expression System
Cloning of the first three helices of BT3 into the commercially available intein
purification vector pKYB1, Table 6.2, from NEB was difficult, but ultimately accomplished
using conventional cloning methodology at the NdeI, N-terminal, and SapI, C-terminal
intein, restriction sites. pKYB1 harbors kanamycin resistance, which was chosen due to
cross-contamination of naturally ampicillin resistant photosynthetic organisms in the Dutton
laboratory. The expression cassette in pKYB1 follows a T7 promoter and contains a Cterminal VMA intein from Saccharomyces cerevisiae followed by a chitin-binding domain (CBD)
for affinity purification on chitin columns. The C-terminal intein is normally used for on
column cleavage of protein thus allowing single step purification, yet it is easily adapted to
chemical ligation by changing the cleavage thiol mixture and eluting the captured thioester.
However, because CBD binding to chitin is essentially irreversible (knocking the
recombinant protein off involves applying strong base to the column), it is all but impossible
to ascertain the efficiency of the cleavage reaction. Nevertheless, expressing the first three
helices of BT3 (BT33) in the commercial vector in BL21(DE3)-RIL cells and attempting
purification and cleavage on a chitin column afforded no protein.

Table 6.2. Manipulation of the expressed BT33 intein fusion protein to obtain soluble expression.
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Following the four primer mutagenesis methodology of Chiu et al.,8,9 a His-tag was
added to the construct, Table 6.2, to allow purification of the intact fusion protein. This was
quite revelatory since it became clear that the BT33-intein construct was expressing as an
insoluble inclusion body. Previously expressed maquettes were often fused to proteins
known for increasing construct solubility like thioredoxin. It seemed likely that the VMA
intein and CBD were insufficient to effect enhanced solubility. MBP, a well established
molecular chaperone that lacks any possibly interfering cysteines,10 was cloned into the CBD
His-tag construct by replacing the CBD gene with an MBP gene from another NEB vector
(pMal-c2x) using similar methodology as was used in generating the His-tag construct, Table
6.2.11
Surprisingly expression of the MBP containing construct at both 16 °C and 37 °C
resulted in further inclusion body formation. Purification of the inclusion body under
denaturing conditions worked satisfactorily, but upon refolding a slow aggregation of the
protein was observed. Solubility with the MBP fusion partner actually appeared worse than
that observed for the intein construct with CBD. It was suspected that since most inteins are
endonucleases the VMA intein was likely to have large positively charged DNA binding
surface. Ordinarily this might not be a cause for concern, but the BT3 maquette was
designed as a highly negatively charged protein with a calculated pI of ~4.7; similarly, MBP’s
isoelectric point is ~5.2. On the other hand the VMA intein, has a pI of approximately 8,
suggesting that under the most common pH conditions, this protein construct would have
two highly negatively charged domains (MBO, BT33) perfectly capable of binding the
positively charged VMA intein domain. Aggregation would naturally occur because
individual proteins would be able to crosslink through ionic interactions. A search of NEB’s
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intein

database

revealed

that

the

Mycobacterium xenopi Gyr A intein has a pI
~5.4. Cloning this intein from NEB’s
pMXB10 vector over the VMA intein in the
MBP construct gave the final expression
vector, Table 6.2. Expression of the
construct

BT33-MxeGyrA-MBP-His6

proceeded in high yield, affording ~50
mg/L of the fusion protein from terrific
broth, see Figure 6.2 for expression of a

3

Figure 6.2. SDS-Page protein gel of BT6 intein
construct from expression to formation of BT63mensa thioester. (A) Novex Sharp Standard
Ladder; (B) Cell pellet from expression; (C)
Supernatant from cell lysis (D) Co-NTA Talon Resin
column flowthrough; (E) Co-NTA Talon Resin
Column peak; (F) Crude Na-MENSA thioester
capture reaction; (G) First ‘peak’ from Superdex 75
gel filtration column; (H) Second ‘peak’ from gel
filtration column; (I) Third ‘peak’ from gel filtration
column corresponding to BT63-mensa thioester.
See text for details.

	
  

subsequent

construct

under

similar

conditions.

6.2.2 Chemical Ligation of BTX3 with Synthetic Helices
Purification of BT33-MxeGyrA-MBP-His6 was straightforward using a Co-NTA
Talon resin affinity column followed by dialysis into cleavage buffer and concentration.
Room temperature capture of the BT33 thioester was also fairly standard, using a large excess
of the highly water soluble and odorless thiol sodium mercaptoethanesulfonic acid (mensa)
at pH 9.12 This reaction was found to proceed more completely when the reaction was run
under argon (or in a glove box) after the solution had been degassed, presumably because
	
  

156	
  

the thioester capture reaction is competitive with disulfide formation when oxygen is
present. Cleavage yields varied, but it is estimated that >90% of the peptide gets cleaved
under ideal conditions. The mensa thioester is stable at pH 7 for up to a month.12 However,
hydrolysis rates rapidly increase with pH, so it was imperative to quickly purify the BT33mensa thioester product, which was effected by a Superdex 75 size exclusion column in pH
7.5 buffer, which cleanly gave the presumptive thioester, Figure 6.2. After serial dilutionconcentration of the appropriate column fractions against water, the BT33-mensa thioester
product was lyophilized. Following the procedure described by Johnson and Kent,12 low mM
BT33-mensa was reacted with 2-3 equivalents of N-terminal cysteine containing BT0.1, Table
6.1, under denaturing conditions in the presence of 200 mM mercaptophenylacetic acid and
the reducing agent TCEP. After completion, the reaction was purified with HPLC since
other chromatographic techniques available cannot separate the full-length protein and the
three-helix fragment. Purification afforded ~70% by HPLC peak integration of the
semisynthetic four-helix bundle BT3.1, Table 6.1, confirmed by MALDI-TOF-MS.
Repeating

this

procedure

with

BT0.2 afforded the first four helix bundle
with

Naq(OMe/OMe),

BT3Naq.

As

described in Chapter 5, this protein, which
accidentally

incorporated

several

unintentional mutations in the synthetic
helix, only bound one heme like full length

Figure 6.3. UV/vis spectrum of BT5.3 incorporating
Naq(OMe/OMe) in 250 mM Sodium Borate, 100 mM
KCl, pH 9.0, showing a characteristic tryptophan
spectrum over that of Naq(OMe/OMe).

	
  

	
  

BT3. Following the same design path as
described in Chapter 5, a new construct was
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created which had a shorted loop between helices 2 and 3, BT53, Table 6.1, which was
exactly analogous to BT5. At the same time BT0.3, which was designed to fix the mutations
incorporated into BT0.2 and place Naq approximately equidistant from the two heme sites,
was synthesized. Chemical ligation as described of BT53 with BT0.3 afforded BT5.3, Table
6.1 and Figure 6.3.

6.2.3 Deprotecting Naq(OMe/OMe) in a Four Helix Bundle
Unlike the previous Naq(OMe/OMe) incorporating peptides, treatment of BT5.3
with stoichiometric DDQ did not effect activation of Naq. However, there was some
evidence of protein modification, possibly due to oxidation of the cysteine or methionine
residues, which have a much lower potential than Naq(OMe/OMe) thereby making these
residues more likely to become modified by DDQ before Naq is activated. As mentioned in
Chapter 3 in the discussion of failed deprotection attempts, the mixture TFA/trimethylsilyltrifluromethane sulfonic acid/thioanisole may have deprotected Naq(OMe/OMe), but this
was quickly followed by both backbone hydrolysis and Naq quinol backbone cyclization.
Since BT5.3 was not soluble in methylene chloride, the common solvent used in methyl
ether deprotection with BBr3, the equivalent reagent B(OTFA)3 was used with BT5.3 in
TFA. Backbone hydrolysis appeared to occur before sidechain deprotection. Without a
suitable oxidative or Lewis-acid deprotection method for Naq(OMe/OMe) in a four-helix
bundle, it proved necessary to rethink the protecting groups on Naq.
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6.3 Reductive Deprotection of Naq in a Four-Helix Bundle
Having searched and tried more labile protecting groups for Naq in the past, the
search for a new protecting scheme was effectively limited. Because the major issues
confronting using Naq(OMe/OMe) in proteins incorporating natural amino acids of all
functional groups were solely due to the fact that oxidative cleavage was the only effective
means to activate Naq from Naq(OMe/OMe), the protecting group search was limited to
reductively labile alkyl groups. This allowed the development of an orthogonally protected
Naq that could, in theory, be used in concert with Naq(OMe/OMe) and be activated under
very different conditions. The broad class of aryl alkyl protecting groups, including benzyl,
was discounted since these groups tend to be fairly acid labile which would be incompatible
with multiple steps of the synthesis route of Naq and peptides incorporating Naq. Similarly,
other protecting groups were eliminated from consideration due to concerns of reactivity
during the course of peptide synthesis, like the 2-ethylhalides. In the end, though it is not the
only option, the underused propargyl protecting group was chosen because of its relative
inertness and ease of incorporation into the established synthetic scheme to FmocNaq(OMe/OMe)-OH.
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6.3.1 Synthesizing Fmoc-Naq(OProp/OProp)-OH
Since the synthesis of Fmoc-Naq(OMe/OMe)-OH is described in detail in Chapter
2, the synthesis of Fmoc-Naq(OProp/OProp)-OH which follows the same exact synthetic
route will only be touched upon, Scheme 6.2. The only major change from the synthesis of
Fmoc-Naq(OMe/OMe)-OH is the combination of the first two steps into a single alkylation
step in which three propargyl groups are attached to the 2-carboxy and 1- and 4- hydroxyls.
The remainder of the synthesis follows without complication due to the propargyl protecting
groups. Purification of the initial O’Donnell amino acid synthesis product, a silica column
which was of limited use in the synthesis of Fmoc-Naq(OMe/OMe)-OH, was entirely

Scheme 6.2. Synthesis of Fmoc-Naq(OProp/OProp)-OH
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skipped with the rational that the final two steps, including the purification of FmocNaq(OProp/OProp)-OH would be sufficient to removed any contaminants.

6.3.2 Incorporation of Naq(OProp/OProp) into Single Helix BT0.4
The previously synthesized single helix C-terminal fragments for chemical ligation
BT0.1-0.3, either had no Naq (BT0.1) or Naq was placed equidistant from the two heme
binding sites using rough approximations of
the topology of the BT3 protein. Upon
further examination of a energetically
minimized structure of HP7 based upon the
crystal structure of H10H24-L6I-L13FL31M generated by the Klein group, Figure
6.4, the best edge-of-heme to edge-of-Naq
equidistant site on the exterior of the fourth
helix was a full turn away (i+4) from the
previously designed site. This error was
likely due to a miscalculation of the width of
the helices, but gives further motivation to
obtaining an actual structure of one of the
holo-maquettes.
Figure 6.4. Energetically minimized structure of
HP7 based upon the crystal structure of H10H24L6I-L13F-L31M. Hemes and ligating histidines are
in red. Structure graciously provided by the Klein
group.

	
  

	
   Naq(OProp/OProp)-OH

Fmoceasily

incorporated into synthetic helix BT0.4,
Table 6.1, as designed.
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6.3.3 Deprotection of Naq(OProp/OProp) in BT0.4
BT0.4, Table 6.1, has nearly all of the side chain functionality of a four-helix bundle
and thus was a good framework to attempt deprotection methodology. Propargyl groups
have been deprotected by using a variety of methods ranging from BBr313 to Pd(II)/TEA.14
The palladium-based methods were particularly attractive since Pd0 is often used to
deprotect alloc groups from peptides. Initial attempts to use TEA as an electron source for
palladium(0)

tetrakistriphenyl

phosphine

(Pd(PPh3)4)

reductive

deprotection

of

Naq(OProp/OProp) at 80 °C in DMF consumed the starting material, but the product was
not identified. In this and all other reaction with Pd(PPh3)4, the palladium catalyst was in
large excess compared to the protein to prevent the cyclization of the propargyl group to the
quinone ring system at the site of its attached oxygen, a reaction that is known to occur with
Pt(II) catalysts.15 Changing the reductant to BH3NH3 appeared to work (MALDI-TOF-MS
mass was 8 D off from expected product mass in an uncalibrated run), but produced
copious quantities of what appeared to be colloidal palladium.
A room temperature deprotection reaction of Naq(OProp/OProp) in BT0.4 using
phenylsilane as the reductant was halted prematurely to allow isolation of intermediates.
Three major products were observed during HPLC, each of which had a slightly different
‘reduced’ Naq spectrum, which matched the observation that Naq(OMe/OMe) has a
significantly blue shifted absorbance spectrum in the 300 nm range compared to Naqred.
MALDI-TOF-MS indicated that none of peaks separated by HPLC was the starting material,
and it appeared that there were three nearly equal mass losses from starting material to
smallest product. This was unanticipated, and it was initially believed that given some of the
inconsistencies of the MALDI-TOF-MS instrument that was used to collect the data, that
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one of the ‘losses’ in mass was simply systematic error in the mass measurement. In order to
gauge the exact mass of the species, ESI-MS was performed, which confirmed the MALDITOF-MS results but because of its higher mass accuracy presented a fuller picture. The
product with the largest mass had a mass that corresponded to the loss of exactly one sulfur
atom. The second largest mass observed corresponded to the loss of a single propargyl from
the peak with the largest mass, exactly. And finally, the smallest mass corresponded to loss
of two propargyls and one sulfur atom from the starting material, exactly. In addition,
collected with the smallest mass peak, was a small amount of peptide that was too heavy by a
single oxygen atom, suggesting that some amount of the double deprotected Naqred had
become modified by oxygen (or oxidized, modified by water and oxidized again).
The observed desulfurization reaction likely produces alanine at the cysteine site.
While it is somewhat surprising that the desulfurization reaction occurs and is seemingly
significantly faster than the depropargylation, there are other textbook methods of
desulfurization of cysteines under reducing conditions, for instance using Raney nickel.
Regardless, this fortuitous observation allows the simultaneous deprotection of
Naq(OProp/OProp) and elimination of the free cysteine sulfur. It is not clear whether the
desulfurization reaction occurs under all conditions (notably whether ammonia borane
effects the same transformation – it would seem not given the previously discussed results)
or whether the reaction will similarly cleave thioethers like that found in methionine.
Nevertheless, it appeared that a method for deprotecting Naq(OProp/OProp) in a nearly
fully functionalized helical segment was possible.
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6.3.4 Incorporation and Deprotection of Naq(OProp/OProp) in a Four Helix Bundle
At the time of the creation of BT5.4, it was not clear whether the N-cap or the long
cross-bundle loop between helix 2 and 3 in BT3 was responsible for changing the heme
binding properties of the single chain maquettes. Since there was no need to leave anything
to chance, a new maquette intein construct was created analogous to BT6 called BT63, Table
6.1. For practical reasons it does not exactly match the sequence of BT6 since the expression
system created for the maquette inteins requires an N-terminal methionine, so instead of
simply having a single N-terminal glycine residue that is present in BT6 due to the TEV
cleavage site, the BT63 fragment begins with the sequence MGG. Chemical ligation of BT63mensa thioester as described with BT0.4, produces BT6.4 with Naq(OProp/OProp) in the
fourth helix, Table 6.1.
Following the deprotection protocol
described

above,

a

single

HPLC

purification’s worth of BT6.4 was dissolved
in a 300 µL of DMF with 100 µL
phenylsilane. Excess Pd(PPh3)4 was added
and the reaction vessel was briefly evacuated
before being placed under positive pressure
argon to eliminate some amount of the
Figure 6.5. Spectrum of BT6.4 after reductive
deprotection of Naq(OProp/OProp). Scattering
background was subtracted by fitting long
wavelength spectral data to the Rayleigh
scattering equation and subtracting the fit from
the raw data. The band at 335 nm matches that
expected for Naq ox. The band at ~260 nm is due
to contaminating triphenylphosphine. See text for
details. Spectrum was taken in 20 mM K2PO4, 100
mM KCl, pH 8.

	
  

atmospheric oxygen. After 2 hours, the
reaction was purified. While the HPLC was
not ideal, a single peak appeared to contain
both BT6.4 with activated Naq and
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significant amounts of a species with a phenyl absorption spectrum, likely the
triphenylposphine ligand of the catalyst. Spectroscopy of the acquired product, after
correction for a significant scattering background (again, likely triphenylphosphine),
produced a spectrum that had some of the hallmarks of an oxidized quinone in a protein
with tryptophans, Figure 6.5. While it is not possible to observe the major absorbance at 252
nm for oxidized Naq because it sits under the phenyl absorbance, the band at ~335 nm is in
approximately the right ratio to the tryptophan band at 290 nm for a protein having four
tryptophans and one Naqox. Obviously this is simply preliminary data, but it is the best
evidence to date that the incorporation and deprotection of Naq in a four-helix bundle has
been accomplished. In addition, though a full heme titration was not performed, BT6.4
binds at least one equivalent of heme, Figure 6.6A, which can subsequently be reduced by
borohydride in the presence of CO, Figure 6.6B. There is clear evidence (data not shown)
that Naq in BT6.4 under these conditions goes reduced based upon difference spectra. It is
not apparent whether heme reduction with borohydride goes through Naq, or whether this
occurs naturally. There are reports of a ferric heme going reduced by borohydride in Cyt-c
oxidase,16 but Cyt-c oxidase has other redox centers capable of reacting with borohydride and
then passing the electrons to the heme, notably the copper centers. In any event, there is
tangible evidence that Naq has been functionally incorporated into a four-helix bundle
capable of binding hemes, allowing for the first time studies of electron transfer between
heme(s) and Naq thus extending the range of maquette functional emulation.
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Figure 6.6. Formation of carboxy-ferrous complex of heme bound BT6.4 upon treatment with
borohydride. Soret region spectrum of BT6.4 bound to 1 equivalent of ferric heme under CO (A); heme
Soret band is near that observed for BT6. BT6.4, under CO, after addition of sodium borohydride showing
a slow formation of the carboxy-ferrous state with time (B). Spectra are uncorrected for large scattering
background due to insoluble triphenylphosphine. Spectrum was taken in 20 mM K2PO4, 100 mM KCl, pH
8.

	
  

6.4 Future Directions
Incorporation of activated Naq into a heme-binding four-helix bundle represents a
major advance in the design of non-natural multicofactor proteins. However, the critical
experiments remain to be done. Importantly, in work done by Sarah Chobot, Naq has also
been incorporated and deprotected in an amphiphilic homotetrameric maquette, and while
heme incorporation was disrupted in the first design, it is clear that with a better site choice
the design possibilities of four helix bundles with Naq are substantial. Experiments that
allow the observation and exploration of electron transfer reactions, photosynthetic and
respiratory intermediates, and the natural engineering principles that guide semiquinone
stability and proton uptake can be cleanly designed with Naq. Practically, the first
experiments for observing electron transfer in a heme-binding maquette between a heme
and Naq are quite simple, Figure 6.7. Starting with a Naq containing protein like BT6.4 and
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binding a single heme, it is possible to capture a high effective potential carboxy-ferrous state
by reducing Naq and the heme in the presence of CO, Figure 6.7A to 6.7B. Re-poising the
electrochemical potential of the sample by oxidizing just Naq sets the stage for observing
transient formation of a semiquinone, Figure 6.7C. Photolysis of the carboxy-ferrous heme
bond, regenerates a low potential heme which is sufficiently reducing to generate, transiently,
a Naq semiquinone, Figure 6.7C to 6.7E. With values of cofactor spacing obtained from the
minimized structure in Figure 6.4, 13 Å, the known solution potentials of the

Figure 6.7. Schematic of CO-flash photolysis of a single heme bound BT6.4-like maquette incorporating
an activated Naq (A). Cofactor identity is across top of each image; Em is drawn to arbitrary scale on left,
note orientation is with respect to free energy and not midpoint potential. Unoccupied lines or boxes
represent oxidized heme or Naq, respectively. Occupied lines or boxes represent reduced heme or Naq
respectively. Grey boxes represent midpoint potentials of Naq’s two semiquinone couples; black boxes
represent two-electron midpoint. Reducing Naq and heme in presence of carbon monoxide generates
the carboxy-ferrous state and fully reduced Naq (B). Poising the system such that Naq is oxidized while
the carboxy-ferrous heme remains reduced sets the stage for CO photolysis (C). Once no longer ligated
to CO, ferrous heme returns to a potential low enough to reduce Naq’s semiquinone (D). Transient Naq
semiquinone state (E) that will eventually relax back to the state in (C) as long as CO is present. See text
for details.
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naphthoquinone semiquinone, ~-200 mV,17 and heme b in HP7, ~-300 mV, and the kinetics
of CO photolysis reactions from studies with HP7,18 the lifetime of the semiquinone in this
construct can be simulated (Chris Moser, personal communication). Significant populations
of semiquinone are theoretically observable for up to 1 s under the most favorable
conditions and up to ~10 ms under the least favorable conditions simulated (Chris Moser,
personal communication). While these calculations ignore the collisional exchange of
electrons between two Naqsq in solution, observation of that particular exchange route,
through non-transient oxidation of the heme, also indicates that semiquinone formation was
likely and, regardless, that electron transfer from the heme to Naq was observed. This
experiment is immediately at hand because the work presented in this chapter and in
Chapter 5 firmly sets the foundation for this simple demonstration of electron transfer
between a quinone and heme in a maquette. Further work will start tackling the larger
unexplored aspects of quinone electron transfer reactions in the various quinone active sites
of photosynthetic and respiratory complexes.
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Chapter 7: Conclusion

	
  
	
  

This work was driven by the fact that quinones in the active sites of the natural

oxidoreducatses of respiration and photosynthesis show a range of electrochemical
properties that have yet to be fully explained by more than a half-century of intense study.
Mutational analysis and studies in which the natural quinone substrates are exchanged for
other quinones have done little to clarify the physical means of biological control of quinone
reactivity. Some of the obfuscation of control mechanisms comes from the complexity of
the natural proteins themselves. The lack of consensus quinone binding sites in the
mitochondrial and chloroplast membrane quinone oxidoreductases makes it nearly
impossible to know whether amino acids in quinone active sites are mechanistically relevant
or simply involved in quinone binding. Recently determined structures of membrane
quinone oxidoreducatses provide some insights, but as of yet quinones have not been
observed in a representative of each type of quinone binding site. Additionally, because of
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the indistinct spectroscopy of multicofactor quinone oxidoreductases, it is difficult to
monitor single site mutagenesis effects on substrate quinone properties. The work presented
in the previous chapters laid the foundation for an entirely new approach to understanding
and using the natural engineering principles of quinone dependent redox enzymes by the
development of a naphthoquinone amino acid capable of being incorporated into simplified
protein maquettes designed to emulate critical natural electron transfer reactions.
The naphthoquinone amino acid, Naq, was designed to maintain quinone function
while being synthesized into peptides. Indeed, the full range of natural quinone
electrochemistry was observed in the short model peptide heptaNaq (Chapter 2).1 In
aqueous solution, heptaNaq demonstrated typical two-electron, two-proton redox chemistry
over a fairly wide pH range, while maintaining an almost identical midpoint to model
compound 2-methyl-1,4-naphthoquinone. This contrasts to several literature reports in
which the incorporation of a quinone at a cysteine residue resulted in large and inexplicable
changes in redox reactivity of the quinones. In addition to maintaining natural reactivity in
an aqueous environment, the Naq cofactor in heptaNaq also demonstrated kinetically
accessible semiquinone states in aprotic electrochemical studies. With a rapidly changing
potential in cyclic voltammetry, proton uptake is bypassed and the anionic semiquinone is
formed to the exclusion of all other redox states. At slower scan rates, and with
stoichiometric protons in the solution, Naq demonstrates two single-electron electron
transfer reactions that are coupled to an intervening protonation event. These three distinct
redox behaviors of heptaNaq under different conditions correspond nicely to the three
broad classes of active sites found in natural quinone oxidoreductases. heptaNaq’s aqueous
solution behavior is reminiscent of the activity of the Qo site in bc1 in which there is little
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evidence of that a semiquinone naturally exists (Chapter 1). In an aprotic medium, with
limiting protons, heptaNaq further demonstrates both the activity of the QA site of the
photosynthetic reaction center where the anionic semiquinone is only formed transiently,
and the Qi site of bc1, where proton uptake is limited enough that a stable semiquinone is
formed but is eventually converted to the hydroquinone. These observations both support
the general concept that proton uptake is possibly the most important limiting factor in the
differentiation of the quinone properties observed at natural binding sites, and demonstrate
that Naq is capable of recapitulating the major mechanistic features of quinones in natural
oxidoreductases.
While the heptaNaq project described in Chapter 2 demonstrated the full
electrochemical mechanistic versatility of Naq in emulating natural quinone cofactor
chemistry, it is important to recognize that Naq is not a natural cofactor. Its very nature as
an amino acid means that Naq interacts with the backbone of peptides in ways that no
natural cofactor could. It was important to confirm that Naq did not interfere with the
common alpha-helix secondary structural element and to gauge a maximum change in
interaction energy with the backbone upon conformation change from coil to helix. The
second property is particularly important since Naq can theoretically be placed in any
structural element, and it would be difficult to separate the local environmental effects from
the more global backbone topology in determining the redox properties of Naq. Adapting a
peptide family that had been used to generate an enthalpic measure of alpha-helix
propensity, it was observed that Naq experiences a -16 mV (~0.7 kcal mol-1) change in redox
potential upon going from an unfolded random coil state to a folded helical state (Chapter
3). This is not a large change in midpoint potential; it is approximately the same energetic
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cost as a slightly destabilizing mutation, so it is not believed that a single Naq alone could
break a stable alpha-helix upon getting reduced. In addition, while it was observed that Naq
acts as a C-capping amino acid for short helices, the unambiguous observation of Naq
within a stretch of alpha-helix in an extended alanine-rich helix suggests that when well
placed in a stable helix Naq should not interfere with secondary structure formation in either
redox state. Otherwise it might be necessary to design specific interactions with Naq to
reduce its tendency to break short helices.
Using SCADS, a computationally guided design approach, Naq was incorporated
into the helix of a miniprotein, NaqCage (Chapter 4). The NaqCage is based upon the 20residue TrpCage, which has a compact hydrophobic core surrounding a buried Trp residue.
By replacing this Trp, the NaqCage was designed to stably incorporate Naq in a similar
structural context, allowing investigations on the effects a well-packed protein environment
on its redox chemistry. While the initial computational designed target was not appreciably
structured due to destabilization of the helix by Naq, the NaqCage was iteratively redesigned
by hand to a point where a solution structure could be determined. Analysis of the NMR
data was complicated by several factors, but nearly all of the backbone protons have been
assigned and further analysis may yield a structure. This would be the first report of stably
incorporating another amino acid at the site of the Trp, but more importantly this work
generated a water-soluble, synthesizable framework for testing the effects of hydrogen
bonding and electrostatic interactions on Naq’s redox chemistry in an aqueous environment
– a crucial set of information that is woefully lacking in the literature.
Finally, to take full advantage of Naq’s potential in the well established heme-binding
maquettes, a cross-bundle loop was added to the sequence of the homodimeric HP7. By
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adding the loop and removing the symmetry, a single chain four-helix bundle maquette that
allowed single site incorporation of mutations (Chapter 5) and the construction of
semisynthetic bundles that incorporated Naq (Chapter 6) was produced. The bundles
incorporating Naq bind at least one heme, which allows the creation of maquettes designed
to explore electron transfer reactions between Naq and heme.
What has been presented here is nothing less than the first stone of a new
foundation for maquette work. In making good use of Naq, profound opportunities exist for
creating proteins that offer more than just a full-throated mimicry of natural systems.
Indeed, maquettes incorporating Naq are not limited to the imagination of nature, and Naq
offers methods of exploring diverse protein environments and cofactor arrangements that
evolution may never have stumbled upon. While it is clear that the most affirmative
knowledge gained from continued use of Naq is in understanding the intricate mechanisms
of quinone active sites in natural proteins, Naq’s long term scientific applicability to more
practical considerations like energy generation and conversion may be its lasting legacy.

7.1 References
(1)
Lichtenstein, B. R.; Cerda, J. F.; Koder, R. L.; Dutton, P. L. Chem Commun
(Camb) 2009, 168.

	
  

174	
  

Appendix A: Experimental Methods

A.1 Introduction
The majority of the methods described below were published as supplemental data
to Lichtenstein et al.1 Where appropriate additional methodology has been added and
described. Raw spectra found in the paper’s supplementary data have been removed for
brevity. As elsewhere, Naq is represented by the single letter code Ϙ, where appropriate.

A.2 General Methods
All reactions were carried out under a positive pressure of argon or nitrogen unless
otherwise indicated. Commercial reagents were from Sigma Aldrich, unless otherwise
indicated, and used as received. HPLC grade diethylether, ethyl acetate, hexanes, methylene
chloride, and acetonitrile were purchased from Fisher Scientific. HPLC grade carbon
tetrachloride was purchased from Sigma Aldrich. Anhydrous dimethylformamide (DMF)
and anhydrous tetrahydrofuran (THF) were purchased from Aldrich and stored under argon.
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Sulfuric acid, glacial acetic acid and hydrochloric acid were purchased from Fisher Scientific.
All other solvents were reagent grade and used as received. Flash chromatography was
performed using Fisher 230-400 silica gel 60 unless otherwise indicated. Analytical TLC was
carried out on Analtech silica gel HLF pre-coated glass plates with detection by UV
illumination unless otherwise indicated. 1H and 13C NMR spectroscopy of small molecules
was performed on a Varian Inova-500 (at 500 MHz and 125 MHz, respectively) using CDCl3
as solvent (unless otherwise noted) and referenced with the residual solvent signal (CDCl3,
7.24 and 77.0 ppm, respectively) or referenced externally. The following abbreviations are
used to describe peak patterns where appropriate: s (singlet), d (doublet), t (triplet), q
(quartet), m (multiplet), br (broad). Small molecule mass spectrometry data were obtained by
the Penn State University Proteomics and Mass Spectrometry Core Facility.

Peptide

synthesis was carried out either a Pioneer Peptide Synthesis System or CEM Liberty
Microwave Synthesiser using standard Fmoc chemistry (protected natural amino acids from
Novabiochem) with HATU/HOAt (Genscript Corporation) as the coupling reagents (4-5.0
mol equivalents of activator/Fmoc-amino acid) on PAL-PEG-PS resin (Applied
Biosciences, most peptides) or Fmoc-Ser(tBu)-Wang resin (Anaspec, peptides containing Cterminal serine carboxylates) . After cleavage and deprotection of the natural amino acids
(Reagent R: 90:5:3:2 TFA/Thioanisole/Ethane Dithiol/Anisole) under argon, the resin was
filtered and washed with 10 mL TFA (3x). The TFA was removed in vacuo, and the crude
peptide precipitated with cold methyl tert-butyl ether. The identity of all peptides was
confirmed with MALDI-TOF-MS using either α-cyano-4-hydroxycinnamic acid or sinapic
acid (Sigma) as the peptide matrix. MALDI-TOF-MS determinations were performed on a
PerSeptive Biosystem Voyager-DE RP. Kjedahl analysis was performed by Galbraith
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Laboratories, Inc. CHN elemental analysis was performed by Midwest Microlab, LLC.
UV/vis spectra were acquired on an Agilent 8453 UV-Visible Spectrophotmeter or a Varian
Cary-50 Spectrophotometer. CD Spectra were acquired on either an AVIV 405 or 410 CD
Spectrophotometer. Automated titrations were performed with a Hamilton Company
automated diluter.

A.3 Naq Synthetic Methods
A.3.1 Methyl 1-hydroxy-4-methoxy-2-naphthoate (1)

(For alternative method see Boger and Jacobson2) 40.83 g (200 mmol) 1,4dihydroxynaphthoic acid was suspended in methanol (200 mL) at room temperature. With
stirring, sulfuric acid (30 mL, 2 eq) was added dropwise to the solution such that the reaction
mixture was nearly refluxing when the addition was complete. The reaction was refluxed for
24 hr at which point an additional 2 equivalents of sulfuric acid and 50 mL of methanol were
added. After an additional 24 hr of refluxing the reaction appeared complete by TLC (eluent
toluene). The reaction was diluted into 700 mL of CH2Cl2 and was added to 1 L of saturated
aqueous sodium bicarbonate into a 2 L beaker with stirring. Solid sodium bicarbonate
(Fisher Scientific) was added until the aqueous layer no longer evolved carbon dioxide at
which point the layers were separated. The organic layer was dried over anhydrous
magnesium sulfate (Fisher Scientific) and the solvent was removed in vacuo. Silica column
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chromatography (eluent toluene) afforded 43.40 g (93.4%) of the methyl 1-hydroxy-4methoxy-2-naphthoate as a pale green solid. NMR 1H (500 MHz) d 3.97 (s, 3H), 4.00 (s,
3H), 7.02 (s, 1H), 7.57 (t, 1H, J=7.5 Hz), 7.63 (t, 1H, J=7.5 Hz), 8.19 (d, 1H, J=8.2 Hz), 8.39
(d, 1H, J=8.2 Hz), 11.62 (s, 1H); 13C (125 MHz) d 52.49, 55.95, 100.71, 104.52, 122.14,
124.04, 125.78, 126.66, 129.26, 130.14, 147.96, 155.88, 171.57; Expected MS: M-H+ 231.1,
Found 231.1.

A.3.2 Methyl 1,4-dimethoxy-2-naphthoate (2)

(For alternative method see Newman and Choudhary3) 35.5 g (153 mmol) of methyl
hydroxynaphthoate 1 was dissolved in 155 mL of anhydrous DMF. To the solution was
added 35.5 g (257 mmol, 1.67 eq) of K2CO3 (Fisher Scientific) with stirring. Iodomethane
(58 mL, 929 mmol, 6 eq) was added and the reaction was refluxed for 48 hours at which
point TLC analysis (eluent toluene) showed that the reaction was complete. The reaction was
diluted into 1L ethyl acetate and extracted three times with 1L water, and once with 1L
brine. The organics were collected and the solvent removed in vacuo. After chromatography
(eluent toluene) the trimethyl naphotoate 2 was obtained in 90% yield (33.9 g) as a beige
solid. NMR 1H (500 MHz) d 3.99 (s, 3H), 4.00 (s, 3H), 4.01 (s, 3H), 7.16 (s, 1H), 7.58 (m,
2H), 8.23 (m, 2H); 13C (125 MHz) d 52.48, 55.93, 63.51, 103.74, 118.88, 122.50, 123.67,
127.25, 127.94, 128.99, 129.40, 151.57, 152.25, 167.01; Expected MS: MH+ 247.1, Found
247.1.
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A.3.3 1,4-Dimethoxy-2-hdroxymethylnaphthalene

(For alternative method see Bulbule et al.4) Methyl naphthoate 2 (33.9 g, 138 mmol)
in 200 mL anhydrous THF was added dropwise to a stirred suspension of LiAlH4 (15.7 g,
414 mmol, 3 eq) in 100 mL anhydrous THF at 0°C. The reaction was allowed to warm to
room temperature and was stirred for 2 hours. The reaction was quenched by the dropwise
addition of 700 mL of saturated sodium potassium tartrate and stirred overnight. The
resulting mixture was diluted with 2L ethyl acetate and was extracted twice with 1L water
and once with brine. The ethyl acetate layer was collected and the solvent removed in vacuo
affording the product hydroxymethyl naphthalene (29.7 g, 99%) as a beige solid. NMR 1H
(500 MHz) d 3.90 (s, 3H), 3.96 (s, 3H), 4.87 (s, 2H), 6.79 (s, 1H), 7.47 (t, 1H, J=7.6), 7.53 (t,
1H, J= 7.3 Hz), 8.02 (d, 1H, J=8.3 Hz), 8.22 (d, 1H, J=8.3 Hz); 13C (125 MHz) d 55.93,
61.20, 62.87, 104.05, 122.02, 122.68, 125.75, 126.54, 126.94, 128.70, 128.78, 147.20, 152.43;
Expected MS: MH+-H2O 201.1, Found 201.1.
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A.3.4 1,4-Dimethoxy-2-bromomethylnaphthalene (3)

(For alternative method see Bulbule et al.4) Hydroxymethyl naphthalene (34.6 g, 159
mmol) was dissolved in 200 mL CCl4 and cooled to 0°C. PBr3 (22.4 mL, 238 mmol, 1.5 eq)
in 70 mL CCl4 was added dropwise to this solution. The reaction was stirred for 30 minutes
at 0°C and for 1.5 hours at RT. The reaction was quenched by the dropwise addition of
saturated aqueous sodium bicarbonate until evolution of CO2 ceased. The mixture was
diluted with 2L CH2Cl2 and extracted three times with 1L saturated aqueous sodium
bicarbonate, and then with brine. Collection of the organic layer and removal of the solvent
in vacuo yielded the product aryl bromide 3 (44.6 g, 95.8%) as a tan solid. This product was
unstable and was used immediately in the next reaction.

A.3.5 N-(Diphenylmethylene)-L-1,4-dimethoxy-2-naphthalanine tertbutyl ester (4)

N-(Diphenylmethylene)-glycine tert-butyl ester (36.0 g, 122 mmol), O-allyl-N-(9anthracenylmethyl)cinchonidinium bromide (7.38 g, 12.2 mmol, 0.1 eq), CsOH•H2O (204.54
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g, 1220 mmol, 10 eq) were suspended in toluene at –20 °C (ethylene glycol/dry ice bath)
with overhead stirring. To this suspension was added dropwise aryl bromide 3 (36.0 g, 125
mmol, 1.02 eq) in 200 mL toluene. The reaction was stirred until TLC analysis indicated
completion (eluent 9:1 hexanes/ethyl acetate with 1% triethylamine) after 6 hours. The
reaction was poured into 1.5 L H2O and partitioned between the aqueous layer and 1 L
diethylether; a precipitate of the catalyst formed between the two layers and was collected
with the aqueous layer. The organic layer was washed with 1 L H2O and 1 L saturated
aqueous sodium chloride and the solvent was removed in vacuo. The collected aqueous layers
were extracted three times with 500 mL methylene chloride to dissolve the cinchonidinium
catalyst which was further purified by recrystalization from methylene chloride/ethylether.
The collected organic solids were dry loaded onto silica in methylene chloride with 1%
triethylamine. After chromatography (silica, eluent 19:1 hexanes/ethyl acetate with 1%
triethylamine followed by 9:1 hexanes/ethyl acetate with 1% triethylamine) 51.85 g (86%)
product 4 was obtained as a slightly yellow solid. NMR 1H (500 MHz) d 1.47 (s, 9H), 3.31
(dd, 1H, J1=10 Hz, J2=13.5 Hz), 3.49 (dd, 1H, J1=3.5 Hz, J2=13 Hz), 3.69 (s, 3H), 3.70 (s,
3H), 4.31 (dd, 1H, J1=3.5 Hz, J2=9.5 Hz), 6.46 (s, 1H), 6.51 (s, 1H), 7.07 (t, 2H, J=7.5 Hz),
7.23 (t, 1H, J=7.5 Hz), 7.27 (t, 2H, J=7.5 Hz), 7.34 (t, 1H, J=7.5 Hz), 7.42 (t, 1H, J=7.5 Hz),
7.49 (t, 1H, J=7.5 Hz), 7.59 (d, 2H, J=7 Hz), 7.93 (d, 1H, J=8 Hz), 8.15 (d, 1H, J=8.5 Hz);
13

C (125 MHz) d 28.38, 34.06, 55.61, 62.35, 67.25, 81.42, 107.24, 122.14, 122.50, 125.12,

125.80, 126.54, 126.68, 127.92, 128.19, 128.38, 128.98, 130.38, 136.40, 139.77, 148.12,
151.28, 170.37, 121.29; Expected MS: MH+ 496.2, Found 496.2.
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A.3.6 L-1,4-dimethoxy-2-naphthalanine hydrochloride (6)

To 14.4 g (29 mmol) of the protected amino acid 4 was added with stirring 10 mL
(119 mmol, 4 eq) ethane dithiol (Sigma-Aldrich) and 60 mL trifluoroacetic acid in quick
sucession. The reaction was stirred for two hours at which point it was diluted to 2L with
water and extracted with 2L 9:1 Hexanes/Ethyl acetate to avoid extraction of the free amino
acid into the organics. The organic layer was extracted with 1L 1.5 M aqueous HCl until it no
longer appeared to have free amino acid by TLC (eluent 9:1 Hexanes/Ethyl acetate; free
amino acid remains at the origin and fluoresces a characteristic blue under UV illumination).
The aqueous layers were combined and solvent was removed in vacuo. The resulting solid was
redissolved in 1.5 M HCl and the solvent was once again removed in vacuo affording 8.9 g
(98.2%) of the product 6 as a white solid. NMR in D2O 1H (500 MHz) d 3.27 (dd, 1H,
J1=14.5 Hz, J2=8 Hz), 3.42 (dd, 1H, J1=14 Hz, J2=5.5 Hz), 3.82 (s, 3H), 3.92(s, 3H), 4.31 (t,
1H, J=6.5 Hz), 6.73 (s, 1H), 7.50t, 1H, J=7.5 Hz), 7.58 (t, 1H, J=7.5 Hz), 7.98 (d, 1H, J=8.5
Hz), 8.11 (d, 1H, J=8 Hz); 13C (125 MHz) d 31.19, 54.30, 56.11, 62.24, 106.43, 121.97,
122.18, 122.92, 126.04, 126.49, 127.63, 128.08, 147.72, 152.05, 121.98; Expected MS: MH+
276.1, Found 276.1.
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A.3.7 Fmoc-Naq(OMe/OMe)-OH (7)

11.3 g (35.7 mmol) of the amino acid hydrochloride 6 was dissolved in 145 mL
DMF. To this stirred solution was added 3 g (35.7 mmol, precisely 1.0 eq) of sodium
bicarbonate.

The

reaction

was

heated

to

60°C

and

N-(9-

Fluorenylmethoxycarbonyloxy)succinimide (13.2 g, 39 mmol, 1.1 eq) was added. After
stirring at 60°C for 3h, the reaction was poured into 2L water and extracted twice with ethyl
acetate 1L. The organics were combined and extracted twice with 2L water and once with 1L
brine. The organics were collected and the solvent removed in vacuo. The crude product was
dry loaded onto silica for chromatography. After purification (silica column chromatography,
eluent 2:1 hexanes/ethyl acetate with 0.1% acetic acid, followed by 5% methanol in
methylene chloride), the product Fmoc-Naq(OMe/OMe)-OH was obtained as an off-white
solid in an 85% yield (15.1 g). NMR 1H (500 MHz) d 3.33 (d, 2H, J=6.5 Hz), 3.91 (s, 3H),
3.92 (s, 3H), 4.15 (t, 1H, J=7.5 Hz), 4.24 (m, 2H), 4.61 (q, 1H, J=6.5 Hz), 6.13 (d, 1H, J=7
Hz), 6.62 (s, 1H), 7.11 (t, 1H, J=7.5 Hz), 7.18 (t, 1H, J=7.5 Hz), 7.33 (t, 2H, J=7.5 Hz), 7.46
(m, 3H), 7.56 (t, 1H, J=7.5 Hz), 7.69 (m, 2H), 8.04 (t, 1H, J=8 Hz), 8.23 (d, 1H, J=8 Hz); 13C
(125 MHz) d 32.00, 32.71, 37.06, 47.28, 55.63, 55.99, 62.31, 105.71, 120.17, 122.14, 122.87,
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124.35, 125.46, 125.77, 127.15, 127.30, 127.91, 128.60, 141.49, 143.96, 144.13, 148.02,
152.65, 156.77, 163.58, 175.98; Expected MS: MH+ 498.2, Found 498.2.

A.4 Naq Deprotection Methods
A.4.1 Deprotection of heptaNaq(OMe/OMe) with Cerium Ammonium Nitrate
HeptaNaq(OMe/OMe) was dissolved in enough 0.1 M aqueous TFA to make a
solution of about 1 mM as determined by absorbance. 2.1 equivalents of cerium(IV)
ammonium nitrate (CAN) was added in an equal volume of 0.1 M aqueous TFA and the
solution briefly vortexed to mix. The mixture was allowed to sit on ice for 1 minute, at
which point it was diluted to 5 mL with 0.1M TFA. The reaction was incubated on ice for an
additional 20 minutes before the deprotected peptide was purified on HPLC. HeptaNaq
(PDPϘPDQ) was obtained after removal of the solvent in vacuo on a lyopholizer taking care
not to let the sample thaw by adding additional ddH2O to dilute the MeCN. Imediately upon
drying, solid de heptaNaq was dissolved in ddH2O, aliquoted into stocks, and flash frozen

A.4.2 Deprotection of P2Naq(OMe/OMe) with Dichlorodicyanoquinone (DDQ)
P2Naq(OMe/OMe) was dissolved in 200 µL TFA and placed on ice. The
oncentration of the peptide in this solution was determined quickly by absorbance (ε301 5065)
and exactly 1 equivalent of DDQ in MeCN (stock ~ 9 mg mL-1) was added with shaking.
The solution becomes dark upon DDQ addition and slowly lightens over the course of at
least 30 minutes on ice. Dilution of the reaction with ddH2O is followed immediately by
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HPLC purification. After purification samples are treated identically to those of deprotected
heptaNaq, above.

A.4.3 Deprotection of Naq(OProp/OProp) in BT6.4
BT6.4 with sidechain protected Naq was dissolved in 200 µL DMF and transferred
to a small round bottom containing a small stir bar. 100 µL of phenylsilane was added. The
solution was frozen with LN2 and excess (~10 mg) solid Pd(PPh3)4 was added on top of the
frozen solution. The mixture was evacuated and thawed under vacuum to roughly remove
the oxygen from the sample. After backfilling the reaction vessel with argon, the reaction
was stirred for 2 hours before being diluted with a mixture of acetonitrile and water. The
catalyst immediately precipitated and was removed by centrifugation. The supernatant was
purified by HPLC. Purified samples were treated identically to those of purified heptaNaq
and P2Naq, above.

A.5 Uncommon Characterization Methods
A.5.1 Determination of Enantiomeric Excess of the Synthesis of Naq
Enantiomeric excess was determined using a Daicel Crownpak CR(+) analytical
HPLC column. A solution of 6 in 15% (v/v) aqueous methanol with 0.1% TFA was applied
to the column and eluted using the same solvent. The eluent was monitored at 240 nm.
Integration of the peaks resulting from the two enantiomers was used to determine the ee of
93%.
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A.5.2 Determination of Molar Absorptivity of heptaNaq
Dry heptaNaq(OMe/OMe) was dissolved in pH 7.4 buffer (100 mM sodium
phosphate) at various concentrations; absorbance spectra of solutions known dilution of
these samples were taken. The concentrations of nitrogen in the original solutions and the
buffer were determined by Kjedahl Analysis at Galbraith Laboratories, Inc. The molar
absorptivity (ε) at 280 nm is ~3070 M-1 cm-1 and at λmax (301 nm) is ~5065 M-1 cm-1. A
similar procedure was used to determine the molar absorotivity of deproected P2Naq.

A.5.3 Spectroelectrochemistry
A schematic representation of the electrochemical cell
that was used for the spectroelectrochemistry experiments is
depicted in Figure A.1. The cell consisted of two 2 x 1 cm gold
slides, a Ag-AgCl electrode (Mircoelectrodes Inc.) and a Pt slide,
used as working, reference and counter electrodes, respectively.
The gold slides were in electrical contact via a gold wire placed in
between them and located on the top cell while a piece of Teflon
(1.0 mm thick) was used on the bottom.

The Pt slide was

separated from the working gold by a Teflon block with a
thickness of 2.0 mm. A Pt wire with a flattened tip was squeezed
Figure A.1. Schematic of
spectroelectochemical
cell
built by José Cerda. The
light path passes through
the gold slides at left.

in between the Pt slide and the Teflon block and used as an
electrical lead. The tip of the Ag-AgCl microelectrode was held
on top of the Teflon block as close as possible to the surface.

The typical sample volume that was used in the cell was 200 -300 mL. Most of the sample
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was located in between the gold slides while the remaining solution made contact with the
other two electrodes. The electrochemical cell was positioned in the spectrometer so that
the UV/vis light beam was centered in between the two gold slides containing the majority
of the sample.
Spectroelectrochemical potentials were set using a BAS 100B workstation
potentiostat (Bioanalytical Systems, Inc., W. Lafayette, IN). To prevent protein aggregation
on the gold surface of the working electrode, the slides were coated with 1-mercapto-6hexanol. Gold slides are polished with 0.05 mm alumina and rinsed with deionized water,
followed by soaking in an ethanol solution containing 2 mM of 1-mercapto-6-hexanol for a
period of 24 hours. During the measurements, the solution was kept under oxygen-scrubbed
argon atmosphere. The samples all contained approximately 50 mM peptide diluted from
the stocks using buffered solutions at a variety of pHs and 5 mM each of the mediators
indigotrisulphonate (ITS; Em, pH 7.0 -90 mV), pyocyanine (PYO; Em, pH 7.0 -34), and phenazine
ethylsulphonate (PES; Em, pH 7.0 55 mV). Spectra were collected on a Perkin Elmer Lambda 35
UV/Vis spectrometer in the 230 to 600 nm range at 20 ºC. For each potential step, various
spectra were acquired until no change was further observed, i.e. until equilibrium was
reached; experiments were preformed in both the reductive and oxidative directions with
each sample with no apparent irreversibility over the pH range examined. The time interval
between potential steps ranged anywhere from 5 to 20 minutes. The normalized difference
in absorbance between 243 nm and 252 nm as a function of redox potential was fit to eq. 1
with Kalaidegraph 4.0 (Synergy Software, Reading PA), derived from the Nernst equation5

Frac. Reduced = O +
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where O is an offset (approximately 0); Δ is the total change in
fraction reduced (approximately 1); Eh is the applied potential; Em is
the measured midpoint potential; 58 mV is the thermal factor at 20
ºC; 2 is the number of electrons (allowing the number of electrons
to float did not significantly improve the fits). Solutions at a variety
of pHs all contained 100 mM KCl and 20 mM respectively of citric
acid (pH 5.22), MES (pH 5.97), PIPES (pH 6.79), HEPES (pH
7.52), and CHES (pH 8.33).

	
  

Figure
A.2.
New
spectroelectrochemical
cell. See text for details.

A.5.4 New Spectroelectrochemical Cell
While the cell in Figure A.2 was not used to collect data presented in this work, it
nevertheless represents some advance over the previously described cell. It is significantly
easier to construct and maintain under an inert atmosphere for low potential observations.
The cell consists of a custom quartz cuvette designed to minimize the volume of the analyte
solution while allowing use of the full beam width of Varian Cary 50 Spectrophotometers.
The electrodes are constructed into a Teflon backed silicon septum which inserts into a
standard GL14 cap. The working electrode is a large homemade platinum mesh (0.7 cm*1.5
cm), the counter electrode is a coiled platinum wire separated from the analyte solution by a
vycor glass frit and the reference is a Ag-AgCl electrode (Mircoelectrodes, Inc.). The solution
can be stirred from the side with a conventional or rare-earth stir bar without disruption of
the measuring beam that passes along the bottom of the sample volume.
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A.5.5 Cylcic Voltammetry of heptaNaq in DMF
Dried fully deprotected heptaNaq was dissolved in anhydrous dimethylformamide to
approximately 300 mM. Tetrabutylammonium hexafluorophosphate was added to 100 mM.
Cyclic voltammetry experiments were performed in an anaerobic glovebox using a BAS
100B workstation potentiostat. A Pt electrode (1.6 mm diam) was used as the working
electrode, a Ag wire was reference, and a Pt wire as the auxiliary electrode. Internal
referencing was to ferrocene.6 At each scan rate, at least five scans were preformed to ensure
stability of the system.

A.6 Chemical Ligation Methods
Chemical ligation followed the protocol described by Johnson et al.7 Briefly, after
expression of the BTX-intein fusion and standard purification over a Co-NTA Talon Resion
Affinity column, the BTX-intein fusion was dialyzed into 4 L pH 9 buffer (20 mM CHES,
300 mM KCl) twice and concentrated to a few mL. The BTX-mensa thioester was captured
by adding solid sodium mercaptoethanesulfonate to 50 mM to the concentrated sample of
the BTX-intein fusion. This reaction was briefly evacuated to eliminate some of the air
above the sample and reacted, without stirring, for ~20 hrs under argon at room
temperature. After the reaction was complete, the BTX-mensa thioester was purified on a
Superdex 75 size exclusion column equilibrated to pH 7.5 (10 mM K2PO4). To eliminate
some of the salt from the samples, fractions containing the BTX-mensa thioester were
concentrated and diluted against water. Lyopholization gave the dry BTX-mensa powder
with a small amount of salt contaminant. The thioester and peptide containing an N-terminal
cysteine residue (like BT0.4) were individually dissolved in a minimal volume of denaturing
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buffer (6 M GdnHCl, 200 mM K2PO4, pH 7.5) and their concentrations determined by
absorbance using the proper molar absorptivities of the chromophores at 280 nm (Naq
3065, Trp 5690). The thioester and cysteine peptide were then combined in a 1:2 molar ratio
and solid TCEP, to 50 mM, and mercaptophenylacetic acid, to 200 mM, were added. The
solution was then brought to the reaction pH (7.5) with microliter volumes of 3 M NaOH.
The solution was then flash frozen and freeze-pump-thawed three times to remove residual
oxygen from the reaction vessel. Back filling with argon, the reaction was stirred for ~24
hours at room temperature and purified on HPLC. It was sometimes necessary to add DTT
to the solution prior to HPLC to ensure that there were no disulfide crosslinked species in
solution.

A.7 Iron(III) 2,4-Dicyanodeuteroprotoporphyrin IX Synthetic Methods
The synthesis of iron(III) 2,4-dicyanodeuteroprotoporphyrin IX described in this
section is based upon the general approach of Caughey et al.8 and La Mar et al.9 While the
dicyanodeuteroporphyrin was not used in the work described in this dissertation, its
synthesis proved necessary for a variety of other projects involving heme-binding maquettes,
which may be reported elsewhere. The changes to the original syntheses take advantage of
recent developments in the selective modification of the porphyrin ring system resulting in a
synthesis that allowed a much higher throughput of material.
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A.7.1 Protoporphyrin IX dimethyl ester

Hemin (2.5 g) was dissolved in 10 mL pyridine and diluted to 150 mL with methanol.
6.0 g ferrous sulfate was added. Using a dropping funnel, to this stirred reaction, 25 mL of
thionyl chloride was added quickly enough to cause the reaction to reflux without external
heating. The reaction vessel was left open to the atmosphere until the thionyl chloride
addition was complete to prevent over pressurization, which can cause the vessel to shatter.
After the addition of the thionyl chloride the reaction was stirred under argon for 30 minutes
allowing it to cool to room temperature at which point argon was bubbled through the
solution for and additional 30 minutes to remove excess HCl and other volatile acids. It is
imperative that the workup be completed as quickly as possible as the free base is sensitive
to aqueous acid. The reaction was quenched with 25 mL H2O and diluted with 300 mL
chloroform. The chloroform solution was washed with 300 mL H2O. The water wash was
extracted three times with 100 mL chloroform and the organics combined and further
washed with 300 mL H2O six times followed by neutralization with 300 mL 1 N NH4OH
twice. After drying with magnesium sulfate, the organics were removed in vacuo. The product
protoporphyrin IX dimethyl ester was confirmed by UV/vis spectroscopy and 1H NMR.
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A.7.2 2,4-Diformylprotoporphyrin IX dimethyl ester10

The synthesis of 2,4-diformylprotoporphyrin IX dimethyl ester reported by Kahl et
al.10 was used with modification. In the first reaction the volatile and toxic osmium tetraoxide
was replaced by the slightly less toxic and non-volatile potassium tetroxide; otherwise both
reactions and workups were identical to that reported.
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A.7.3 2,4-Dicyanoprotoporphyrin IX dimethyl ester

2,4-Diformylprotoporphyrin IX dimethyl ester (388 mg) was dissolved in 100 mL
pyridine to which was added 10 equivalents of hydroxylamine hydrochloride (450 mg). After
heating at 80 °C for 30 minutes an excess of POCl3 (7 mL) was added dropwise. The
reaction was allowed to stir at this temperature for an additional 3 hours at which point the
reaction appeared complete by alumina TLC (eluent chloroform). The reaction was cooled
to room temperature and quenched by dropwise addition of saturated aqueous NaHCO3.
The product was extracted into chloroform which was dried with magnesium sulfate and
removed in vacuo. Purification was effected using an alumina column (eluent
CHCl3/ClCH2CH2Cl 8:2) followed by precipitation from chloroform/methanol twice. The
product (253 mg, 65%) was confirmed by MALDI-TOF MS and IR spectroscopy.
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A.7.3 Iron(III) 2,4-Dicyanoprotoporphyrin IX dimethyl ester

Iron(III) 2,4-Dicyanoprotoporphyrin IX dimethyl ester was synthesized following
the iron insertion procedure of Smith et al.11 Better degassing of the reactants was effected by
several freeze-pump-thaw cycles. Incomplete reactions as determined by TLC were
recommitted to the reaction to increase yield with no obvious ill effects.
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A.7.4 Iron(III) 2,4-Dicyanoprotoporphyrin IX

Removal of the methyl esters from iron(III) 2,4-dicyanoprotoporphyrin IX dimethyl
ester was effected by refluxing this compound in THF in the presence of saturated lithium
iodide for 48 hours; reaction progress was checked by alumina TLC (eluent CHCl3 with
0.1% MeOH). The reaction was quenched by the addition of 200 mM aqueous HCl and the
product was extracted into a methylene chloride. This extraction was eased by addition of
small portions of methanol to the extraction until the product became soluble in the organic
layer. The organics were washed once more with 200 mM aqueous HCl followed by brine. It
was important that the organics not be dried using magnesisum or sodium sulfate as this was
associated with the formation of intractable aggregates. The organics were removed in vacuo.
Attempts at crystallization failed and the product was deemed pure enough by UV/vis
spectroscopy for use in the maquettes.
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